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Abstract 
The lens of the eye needs to be completely transparent in order to allow all light 
entering the eye to reach the retina. This transparency is maintained by the highly 
ordered structure of the lens proteins the crystallins. Any disruption to the lens 
proteins can cause an opacity to develop which is known as cataract. During cortical 
cataract formation there is increased truncation of the lens crystallins. It is believed 
that overactivation of calcium-dependent cysteine proteases, the calpains, is 
responsible for the increased proteolysis of the crystallins seen during 
cataractogenesis. Within the ovine lens there are three calpains, calpain 1, 2 and the 
lens specific calpain Lp82. The aim of this thesis was to determine the changes in the 
lens proteins during ageing and cataractogenesis, and to establish the role of the 
calpains in these processes. 
 
Calpain 1 and 2 were purified from ovine lung and Lp82 was purified from lamb 
lenses using chromatography. Activity and presence of the calpains was determined 
by using the BODIPY-FL casein assay, gel electrophoresis, Western blot and casein 
zymography. Changes in the lens proteins, specifically the crystallins, were visualised 
using two-dimensional electrophoresis (2DE). Lenses from fetal, 6 month old and 8 
year old sheep were collected, as well as stage 0, 1, 3 and 6 cataractous ovine lenses. 
The proteins from the lenses were separated into the water soluble and urea soluble 
fractions and analysed by 2DE. Mass spectrometry was used to determine the masses 
and therefore modifications of the crystallins. Finally, the individual crystallins were 
separated using gel filtration chromatography and incubated with the purified calpains 
in the presence of calcium. The extent of the proteolysis was visualised using 2DE 
and truncation sites determined by mass spectrometry. 
 
 ii
Purification of the calpains resulted in samples that were specific for each calpain and 
could be used in further experiments. 2DE analysis showed that there were changes to 
the crystallins during maturation of the lens. The α-crystallins become increasingly 
phosphorylated as the lens ages and a small amount becomes truncated. The β-
crystallins were also modified during ageing by truncation and deamidation. When 
crystallins from cataractous lenses were compared using 2DE there were changes to 
both the α- and β-crystallins. The α-crystallins were found to be extensively truncated 
at their C-terminal tail. Four of the seven β-crystallins, βB1, βB3, βB2 and βA3, 
showed increased truncation of their N-terminal extensions during cataract formation.  
 
All three calpains truncated αA and αB-crystallin at their C-terminal ends after 
incubation. Calpain 2 and Lp82 each produced unique αA-crystallin truncations. All 
three calpains truncated βB1 and βA3 and calpain 2 also truncated βB3.  
 
When the truncations from the calpain incubations were compared to those seen 
during cataract formation, many of the truncations were found to be similar. Both the 
unique truncations from calpain 2 and Lp82 were found in cataractous lenses, with the 
Lp82 more obvious in the 2DE. The β-crystallin truncations found after incubation 
with the calpains were similar to those found during cataractogenesis. 
 
In conclusion this study documents the changes to the ovine lens during maturation 
and cataractogenesis and indicates a role for the calpain family in the increased 
proteolysis observed in the ovine cataract. 
 
Keywords: Cataract, calpain 1, calpain 2, Lp82, α-crystallin, β-crystallin, lens, 
ageing, 2DE, sheep, Fast protein liquid chromatography,  
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   Chapter 1 
Literature Review 
 
1.1 Introduction 
 
The primary role of the lens in the eye is to transmit and focus light onto the retina 
which contains the light sensing cells of the eye. For this to occur, the lens needs to be 
completely transparent. Any change to the transparency of the lens leads to scattering 
of light entering the eye and subsequent loss of vision. This opacification of the lens is 
known as a cataract. The opacification can become so severe that no light enters the 
eye resulting in blindness. The causes of cataracts have been extensively studied 
throughout the world. However the aetiology of the diseases is not entirely 
understood.  
 
 
Figure 1-1 Cross Section of an eye 
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1.2 The lens 
 
The lens is a transparent avascular tissue located in the anterior section of the eye 
behind both the pupil and iris (Figure 1-1). The lens is encased in a capsule. Attached 
to the capsule at the equatorial region are zonular fibres. These fibres connect the lens 
to the ciliary muscle and hold the lens in place. The zonular fibres and ciliary muscle 
are also involved in helping the lens to focus the light entering the eye. 
 
The posterior surface of the capsule is in contact with the vitreous humor and the 
anterior surface with the aqueous humor. These provide the nutrients required for lens 
growth and development. 
 
The role of the lens is to focus light onto the retina. This requires the lens to be 
transparent and have a high refractive index. The transparency of the lens is achieved 
by the highly ordered structure of soluble proteins in the lens called the crystallins. 
The arrangement of the crystallins as well as their high concentration helps contribute 
to the high refractive index of the lens. 
  
The lens consists of two types of cells, epithelial cells and elongated fibre cells. The 
epithelial cells are found in a single layer along the anterior surface of the lens (Figure 
1-2).  The epithelial cells and immature fibre cells are the only fully metabolically 
active cells in the lens, and are the only cells that can synthesise protein.  The fibre 
cells are found on the posterior surface and the internal region of the lens and provide 
the bulk of the lens cells. 
 
The lens has a unique growth and development pattern. Epithelial cells migrate from 
the germinative zone of the anterior surface to the equatorial elongation region where 
they differentiate into fibre cells. During this differentiation the epithelial cells 
elongate, their intracellular organelles are lost and they start synthesising the fibre cell 
specific crystallins and other fibre cell specific proteins. The removal of intracellular 
organelles is essential for the clarity of the lens as even small organelles will scatter 
light. As more fibre cells are formed they layer on top of existing fibre cells, 
producing a structure which looks like an onion. This process means that the cells in 
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the nucleus of the lens are the oldest and those closest to the equator are the youngest. 
As fibre cells are not turned over, the cells and their contents in the centre of the lens 
are as old as the lens and organism itself. The fibre cells in the nucleus of the lens 
contain a high concentration of tightly compacted crystallins. This leads to the high 
refractive index found in the centre of the lens. Nuclear cell morphology is similar to 
that of cortical cells but they are more tightly packed and smaller (Davson, 1980).  
 
 
Figure 1-2 Drawing of cross section of a lens, adapted from Gupta et al., (2005). The capsule 
surrounds the lens and houses the lens. The epithelial cells migrate from the centre of the 
anterior surface towards the equatorial region. There they differentiate into cortical fibre cells 
and eventually become nuclear fiber cells (note individual nuclear fibre cells are not shown in 
this diagram). 
 
On the anterior and posterior surface of the lens there are visible Y-shaped lines 
known as suture lines.  These lines are the junction points where fibre cells from 
opposite sides of the lens meet.  
 
For the lens to focus light from both distant and near objects it needs to be able to 
change its shape which either increases or decreases the refractive power of the lens. 
This change in shape is known as accommodation and involves the ciliary muscles 
and zonular fibres. When the eye focuses on a near object the ciliary muscle around 
the lens contract towards the lens, this causes the zonular fibres to relax. Relaxation of 
the zonular fibres results in the lens becoming more spherical. When the ciliary 
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muscles contract they pull on the zonular fibres taut which causes the lens to flatten. 
This occurs when focusing on distant objects (Bray et al., 1999). 
 
1.3 Crystallins 
 
Protein makes up to 30-35% of the lens wet weight and of these proteins 90% are 
crystallins (Hoenenwarter et al., 2006). The unique packing of the crystallins provides 
both the clarity and the refractive index of the lens. The crystallins can be separated 
into 3 families: the α, β and γ crystallins. The α-crystallins are a family and the β and 
γ crystallins are closely related and belong to the same super family of proteins.  
 
1.3.1 α-Crystallin 
 
Crystallins are the most common protein in the lens and of the crystallins, α-crystallin 
is the most abundant. It is a multimeric protein made up of two types of subunit, αA-
crystallin and αB-crystallin. They are coded for by different genes on different 
chromosomes but share approximately 60% homology in protein sequence (Graw, 
1997). αA crystallin is a lens-specific protein, whereas αB-crystallin is found in a 
variety of tissues outside the lens; including the brain, heart, muscle and kidney 
(Iwaki et al., 1990). In sheep these subunits have masses of 19875Da for αA and 
20148Da for αB (Robertson et al., 2005). The larger αB-crystallin is more basic than 
the smaller αA. The ovine α-crystallin subunits share 43% sequence homology to each 
other and there are multiple areas that contain conserved residues, including the C-
terminal region. Comparison of α-crystallin sequences has shown that the genes have 
evolved slowly, a change of 3% per 100 million years compared with haemoglobin 
which changes at a rate of 20% per 100 million years (de Jong and Hendricks, 1986). 
Sequences for ovine αA and αB have been determined (Figure 1-3), they share 
99.42% and 98.29% sequence homology with bovine α-crystallins respectively, and 
93.46% and 97.14% sequence homology with human αA and αB crystallins 
respectively (Robertson et al., 2008). 
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Figure 1-3 Protein Sequences for ovine, bovine and human αA and αB crystallin. Sequence 
homologies to ovine αA are 99.42% and 93.46% for bovine and human αA respectively. Ovine 
αB sequence homology is 98.29% and  97.14% for bovine and human αB respectively. Sequences 
were acquired from Genbank (http://www.ncbi.nlm.nih.gov/genbank). Genbank Accession 
numbers, αA ovine: AY819022, bovine: NM_174289 and human: NM_000394, αB ovine: 
AY819023, bovine: NM_174290, and human: NM_001885. 
 
The secondary structure of the α-crystallins have not been fully elucidated due to the 
inability to crystallise the α-crystallin subunits. Comparison of sequences amongst 
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other proteins has shown that both αA-crystallin and αB-crystallin are homologous 
with members of the small heat shock protein (sHSP) family (Ingolia and Craig, 
1982). This led to the discovery of a common 80 amino acid motif amongst α-
crystallin and the sHSPs termed the α-crystallin domain (Figure 1-4) (Caspers et al., 
1995). Predictions from circular dichroism and infrared measurements are that α-
crystallin contains predominantly β-sheet and a small amount of α-helix (Thomson 
and Augusteyn, 1989). Although the tertiary structure is unknown it can be predicted 
from other members of the sHSP family and in particular the heat shock protein, hsp 
16.9 (Figure 1-4), which has an ordered N-terminal extension (green) and the α-
crystallin domain (red). The α-crystallin domain contains a C-terminal extension, β-
sheet sandwich in the middle and an interdomain loop at the top (van Montford et al., 
2001).  
 
 
Figure 1-4 Structure of hsp 16.9.  The ordered N-terminal region is in green. The α crystallin 
domain is in red containing the C-terminal region, seven stranded β-sandwich and an 
interdomain loop (top). Adapted from van Montford et al., (2001) 
 
In human lenses the ratio of αA to αB crystallin varies with age. In the fetal lens the 
ratio is 2:1 which decreases to 3:2 in the adult lens (Ma et al., 1998). Although the 
ratio of the two types of α-crystallin are known, the exact molecular weight of α-
crystallin molecules in the lens is unknown.  This is due to the polydispersity of α-
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crystallin in the lens, and there is also a large variation in the size of α-crystallin 
isolated from the lens. Some papers report a size of approx 200kDa (Thomson and 
Augusteyn, 1988) while others report the size of α-crystallin in the mega Dalton range 
(Spector et al., 1971). This large variation in the molecular size of α-crystallin is due 
in part to the differences in isolation techniques and conditions. For example, isolation 
of α-crystallin at body temperature reveals an average molecular weight of 320kDa 
whereas isolation at 5ºC result in average molecular weights of 800kDa (Augusteyn, 
2004). Another cause for the various sizes of α-crystallin molecules is that the size of 
the protein aggregates increase as the lens ages. Therefore α-crystallin in the nucleus 
of the lens is larger than that in the cortex and epithelium (Augusteyn, 2004). This is 
thought to be due to the increased packing of protein and removal of water that is seen 
in the nucleus. This is required for creating the refractive index gradient. Research 
continues to determine the lowest molecular weight subunit consisting of αA and αB 
that make up the larger proteins seen across the lens. 
 
A major breakthrough in α-crystallin research occurred in 1992 when it was 
discovered that α-crystallin can act as a chaperone (Horwitz, 1992). Horwitz showed 
that purified bovine α-crystallin could prevent the thermal aggregation of some 
enzymes as well as β/γ-crystallins. Since this time a large amount of α-crystallin 
research has studied the chaperone effect and its role in the lens.  
 
In order for the lens to remain transparent the crystallins must remain stable and in 
solution. As there is no protein turnover to remove and replace denatured crystallins 
another system must be in place to prevent their aggregation. Otherwise these 
aggregates would lead to cataract formation. It was thought initially that α-crystallin 
may bind β and γ-crystallin as they became denatured and prevent aggregation and 
precipitation of the crystallins and hence prevent cataracts forming (Horwitz, 1992). 
As α-crystallin comprises approximately 50% of the lens protein it would be logical to 
assume that α-crystallins could act as a sink to bind and hold in solution denatured 
proteins in the lens and so prevent their aggregation. Once this ‘sink’ of α-crystallin is 
used up proteins would start to aggregate and cataracts would form (Horwitz, 1992).  
There is substantial evidence that α-crystallin binds to both β and γ-crystallins and 
prevents their aggregation as well as that of other lens proteins (Horwitz, 2003). Once 
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bound to α-crystallin the denatured protein is not refolded and released like the action 
of other sHSP (Bloemendal et al., 2004). In most cells α-crystallin directs the bound 
proteins to either proteolysis machinery or to other chaperones for refolding and 
release (Bloemendal et al., 2004). In the lens this is thought not to occur as the fibre 
cells are not in a metabolically active state and that the α-crystallins store the 
substrates in a partially folded state.  
 
The exact mechanism of chaperone action by α-crystallin is unknown. It is known that 
the quaternary structure of α-crystallin is highly dynamic with a temperature 
dependent subunit exchange (Bova et al., 1997). In α-crystallin oligomers the 
hydrophobic areas of individual subunits are buried. However the hydrophobic areas 
are exposed during subunit exchange, which is the reversible exchange of subunits 
between oligomers. This allows for substrates to bind to the α-crystallin subunits 
(Andley, 2007). Subunit exchange is increased at physiological temperatures which 
results in more hydrophobic faces being exposed to potential target proteins. 
Interestingly increased temperatures result in a shift towards smaller oligomers which 
increases the number of hydrophobic sites available (Andley, 2007). This would 
enhance the chaperone ability of α-crystallin, which would be required as proteins 
start to denature at higher temperatures. 
 
Many studies have been conducted to determine the functional sequences in α-
crystallins that are required for chaperone activity. Using protein pin array Ghosh et 
al., (2005), showed a number of sequences within the α-crystallin core domain had the 
ability to bind normal and heated (denatured) proteins. They used β-crystallins, γD 
crystallin, alcohol dehydrogenase and citrate synthase as target proteins. The 
consensus from all the experiments resulted in 7 common chaperone sequences that 
interacted with at least 3 or more of the proteins. Two sequences were found in the N- 
terminus, 4 were in the α-crystallin core domain and one was in the C-terminal 
extension. Interestingly 5 of 7 of these sequences are also involved in subunit-subunit 
interactions within αB-crystallin oligomers (Ghosh and Clark, 2005). 
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1.3.2 β- and γ-Crystallins 
 
The β and γ crystallins are structurally and evolutionarily related and are part of the 
β/γ-crystallin super family. The common element amongst the β/γ super family is that 
the protein structures are all built on a Greek Key motif. The differences between 
them are that the β-crystallins are oligomeric and have N-terminal extensions, whilst 
the γ-crystallins exist as monomers and lack an N-terminal extension. 
 
There are two types of β-crystallin, acidic (βA1, βA2, βA3 and βA4) and basic (βB1, 
βB2 and βB3), with the basic proteins having a C-terminal extension (Bloemendal et 
al., 2004). βA3 and βA1 proteins are coded from the same gene, where the 
transcription of βA3 starts upstream of βA1 and therefore the only difference between 
the proteins is the length of the N-terminal extension. As a consequence of this βA1 
and βA3 are often represented as the same protein as discerning between them is 
difficult. β-crystallin expression is varied throughout development and they are fibre 
cell specific.  
 
β-crystallin assemblies separate into two categories based on elution profiles from gel 
permeation chromatography: βH- which represents the hexamers/octamers and βL 
which represents dimers. There is a gradient of β-crystallin assemblies across the lens 
from βL in the cortex to βH in the nucleus. This is due to the increased crystallin 
packing required in the centre of the lens for refractive index. 
 
There are 7 γ-crystallins found in mammalian lenses, γA-F and γS. γA-F are closely 
related and are coded for within a linked gene cluster with a similar sequence. The 
other γ-crystallin is γS which is coded for on another chromosome and has a different 
structure and sequence to the other 6 γ-crystallins. The γ-crystallins are monomeric 
and are the smallest crystallins with molecular weights of around 20kDa. They are 
also the most basic of the crystallins (Graw, 1997). The γ-crystallins are fibre cell 
specific. They are expressed early in lens development and their expression decreases 
postnatally, as a consequence of this they are found in higher levels in the nucleus 
compared to the cortex. The proportion of different γ-crystallins in the lens varies 
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widely according to the species studied. Those species that require a ‘hard’ lens (e.g. 
rodents) contain all 7 γ-crystallins whereas those species requiring ‘soft’ lenses (e.g. 
humans) only contain γC and γD in high concentrations. 
 
1.3.3 Post-translational modifications 
 
Crystallins are not replaced throughout the lifetime of a lens. Therefore they are 
extensively post-translationally modified to continue their development within the 
lens. There are 4 major methods of modifying crystallins: deamidation, 
phosphorylation, disulfide bond formation and truncation. Early studies suggested that 
post-translational modification was a marker for lens ageing and increased as the lens 
matured. However modifications in human lens have been observed in lenses as 
young as 3 years old and the modifications seen in a 17 year old lens are very similar 
to that in a 54 year old lens (Lampi et al., 1998).  
 
Deamidation is a common post-translational modification where asparagine is 
converted to aspartate. It is the most common post-translational modification of lens 
crystallins (Wilmarth et al., 2006, Hains and Truscott, 2007a). Chemically, 
deamidation is the conversion of the –NH2 group of asparagine to –OH. This gives 
the amino acid a mass increase of 1Da and a decrease in the isoelectric point. The 
mass change of only 1 made deamidation difficult to detect in early mass 
spectrometry experiments as the mass change was within the error associated with the 
technique. However with more powerful mass spectrometers and software, 
deamidation can now be readily detected and appears to be an important modification 
of the crystallins. Currently the exact role of deamidation in proteins is uncertain but it 
is thought the process may be a precursor to proteolytic cleavage. αA, βB1, βB2, 
βA3, βA4, and γS are the main crystallins that undergo deamidation in the adult 
human lens (Lampi et al., 1998).  
 
Phosphorylation of proteins occurs in many cellular processes and is evident in the 
lens. Phosphorylation occurs on serine, threonine, histidine and tyrosine residues. In 
the lens the major proteins phosphorylated are αA and αB-crystallin (Hoehenwarter et 
al., 2006). To a lesser extent some β-crystallins become phosphorylated namely, 
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βA1/A3, βA4, βB1, βB2 and βB3 (Hoehenwarter et al., 2006). The exact role of 
phosphorylation in crystallin maturation is unknown. Research suggests that α-
crystallins chaperone ability is modified with phosphorylation (Horwitz, 2003, 
Aquilina et al., 2004, Ecroyd et al., 2007). 
 
Disulfide bond formation is the bonding of two thiol moieties from cysteine amino 
acids. The disulfide bonds can be within protein molecules to stabilise tertiary protein 
structures or can be between different proteins. γS crystallins contain disulfide bonds 
which can bind monomers to form a dimer, whose function is unknown (Bloemendal 
et al., 2004). 
 
Almost every crystallin in the lens undergoes truncation during its lifetime. In 
particular the α-crystallins are truncated at the C-terminal, and the β-crystallins are 
truncated at both their N- and C- terminal ends. Many of the truncations of α-
crystallins have been shown to be calpain specific in mouse (Ueda et al., 2002a). This 
study showed that both calpain 2 and Lp82 are responsible for the truncations seen 
during ageing on the C-terminal arm of α-crystallin (For more see 1.4.1). 
 
1.4 Cataract 
 
Cataracts are described as opacification of the lens of the eye that partially or totally 
scatters and/or absorbs the light entering the eye resulting in loss of some, if not all of 
vision. Cataracts are the leading cause of blindness accounting for 50% of the total 
blindness in the world (Hammond, 2001). There are numerous types of cataracts, that 
can be classified by (i) their location in the lens e.g. nuclear, cortical, posterior, 
anterior, or (ii) their colour, e.g. white through to yellow to brown/black or (iii) cause 
e.g. age related, diabetic cataracts (Hammond, 2001). Many cataracts are mixed and 
have both corical and nuclear invovlment. Nuclear cataracts are the most common age 
related cataract and accounted for 60% of cataracts in the Beaver Dam Eye study 
whilst cortical cataracts made of 30% of the cataracts (Klein et al., 2002).  
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Age is the most common factor contributing to cataractogenesis. The Beaver Dam 
Eye Study showed that 45% of 55-64 year olds and 88% of those aged over 75 have 
cataracts (Klein et al., 2002). 
 
This thesis will concentrate on changes in crystallins as a factor in the formation of 
cataracts and in particular the truncation of the crystallins. As mentioned above 
crystallins can undergo a number of post-translational modifications including 
truncation, deamidation, phosphorylation and disulfide bond formation. All of these 
modifications to crystallins have been implicated in cataractogenesis. 
 
1.4.1 α-Crystallin 
 
Phosphorylated α-crystallin has been found in both normal and cataractous human 
lenses (Lund et al., 1996). Interestingly in a recent study α-crystallin was shown to be 
phosphorylated in normal lenses but not in the urea soluble fraction of age matched 
cataractous lenses (Hains and Truscott, 2007a). The authors postulated that this is 
because the phosphorylated α-crystallins were involved in other reactions and were 
therefore not detectable in the urea soluble proteins from a cataractous lens. As yet the 
exact role of phosphorylating crystallins is not known.  There is evidence that 
phosphorylation of α-crystallin has an effect on its chaperone abilities. Some studies 
suggest phosphorylation decreased chaperone activity (Kamei et al., 2001) whilst 
others have concluded that there was an increase in activity (van Boekel et al., 1996).  
This makes it difficult to establish how the phosphorylation of crystallins affects 
cataract formation. 
 
Truncation of the lens crystallins during the formation of cataracts is well 
documented. Recently, Hoehenwater et al., (2006) conducted a review of the eye lens 
proteomics and documented all known changes to the crystallins in normal ageing and 
cataract in humans, mice, rats and cows. 
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Crystallin Total Truncations Normal Lens Cataract Lens 
αA 20 19/20 11/20 (1) 
αB 15 15/15 5/15 (0) 
Table 1-1 Summary of α-crystallin truncations from Hoehenwarter et al., (2006).  Table shows 
the total truncations from human, mouse, rat and bovine species, of the total truncations the 
table indicates those that are found in normal lenses of any age and those found in cataractous 
lenses. Numbers in brackets indicates number of truncations unique to the cataract lens. 
 
As of 2006 there have been 20 reported truncations of αA-crystallin in human, bovine, 
mouse and rat lenses (Table 1-1), of these 20 truncations 19 have been found in 
normal lenses and 11 found in cataractous lenses. This overlap suggests that αA-
crystallins from cataractous lenses are not that different to those found in normal 
lenses. What is interesting about the truncations found in the cataract lens is that all 11 
truncations are found at the C-terminal end of αA-crystallin (amino acids 118-173) 
and that only 1 truncation of αA-crystallin is unique to cataract. All the others are 
found at some stage in the ageing lens. This table and summation does not quantify 
the relative amounts of the proteins in normal and cataractous lenses only to confirm 
the presence of the species. Therefore some modifications reported may only be found 
in minor amounts within the lens. 
 
According to Hoehenwarter et al., (2006) there are 15 αB truncations found in the lens 
(Table 1-1). All 15 of these are found in the normal lens and 5 are found in 
cataractous lenses. The results were similar to αA-crystallin in that most of the 
truncations are found in the C-terminal end of αB-crystallin and none of the 
truncations are unique to cataracts.  
 
1.4.2 Chaperone function of α-crystallin 
 
The chaperone function of α-crystallin, where it binds denatured proteins and prevents 
them from becoming insoluble, is vital to maintaining lens transparency. Loss of this 
activity is suggested to play a role in the formation of cataract. During ageing of the 
lens there is a decrease in the chaperone activity of α-crystallin, with fetal bovine lens 
able to provide better protection to β-crystallins denatured by heat than aged bovine α-
crystallin (Horwitz et al., 1992). α-Crystallins’ chaperone function also varies across 
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the lens, with the cortical region, containing the youngest α-crystallin, providing 
better chaperone protection than the nuclear region which contains the oldest α-
crystallin within the lens (Augusteyn et al., 2002). 
 
Many modifications to α-crystallin within the lens could be attributed to this change 
in chaperone function both with age and across the lens, including glycation, 
deamidation, phosphorylation and proteolysis. For the purpose of this study only 
proteolysis and phosphorylation will be examined in further detail.  
 
As described above there is an increase in phosphorylation of the α-crystallins with 
ageing. There are conflicting results on the effect that phosphorylation has on 
chaperone function. Some studies show that phosphorylation has no effect on the 
chaperone function of α-crystallin (Wang et al., 1995, Augusteyn et al., 2002) whilst 
others report a change in chaperone function with either an increase (Ecroyd et al., 
2007, Ahmad et al., 2008) or decrease (Kamei et al., 2001, Aquilina et al., 2004) in 
activity. However it is important to note some of the studies that showed changes in 
chaperone function used a phosphorylation mimicking α-crystallin (Ecroyd et al., 
2007, Ahmad et al., 2008). Phosphorylation mimicking involves the production of 
recombinant α-crystallin incorporating charged residues at the places of normal 
phosphorylation, instead of using native α-crystallin with a phosphorous moiety on 
the affected residue. This places a limitation on the research’s application within the 
lens, whereas the studies that showed no change used native phosphorylated α-
crystallin. As a result of this, additional research is required to determine the role 
phosphorylation has in the lens and what effect phosphorylating α-crystallin has on 
the chaperone function that is so vital to lens transparency. 
 
Within the structure of both α-crystallins is the unstructured and flexible C-terminal 
tail, from residues 140-173/5 of αA/B-crystallin, which is essential for chaperone 
function. Many studies involving truncation and site-directed mutation of the C-
terminal tail have shown the importance of this region for chaperone activity. 
 
In 1993 Takemoto et. al., showed that removal of the C-terminal region of αA-
crystallin by tryptic digestion decreased the ability to protect alcohol dehydrogenase 
from heat induced aggregation. Further work by the same researcher identified that 
14 
the loss of residues 158-173 of αA resulted in decreased chaperone function 
(Takemoto, 1994). A similar study involving the use of calpain 2 to remove 11-12 
residues from the C-terminus of α-crystallin, showed that the truncated α-crystallin 
had reduced chaperone activity (Kelley et al., 1993). When αA-crystallin was cloned 
with the last 17 residues deleted there was a reduction in the chaperone function of the 
mutant (Andley et al., 1996). Removal of between 5 and 11 residues reduced the 
chaperone function of αA-crystallin and as more resides were removed the effect on 
chaperone function was more pronounced (Rajan et al., 2006, Aziz et al., 2007). 
Interestingly, the removal of the C-terminal serine of αA results in a protein with 
increased chaperone function (Aziz et al., 2007). Many studies on α-crystallin use 
site-directed mutagenesis to determine the role of specific regions, motifs and residues 
on chaperone function. Mutation of the final two C-terminal serines in αB-crystallin 
reduces its chaperone function (Plater et al., 1996). Insertion of charged residues into 
the C-terminal tail of αA-crystallin has no effect on chaperone function but the 
insertion of hydrophobic resides greatly reduces chaperone function (Smulder et al., 
1996). 
 
Recent work has focused on the role of the C-terminal extensions of αA and αB-
crystallin, in forming homo- and heteroaggregates (Kallur et al., 2007). This study 
researched the effect of the most common truncations in αA (αA1-172, αA1-168, αA1-162) 
on their ability to form homoaggregetes with wildtype αA and heterodimers with 
wildtype αB. It showed that removal of 1 or 5 residues from the C-terminal end of αA 
resulted in a two fold decrease in subunit interaction and that removal of 11 residues 
resulted in a six fold reduction in subunit interaction. The conclusion from this is that 
the formation of α-crystallin complexes is reduced with truncation of αA-crystallin C- 
terminal residues, leading to a reduction in the ability of α-crystallin to act as a 
molecular chaperone. 
 
All of this research clearly shows a role for the C-terminal region of the α-crystallins 
in chaperone function and any disruption to this region can have severe consequences 
on chaperone function.  
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1.4.3 β-Crystallins  
 
Truncation of crystallins is not limited to just α-crystallins, β-crystallins also undergo 
truncation during ageing and cataractogenesis. Table 1-2 shows the β-crystallins that 
undergo truncation and their incidence in the normal and cataract lens. The βA1/βA3 
species has been reported to be truncated 5 times in vivo (David et al., 1993, Lampi et 
al., 1997, Lampi et al., 1998, Srivastava and Srivastava, 1999).  Of these truncations, 
3 are found in normal lenses only and 2 are unique to cataractous lenses. βA3 alone 
has one truncation which is found in both cataractous and normal lenses (Shih et al., 
1998, Ueda et al., 2002b). Similarly βA4 only has one known truncation which is only 
found in cataractous lenses (David et al., 1993). The largest crystallin, βB1 has been 
shown to have 13 truncations of which 9 are in the normal lens and 4 in the 
cataractous lens only (David et al., 1993, David et al., 1994, David et al., 1996, Shih 
et al., 1998, Ma et al., 1998, Wilmarth et al., 2004). The β-crystallin results indicate 
that truncation occurs during normal maturation and ageing of the lens. However 
“incorrect” truncation is found in the cataractous lenses indicating that uncontrolled 
truncation of the β-crystallins may be one of the contributing factors to 
cataractogenesis.  
 
Crystallin Total Truncations Normal Lens Cataract Lens 
βA1/βA3 5 3/5 2/5 (2) 
βA3 1 1/1 1/1 (0) 
βA4 1 0/1 1/1 (1) 
βB1 13 9/13 4/13 (4) 
βB3 3 2/3 2/3 (1) 
βB2 2 2/2 0/2 (0) 
Table 1-2 Summary of β-crystallin truncations from Hoehenwarter et al., (2006).  Table shows 
the total truncations from human, mouse, rat and bovine species. This table indicates those that 
are found in normal lenses of any age and those found in cataractous lenses. Numbers in brackets 
indicates number of truncations unique to the cataract lens. 
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1.5 The Calpain Proteolytic System 
 
The calpains, previously known as calcium-dependent neutral proteases, are a family 
of calcium-dependent cysteine proteases. There are two major ubiquitously expressed 
calpains, calpain 1 (also known as μ-calpain) and calpain 2 (also known as m-
calpain), as well as other ubiquitous and tissue specific calpains. 
 
1.5.1 Calpain isoforms 
 
There are genes for 14 different calpains in the human genome. The major calpains 
are calpain 1 and calpain 2 which are distributed ubiquitously. The calpain family can 
be split into two groups the typical calpains and the atypical calpains (Table 1-3) 
(Suzuki et al., 2004).  The domain structure of the large subunit of the typical calpains 
is similar to that of the large subunit found in calpains 1 and 2. The typical calpains 
are calpains 1, 2, 3, 8, 9, 11, 12, 13 and 14.  The atypical calpains do not have the 
calmodulin like EF hands in domain IV of the large subunit and some lack domain IV 
altogether. Atypical calpains also cannot form a dimer with the small 30kDa subunit. 
The atypical calpains are 5, 6, 7, 10 and 15. It is important to note that the small 
subunit is also known as calpain 4. 
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Calpain Other Names Tissue 
Distribution 
Typical Reference 
Calpain 1 μ-calpain Ubiquitous Yes (Cong et al., 1989) 
Calpain 2 m-calpain Ubiquitous Yes (Cong et al., 1989) 
Calpain 3a p94 Muscle Yes (Sorimachi et al., 1989) 
Calpain 8 nCL-2 Stomach Yes (Sorimachi et al., 1993) 
Calpain 9 nCL-4 Digestive Tract Yes (Lee et al., 1998) 
Calpain 11 - Testis Yes (Dear et al., 1999) 
Calpain 12 - Hair follicle Yes (Dear et al., 2000) 
Calpain 13 - Ubiquitous Yes (Dear and Boehm, 
2001) 
Calpain 14 - - Yes (Dear and Boehm, 
2001) 
Calpain 5 hTRA-3, nCL-3 Ubiquitous No (Dear et al., 1997) 
Calpain 6 CANPX Muscle No (Dear et al., 1997) 
Calpain 7 PalBH Ubiquitous No (Futai et al., 2001) 
Calpain 10 - Ubiquitous No (Horikawa et al., 2000) 
Calpain 15 SOLH Ubiquitous No (Kamei et al., 1998) 
Table 1-3 Family of Calpains and their distribution within tissues. 
 
An important member of the calpain family of proteases is calpain 3, which has a 
number of splice variants, including a lens specific isoform, Lp82 (Ma et al., 1998a). 
 
An important component of the calpain proteolytic system is the endogenous calpain 
inhibitor, calpastatin (Dayton et al., 1976). Calpastatin is the only endogenous protein 
inhibitor for calpain and is specific to calpain enzymes. It has been shown not to react 
with other cysteine proteases i.e. papain, cathepsin B, or bromlin. It also fails to  react 
with other types of protease e.g. trypsin, chymotrypsin, pepsin (as reviewed by Goll et 
al., 2003).  
 
Although there is a single gene for calpastatin there are up to 9 different isoforms, 
found in various tissues in the body. This is due to the use of different promoters 
and/or alternative splicing mechanisms (as reviewed by Goll et al., 2003). Calpastatin 
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is a multi headed inhibitor and is capable of inhibiting more than one calpain 
molecule at a time. Calpastatin consists of 4 domains (I-IV), which can inhibit one 
calpain molecule each and a N-terminal region, named L, which has no calpain 
inhibitory properties (Maki et al., 1987, Takano et al., 1988, Hanna et al., 2007). Each 
of the inhibitory domains I-IV can be further divided into 3 conserved subdomains A, 
B and C (Maki et al., 1988). 
 
1.5.2 Calpain structure 
 
The classical calpains 1 and 2 are the most researched and best characterised of the 
calpains. They are both heterodimers, with a large subunit (80kDa), which contains 
the catalytic triad, and a small subunit (28kDa), which is involved in the regulation of 
calpain. Calpain 2 has a flat oval disc shape with dimensions of 115Å long, 70Å wide 
and up to 50Å thick (Reverter et al., 2001a). Originally a four domain structure was 
proposed based on the amino acid sequence analysis for the large subunit and a two 
domain structure for the small subunit (Ohno et al., 1986, Imajoh et al., 1988). This 
six domain structure was confirmed when the crystal structures for rat (Hosfield et al., 
1999) and human calpain 2 were determined (Strobl et al., 2000) (Figure 1-5).  
 
Domain I (dI) is an α-helix that sits in a cavity of domain IV and plays a role in 
anchoring both domains together. Domain II (dII) contains the catalytic site and has 
been split into two subdomains dIIa and dIIb (Reverter et al., 2001b). DIIa contains 
the papain-like ‘active site helix’, which harbours the active site residue Cys105.  The 
subdomain IIb has a barrel like shape similar to that of papain. The other two residues 
form the catalytic triad, His262 and Asn286, reside in dIIb. The substrate binding cleft 
is between the two subdomains dIIa and dIIb, however this cleft has a wide gap of 
15Å. This large gap disrupts the catalytic triad which makes it incompatible with 
binding and cleavage of the substrate (Reverter et al., 2001a). Domain III (dIII) is 
folded in a β-sandwich and shows similar topology to C2 domains, which are found in 
a large number of proteins and in particular those involved in intracellular signalling 
e.g. protein kinase C, phospholipase C, etc. DIII has been shown to bind both Ca2+ and 
phospholipids (PL) and is involved in the activation of calpain 2 (Strobl et al., 2000) . 
Of particular interest is the extended exposed acidic loop in dIII (Figure 1-5). Within 
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this 11 residue loop are 10 acidic residues, these residues interact electrostatically 
with the positive charges on the surface of subdomain dIIb. Domain IV (dIV) is a 
calmodulin-like domain, consisting of 8 α helices. These α-helices contain 2 pairs of 2 
EF hand structures. dIV also contains a potential fifth EF hand, when paired with 
domain VI. EF hands are protein secondary structures that bind Ca2+ ions, and consist 
of a long α-helix with two perpendicular smaller α-helixes at each end. The final 
domain of calpain is domain VI (dVI) in the small subunit. dVI has similar structure 
to dIV of the large subunit, dVI contains 2 pairs of 2EF hand structures and could 
possibly form a fifth EF hand when associated with dIV (Reverter et al., 2001b).   
 
 
 
Figure 1-5 Ribbon Structure of human calpain 2 (Reverter et al., 2001b).  The active site is 
between domain IIa (yellow) and domain IIb (red). The catalytic triad residues are shown Cys105 
in subdomain IIa and His262 and Asn286 in subdomain IIb. 
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1.5.3 Activation of calpain 
 
Activation of the calpain molecules has been an area of extensive research and a 
number of theories about this mechanism have been proposed. One of the unique 
properties of the calpain family is an absolute dependence on calcium for activation. 
As mentioned above the catalytic triad is located between dIIa and dIIb, however 
when calcium is not bound the distance between the catalytic residues of Cys105 and 
His262 and Asn286, is over 15Å (Reverter et al., 2001b). This is too wide to allow 
substrate binding and catalytic cleavage of the substrate so in its native state (ie with 
no calcium bound) calpain is inactive. Therefore activation of calpain upon calcium 
binding requires a conformational change to the molecule to allow the catalytic 
residues to move close enough for successful binding and cleavage of substrates. The 
calcium concentrations required for half activation of calpain 1 and calpain 2  in vitro 
are 3-50μm and 400-800μM respectively (Goll et al., 2003). These concentrations are 
considerably higher than in vivo intracellular Ca2+ concentrations of <1μM (Goll et 
al., 1992). 
 
There are three calcium binding sites within the calpain 2 molecule, (i) the EF hands 
in the calmodulin-like domains of dIV and dVI (Blanchard et al., 1997), (ii) the acidic 
loop region of the C2-like dIII (Strobl et al., 2000) and (iii) within dII (Moldveanu et 
al., 2002).  
 
Calcium binding to calpain is followed by rapid autolysis. This involves the autolytic 
removal of N-terminal amino acids from both the large and small subunits (Elce et al., 
1997). This reduces the mass of calpain 1 large subunit from 80kDa to 76kDa, the 
mass of calpain 2 large subunit from 80kDa to 78kDa and the mass of the small 
subunit from 28kDa to 18kDa (Edmunds et al., 1991). This autolysis reduces the Ca2+ 
concentration required for activation of calpain. The Ca2+ concentration for half 
maximal proteolytic activity of  calpain 1 reduces from 3-50μM to 0.5-2μM and that 
of calpain 2 from 400-800μm to 50-150μM (Goll et al., 2003).  
 
As mentioned above the dI region of the calpain molecule is a molecular anchor 
sitting within a hydrophobic pocket of dVI. This not only binds the large and small 
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subunits together but also constrains the movement of dI. Proteolytic cleavage of dI 
removes this anchor. There is evidence that this results in dissociation of the large 
80kDa subunit from the small 30kDa subunit (Michetti et al., 1997, Nakagawa et al., 
2001). However separation of the subunits is not necessary for the activation of 
calpain (Elce et al., 1997). The removal of the anchor allows the remaining dI to have 
more freedom of movement which eases the tension of dIIa and allows it to move 
towards dIIb. This movement closes the gap between the two subdomains (Jia et al., 
2001). However the movement acquired by dIIa after removal of dI is not enough to 
close the catalytic triad for proteolytic cleavage (Jia et al., 2001). Therefore dIIb also 
needs to move into the proteolytic cleft to align the catalytic triad, but it is held in 
place by hydrostatic interactions with dIII (Reverter et al., 2001a).  
 
Calcium can also bind to dIII. This binding can play a role in the activation of the 
calpain molecule. The part of dIII that plays a role in the activation of calpain is the 
acidic loop (Figure 1-5). The acidic loop contains 10 negatively charged acidic 
residues which interact with the positively charged residues in dIIb and so prevent 
dIIb from moving to reduce the gap in the catalytic triad. It has been suggested that 
calcium binding to the acidic loop would reduce its electrostatic charge and therefore 
electrostatic interaction with dIIb. This would allow dIIb the freedom to rotate over 
dIIa  and to form a functional catalytic domain (Strobl et al., 2000).  
 
Another major site of Ca2+ binding in the calpain molecule is to the EF hands in 
domains IV and VI. It was initially suspected that these two domains and in particular 
the EF hands within them, were the key to understanding the requirement of calpain 
for Ca2+. This view changed when the crystal structure of calpain was elucidated. It 
was discovered that the structural changes induced by calcium binding to the EF 
hands was too limited to have a major effect on the enzyme (Reverter et al., 2001a). 
However calcium binding is required for activation of the enzyme but no specific EF 
hand is required (Dutt et al., 2000). One effect calcium has on its binding to dVI is the 
disruption of the dILys7-dVIAsp154 salt bridge that holds dI and dIV together. This 
frees dI and allows it to go under autolysis as described above (Reverter et al., 2001a). 
 
The final area of calcium binding in the calpain molecule is within dII. It has been 
shown that one calcium ions binds each of the subdomains IIa and IIb. These calcium 
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ions help in the formation of the catalytic cleft by allowing rotation of the domains to 
form an active calpain molecule (Moldveanu et al., 2002). 
 
All of the above mechanisms require calcium for the activation of calpain. There is 
evidence for other factors involved in the activation of the calpain system, in 
particular PL have been shown to be involved with calpain activation (Pontremoli et 
al., 1985, Arthur and Crawford, 1996). Domain III is a C2-like domain, and like C2 
domains in other enzymes (Phospholipase C and protein kinase C, for example) binds 
PL (Tompa et al., 2001). The inclusion of PL in buffers has been shown to decrease 
the calcium concentration required for autolysis of calpain in vitro (Coolican and 
Hathaway, 1984). Extensive studies by Arthur and Crawford (1996)  showed that 
phosphotidyl -inositol; -choline; - glycerol; - serine; - ethanolamine and phosphatidic 
acid all reduce the Ca2+ concentration required for autolysis and hence the Ca2+ 
concentration for activation. It was postulated in the above paper that the PL was 
bound to the N-terminus of the small subunit of calpain. However once the crystal 
structure of calpain 2 was determined it was shown that it was dIII that bound PL 
(Tompa et al., 2001). Binding of PL to dIII was shown to promote Ca2+ binding 
several fold (Tompa et al., 2001) and consequently, PL could play a  role in reducing 
the gap between in vivo and in vitro Ca2+ concentration for the activation of calpain.   
 
 
Figure 1-6 Calpain 2 activation with the presence of calcium and phospholipid. Each domain is 
represented by a shaded sphere as in Figure 1-5. Adapted from Reverter et al., (2001a). 
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In summary activation of calpain by calcium and PL is a complex process and not one 
that is fully understood. For full activation of calpain there needs to be up to 10 Ca2+ 
ions bound to the calpain. As shown in Figure 1-6 calcium binding to the EF hands in 
dVI disrupts the salt bridge between dVI and dI which frees dI for autolysis. Calcium 
also binds to the negative acidic loop region of dIII which relieves the hydrostatic 
tension between dIII and dIIb. This allows movement of dIIb to form an active 
catalytic domain with dIIa. PL also bind dIII and reduces the hydrostatic interaction 
between the two domains. Calcium binding within the catalytic domain also helps in 
catalytic domain fusion.  
 
Binding of calpastatin to calpains was found to be dependent on the presence of Ca2+ 
(Imajoh and Suzuki, 1985) and that subdomain A bound to dIV (Ma et al., 1994), and 
subdomain C bound to dVI (Takano et al., 1995). At present the binding site for 
subdomain B has not been elucidated but it is suspected to bind in domain III (Wendt 
et al., 2004). 
 
1.5.4 Calpains in the lens 
 
There has been extensive research on calpains in the lens. Calpain activity has been 
found in human (Shih et al., 2001), sheep (Robertson et al., 2005), cow (Yoshida et 
al., 1985), mouse (Fukiage et al., 1997), rat (David and Shearer, 1986), rabbit 
(Fukiage et al., 1997) and guinea pig (Fukiage et al., 1998) lenses. At present five 
calpains have been discovered in the lens, these being calpain 2 (Yoshida et al., 1984, 
Yoshida et al., 1985), calpain 1 (Roy et al., 1983), Lp82 (Ma et al., 1998b), Lp85 (Ma 
et al., 2000b) and calpain 10 (Ma et al., 2001). Of these calpains calpain 2 is the most 
abundant isoform. Calpain 2 is found in the epithelium, cortex and nuclear region of 
the lens with highest activity being in the epithelium, then cortex and the lowest 
activity being found in the nucleus (Yoshida et al., 1985).  
 
The lens specific calpain Lp82 was discovered in rats by Ma et al., (1998a). It is a 
splice variant of the muscle specific calpain 3 (p94), resulting from deletion of the IS1 
and IS2 regions of calpain 3 and a different exon 1 (Ma et al., 1998a). So far Lp82 has 
been isolated in mice (Ma et al., 1999), rats (Ma et al., 1998b) and cattle (Ueda et al., 
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2001).  In rats Lp82 was found in all regions of the lens with the highest activity in the 
nucleus then the cortex and lowest levels in the epithelium (Ma et al., 1998b), which 
is the reverse of calpain 2 which has the relative activity of 
epithelium>cortex>nucleus. Biochemical analysis of bovine Lp82 found that it 
migrated to 82kDa on SDS-PAGE and that the calcium concentration for half 
maximal concentration of Lp82 was 20μM (Ueda et al., 2001). This is lower than that 
of calpain 2, which suggests that it may play more of a role than calpain 2 in the lens 
at lower calcium concentrations. The optimal pH for activation of Lp82 was found to 
be 7.2, which is lower than the 7.5 optimum found for calpain 2 from the lens (Ueda 
et al., 2001). 
 
During purification of Lp82 another lens specific calpain was discovered named 
Lp85. It co-eluted with Lp82 on a DEAE Sepharose column (Ma et al., 2000b). After 
analysis of the sequence Lp85 was discovered to have the same sequence as Lp82 
with a 28 amino acid insertion in the calcium binding domain IV. This resulted in a 
protein that migrates to 85kDa on SDS PAGE. Lp82 and Lp85 have very similar 
characteristics. Both require the same calcium concentration, 20uM, for 50% 
activation and have the same optimal pH of 7.2 (Ma et al., 2000b). They have the 
same distribution profile across the lens with relative levels being 
nucleus>cortex>epithelium. One difference between Lp82 and Lp85 is that Lp85 
shows distribution around the peri-nuclear region of the nucleated cortical fibres (Ma 
et al., 2000a) conversely Lp82 was found to be in the cytoplasm of the nuclear and 
cortical fibre cells (Ma et al., 2000a). Thus it was proposed that the insertion sequence 
promotes the association of Lp85 with the nuclear membrane. Importantly Lp85 at 
present has only been found in young rodent lenses.  
 
It is also important to note that neither Lp82 nor Lp85 are expressed in human lenses 
due to a stop codon in the sequence (Fougerousse et al., 2000). This is due to a 
difference in human intron 18, where it is 2 bases longer. This produces a frame shift 
and consequently the formation of a stop codon 4 nucleotides into exon 4 
(Fougerousse et al., 2000).   However a Lp82-like cleavage site on α-crystallin has 
been found in human lenses (Takemoto, 1995b). Interestingly calpain 3 isoforms have 
been found at a genetic level in human lens epthelial cells hUp84 and hUp49 and it 
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has been suggested these isoforms play a role in human cataract formation similar to 
that of Lp82 (Kawabata et al., 2003). 
 
1.6 Calpains, Crystallins and Cataracts 
 
Many studies have looked at the concentration of metal ions in normal and cataractous 
lenses and in particular Ca2+, with a number showing an increase in cystolic Ca2+ in 
association with opacification of the lens (Duncan and Bushell, 1975, Hightower et 
al., 1987, Sanderson et al., 2000, Robertson et al., 2005). Some of these authors 
concluded that this increase in free Ca2+ could result in the activation of the calcium-
dependent cysteine proteases; the calpains. Interestingly only cortical and not nuclear 
cataracts are associated with an increase in calcium concentration (Duncan and 
Bushell, 1975, Sanderson et al., 2000).  
 
The calpain family of proteases have an absolute requirement for Ca2+ for activation. 
Several human diseases are the result of overactivation of calpains responding to 
increased levels of intracellular Ca2+, and include muscular dystrophies, myocardial 
infarctions and strokes (Goll et al., 2003, Zatz and Starling, 2005). Cataracts are 
another disease characterised by a loss of Ca2+ homeostasis and uncontrolled calpain 
activity. Calpains have been implicated in various animal models of cataract which 
include the selenite (David et al., 1993), diamide (Azuma and Shearer, 1992), 
galactose (Azuma et al., 1995) and Shumiya (Inomata et al., 1997b) rat cataracts. 
 
1.6.1 Calpain 2 
 
Calpain 2’s role in the lens has been extensively researched since its discovery in the 
lens in 1984 (Yoshida et al., 1984). Early studies showed that the crystallins are 
substrates for calpain 2 (David and Shearer, 1984). Since then more evidence has 
supported a role for calpain 2 in cataractogenesis. Calpain 2 has been shown to 
proteolyse both α and β-crystallins but to have no effect on the  γ-crystallins (David 
and Shearer, 1986). Calpain 2 activity on crystallins and in cataract lenses has been 
demonstrated in various animals and animal models of cataractogenesis, including rat 
26 
(Fukiage et al., 1997, Ueda et al., 2002b), mouse (Fukiage et al., 1997, Ueda et al., 
2002a), guinea pigs (Fukiage et al., 1997), cows (Ueda et al., 2001), monkeys 
(Nakajima et al., 2001) and sheep (Robertson et al., 2005).  
 
Lens culture systems are a valuable tool for assessing cataract formation and the role 
of calpains in a controlled in vitro system. Many of the lens culture systems use 
calcium ionophores as the initiators for cataract formation (Marcantonio and Duncan, 
1991, Sanderson et al., 1996, Lee et al., 2008). These ionophores elevate cystolic Ca2+ 
levels by transporting Ca2+ across the cellular membrane. When the Ca2+ ionophore, 
ionomycin, is added to lens culture systems the lenses develop opacification, which is 
not observed when ionomycin was added to the lens cultures without Ca2+ (Sanderson 
et al., 1996, Lee et al., 2008). In these studies it was shown that in the lenses that lose 
transparency, the cytoskeletal proteins vimentin and spectrin were proteolysed. These 
cytoskeletal proteins are known calpain substrates. To further test the role of calpains 
in the ionomycin model of cataracts, known calpain inhibitors were added to the 
culture system. The addition of the calpain inhibitors attenuated the formation of the 
opacity associated with ionomycin (Sanderson et al., 1996, Lee et al., 2008).  
 
The above experiments were carried out using rat and ovine lenses, similar studies 
using human lenses to assess calpain’s role in the formation of human cortical 
cataracts have been performed (Sanderson et al., 2000). Opacification was seen in the 
human cultured lenses after the addition of ionomycin, and the opacification was 
prevented when the calcium had been chelated with EGTA. Again there was 
proteolysis of the cytoskeletal protein vimentin and also a loss of the crystallins from 
the water soluble fraction of the lens (Sanderson et al., 2000). This evidence shows a 
role for calpain 2 in both human and other mammalian lens cataract models. 
 
In the sheep model of cataracts Robertson et al., (2005) showed that the levels of 
calpain 2 decreased as the cataract development progressed. This indicated that 
calpain 2 had been autolysed which is consistent with the activation of calpain 2 
having an involvement in cataractogenesis. 
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1.6.2 Lp82 
 
Since the lens specific calpain Lp82 was discovered it has been suggested to play a 
role in the proteolysis observed during cataractogenesis (Ma et al., 1999). Lp82 
activity has been reported in  rats and mice (Nakamura et al., 2000), cows (Ueda et 
al., 2001) and sheep (Robertson et al., 2005). So far only rodent Lp82 has been shown 
to be active during cataract formation (Nakamura et al., 2000). In the young rat lens 
there are equal quantities of both Lp82 and calpain 2 and, consequently, both are 
suggested to play a role in lens maturation and cataract formation (Shearer et al., 
1998). However in the young mouse it was discovered that Lp82 is the dominant form 
of calpain (Ma et al., 1999). The authors suggested that the majority of the proteolysis 
seen during cataract formation in young mouse lenses could be attributed to Lp82 
rather than calpain 2. 
 
1.6.3 Calpains and α-crystallin 
 
Both calpain 2 and Lp82 from bovine (Yoshida et al., 1986, Ueda et al., 2001), rat 
(Ueda et al., 2002b) and mice (Nakamura et al., 2000, Fukiage et al., 1997) can 
truncate αA- and αB-crystallin. What however is interesting is that they have two 
different specific places where they cleave αA crystallin, calpain 2: αA1-163 and Lp82: 
αA1-168 (Yoshida et al., 1986, Ueda et al., 2001). Bovine (Yoshida et al., 1986) and 
rat (Ueda et al., 2002b) calpain 2 truncate αA-crystallin in a number of places but 
there are two main truncated forms of αA-crystallin found after the exogenous 
incubation of αA with calpain 2 in the presence of Ca2+.  The first was αA1-162 which 
is missing 11 amino acids from its C-terminus and the second was αA1-163 missing 10 
amino acids from its C-terminus (Figure 1-7) (Yoshida et al., 1986, Ueda et al., 
2001). But crucially calpain 2 did not truncate αA crystallin at αA1-168 (Yoshida et al., 
1986, Nakamura et al., 2000, Ueda et al., 2001, Inomata et al., 2002). 
 
Lp82 from bovine and rat lenses has only one main truncation product when 
incubated with exogenous αA-crystallin, that is αA1-168 (Ueda et al., 2001, Ueda et al., 
2002b) where five amino acids are missing from the C-terminus of αA crystallin 
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(Figure 1-7). It has also been found that the αA1-163 truncation was produced by Lp82 
but not the A1-162 truncation. 
 
These two different and specific truncation sites for calpain 2 (αA1-162 missing 11 
amino acids) and Lp82 (αA1-168 missing 5 amino acids) allow assessment of which 
calpain is more dominant in the lens by measuring the relative abundance of these two 
species during lens maturation and cataractogenesis. In the selenite cataract the major 
αA truncation product seen after 16 days was the Lp82 truncation product αA1-168, 
with a small amount of αA1-163 being found as well (Ueda et al., 2002b). However 
αA1-162, the calpain 2 truncation product, was not found in the cataract. This showed 
that the proteolysis seen during selenite cataract formation was due to Lp82 and not 
calpain 2. It is important to note that the selenite cataract is a nuclear cataract.  
 
αA
N term 160 P V S  R  E E K P S  S A P S S  173 C term
αB
N term 162 R E E K P A V T  A A P K K 175 C term
-11aa
-5aa-10aa
-5aa
 
Figure 1-7 αA and αB crystallin C-terminal amino acid sequence. Arrows represent cleavage 
points for calpain 2 (Block arrow), Lp82 (striped arrow) and both calpain 2 and Lp82 (white 
arrow).  
 
Both calpain 2 and Lp82 from bovine (Yoshida et al., 1986, Ueda et al., 2001) and rat 
(Ueda et al., 2002b) truncate αB crystallin when incubated in vitro. Unlike αA-
crystallin both calpain 2 and Lp82 truncate αB-crystallin at the same place, αB1-170,  
cleaving 5 amino acids from the C-terminus (Figure 1-7) (Ueda et al., 2001, Ueda et 
al., 2002b). This αB-crystallin species missing 5 amino acids from its  C-terminus is 
found in cataractous lenses from the selenite rat (Ueda et al., 2002b), Shimuya rat 
(Inomata et al., 1997a) and ICR/f rat (Takeuchi et al., 2004). As this truncation is 
produced by both calpain 2 and Lp82 it is not possible to determine which calpain is 
responsible for the modification seen during cataract formation.  
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The lens specific Lp82 is not found in human lenses due to there being a stop codon in 
the sequence (Fougerousse et al., 2000). However C-terminally truncated α-crystallin 
with cleavage sites identical to those associated with bovine, rat and mouse Lp82 
cleavage of α-crystallins (αA1-168) have been found in human lenses (Takemoto, 
1995b, Lund et al., 1996) and cataracts (Baruch et al., 2001).  
 
The α-crystallins are related to the small heat shock proteins and can act as molecular 
chaperones within the lens environment (Horwitz, 1992). The C-terminal extension of 
α-crystallin is essential for chaperone activity. It is involved in subunit to subunit 
interaction as well as subunit-substrate interaction. In 1994 Takemoto showed that 
loss of amino acids from 158-173 of αA-crystallin resulted in loss of chaperone 
activity. Therefore calpain induced truncation of α-crystallin would reduce the 
chaperone function of α-crystallin. 
 
1.6.4 Calpains and β-crystallins 
 
Although β-crystallins are the second most abundant protein in the lens, little research 
has focussed on the effect of calpain 2 on the β-crystallins. In 1992 David et al., 
showed in rats that calpain 2 can proteolyse β-crystallin and produce similar 
fragments, when analysed by electrophoresis, as those found in the selenite cataract. 
The study also showed that the β-crystallins that were truncated became insoluble in 
solution. Insolubilisation of β-crystallins is one of the hallmarks of cataract. Insoluble 
β-crystallins tend to aggregate in the lens which leads to light scattering. Further to 
this research it was found that the β-crystallins were truncated at their N-terminus, by 
calpain 2 (David and Shearer, 1993) and that β-crystallin insolublised by calpain 2 in 
vitro was truncated at the same sites as that found on β-crystallin in cataractous 
lenses. Sequence analysis showed that calpain 2 cleaved between 5 and 49 amino 
acids from the N-termini of βB3, βB1, βA4, and βA1/A3, and these identical 
truncated species were found in the cataractous lenses (David et al., 1993). Only a 
small amount of work has examined the role of Lp82 (the lens specific calpain) in the 
truncation of the β-crystallins. When Lp82 is incubated with βA3 crystallin, it cleaves 
βA3 at the same position as calpain 2 (Ueda et al., 2001), suggesting that Lp82 may 
also have a role in β-crystallin truncation. This evidence suggests that calpains cleaves 
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β-crystallins in vivo and that these truncated products become insolublised in the lens 
and contribute to the formation of cataracts. 
 
1.7 Heritable Ovine Cataract 
 
There are rodent models of cataract using mice (Kuck, 1990, Ai et al., 2000) and rats 
(David and Shearer, 1984, Shumiya, 1995). These models of cataract are from small 
rodents which, although they have functional eyes with a similar structure to human 
eyes, have a lens that is spherical in shape compared with the elliptical shape of the 
human lens. The rodents also focus light by a different mechanism to humans. To 
focus light humans change the shape of the lens (for more see 1.2 The Lens), whereas 
rodents don’t change the shape of the lens but shift the entire lens backwards and 
forwards, to focus light on the retina. 
 
So although the rodents are a model for human lenses they have their limitations as far 
as replicating the human lens. A larger mammal model of cataract would provide 
more valuable information for treatment of human cataracts. 
 
In 1982  Brooks et al., described a Romney sheep with inherited cortical cataracts. 
The cataract was inherited in an autosomal dominant fashion. The opacity starts to 
develop by 1-2 months of age and reaches maturity by 10-12 months of age (Brooks 
et al., 1982/1983, Robertson et al., 2005). An independent scoring system was 
developed in which lenses were graded from 0 (no cataract) to 6 (mature cataract) 
(Figure 1-8).  The initial description of the ovine cataract reported an increase in 
calcium levels in the cataractous lens. It has been shown that as the cataract 
progresses intracellular lens calcium levels increase (Brooks et al., 1982/1983, 
Robertson et al., 2005). This led to the suggestion that calpain may be activated in the 
ovine cataract lens by increased calcium levels.  
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 Figure 1-8 Progression of the ovine cataract and scoring system. 1) Small opacities at either 
posterior or anterior suture lines, 2) Small opacities at both suture lines, 3) Opacities at sutures 
lines and mild cortical involvement, 4) Moderate to severe cortical involvement, 5) Immature 
cataract involving the whole lens, 6) mature cataract. Adapted from Robertson et al., (2005). 
 
Calpain 2, calpain 1 and Lp82 have all been found in the ovine lens, and interestingly 
the level of active calpain 2 decreases as the cataract progresses, which is in indication 
that the calpain 2 has been activated and subsequently autolysed (Robertson et al., 
2005). In the same study a calpain inhibitor SJA6017 was applied to the eye of sheep 
with inherited cataracts and the inhibitor was shown to slow the progression of the 
cataract over the first month of treatment. 
 
Study of the crystallins in the ovine lens reveals the usual complement found in most 
other mammalian species, αA, αB, βA1, βA1/βA3, βA2, βB1, βB2, βB3, γS and γA-F 
(Robertson et al., 2008). In the ovine cataract some of these crystallin are truncated, in 
particular, αA, αB, βB1, βB2 and βB3. The modifications to α-crystallins are the same 
as those found in other cataract models and are known calpain 2 and Lp82 truncation 
sites (Robertson et al., 2008). The cytoskeletal proteins spectrin and vimentin were 
both truncated during ovine cataract formation (Robertson et al., 2005). 
 
All this evidence indicates a role for the calpain family of proteases in the heritable 
ovine cataract. 
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   Chapter 2 
Experimental Rationale 
 
A variety of biochemical changes occur in the lens during cataractogenesis. 
Specifically the lens crystallins are modified by deamidation, phosphorylation and 
truncation. The aim of this research is to document the changes that occur within the 
ovine lens during maturation and cataractogenesis. The research will focus primarily 
on the crystallins and their truncation. It will also aim to establish the role that the 
calpain family of proteases play in truncation of the crystallins. The three calpains that 
have been found in the ovine lens, calpain 1, 2 and Lp82, will be studied.  
 
Hypothesis: (i) the crystallin truncations seen in cataractogenesis are unique to this 
disease and different to the truncation seen with normal maturation of the lens. 
 
(ii) That incubation of calpains 1, 2 and Lp82 with the crystallins will result in 
truncation of the crystallins in a similar manner to that seen in cataractogenesis. 
 
Chapter 3  Calpain Purification 
 
The aim of this chapter was to purify the calpains that are found in the lens. This was 
achieved using chromatography techniques. Combinations of hydrophobic, ion 
exchange and gel filtration chromatography were used. The ubiquitous calpains 1 and 
2 were purified from ovine lung and the lens specific Lp82 was purified from lamb 
lenses. These purified calpains were used in further experiments (Chapter 5) 
 
Chapter 4 Ovine Crystallins 
 
The changes to the lens crystallins during maturation of the lens need to be 
determined before the changes that occur during cataractogenesis could be 
determined. Therefore lens proteins from fetal, 6 month old and 8 year old sheep were 
visualised by 2DE and the changes determined using mass spectrometry. Lenses from 
cataract stages 0, 1, 3 and 6 were obtained to determine the crystallin changes that 
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occur during cataractogenesis. The changes in the crystallins were visualised by 2DE 
and the modifications of the crystallins determined by mass spectrometry.  
 
Chapter 5  Calpains and Crystallins 
 
To study whether the calpains could truncate lens proteins, the purified calpains from 
Chapter 3 were incubated with lens proteins. Calpains 1, 2 and Lp82 were all 
incubated individually with α- and β-crystallins. The truncations produced by these 
incubations were visualised by 2DE and the exact truncation sites were determined 
using mass spectrometry techniques. Calpains 2 and Lp82 were also incubated with 
the lens cytoskeletal proteins. The truncated proteins from incubation with the 
calpains were compared to the truncated proteins seen during cataractogenesis 
 
Chapter 6  General Conclusion and Future Directions 
 
In this chapter the results from each chapter are highlighted and related to the 
hypotheses generated at the start of this thesis. Future directions are also discussed to 
carry on this research. 
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   Chapter 3 
Calpain Purification 
 
3.1 Introduction 
 
The calpains are a family of calcium-dependent cysteine proteases. They make up a 
vital part of the cellular proteolytic machinery. Currently there are 14 different 
isoforms of calpain, 7 of these are ubiquitously expressed and include the two major 
calpains, calpain 1 (μ-calpain) and 2 (m-calpain). The remaining 7 are tissue specific 
calpains and are found in muscle, lens, stomach, digestive tract, testis and hair 
follicles (Goll et al., 2003).  
 
All the calpains have an absolute requirement for Ca2+ to become active but have 
different concentration requirements for Ca2+. For example, calpain 1 requires 3-
50μm  and calpain 2  400-800μM Ca2+ for half maximal activation in vitro  (Goll et 
al., 2003). These values are substantially higher than the Ca2+ concentration found in 
vivo which is <1μM (Goll et al., 1992), therefore other events must occur in vivo that  
reduce the amount of Ca2+ required for activation to the physiological levels of Ca2+ 
found in cells. Two events that may accomplish this are autolysis and phospholipid 
binding. Autolysis is a common feature of calpain activation and involves the 
autolytic removal of N-terminal amino acids from both the large and small subunits 
(Elce et al., 1997). Autolysis reduces the calcium requirement of calpain 1 to 0.5-2 
μM and that of calpain 2 to 50-150μM (Goll et al., 2003). Binding of calpains to 
phospholipids in the cellular membrane has also been shown to reduce their calcium 
activation  requirement in vitro (Pontremoli et al., 1985, Arthur and Crawford, 1996). 
 
Within most mammalian lenses there are 4 isoforms of calpain, the 2 major ubiquitous 
calpains 1 and 2, the lens specific calpain Lp82 and calpain 10. At present calpain 
activity in the lens has been found in a variety of animal species, including humans 
(David et al., 1989), sheep (Robertson et al., 2005), cow (Yoshida et al., 1985), 
mouse (Fukiage et al., 1997), rat (David and Shearer, 1986), rabbit (Fukiage et al., 
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1997) and guinea pig (Fukiage et al., 1998). Calpain 2 is the dominant isoform in the 
sheep lens (Robertson et al., 2005), and has been shown to have roles in lens 
maturation and cataractogenesis in rodent and bovine lenses (David and Shearer, 
1984, Ueda, 2001, Ueda et al., 2002b).  
 
There is a lens specific calpain, Lp82. This was discovered in 1998 by Ma et al., and 
has been described in rats (Ma et al., 1998a), mice (Ma et al., 1999) cattle (Ueda et 
al., 2001) and sheep (Robertson et al., 2005). Importantly, however the human Lp82 
gene contains a stop codon in the middle of the sequence and therefore is not 
translated in human lenses (Fougerousse et al., 2000). Recently other calpain 3 splice 
variants have been found in human and monkey lenses (Nakajima et al., 2001, 
Kawabata et al., 2003). 
 
This chapter deals with the three main calpains found in the sheep lens, calpain 1 and 
2 and Lp82. The calpains were purified from lung tissue (calpains 1 and 2) or the lens 
(Lp82), and their biochemical properties were determined. This experiment is 
important for determining the role that the calpains play in lens maturation and 
cataractogenesis in the ovine cataract model. 
 
3.2 Methods 
 
The different calpains were purified using protein liquid chromatography. Different 
combinations of ion exchange, hydrophobic and size exclusion chromatography 
media were used in the purifications. All columns were run using a BioLogic 
DuoFlow Chromatography System (BioRad, Ca., USA). 
 
3.2.1 Calpain 1 and 2 purification 
 
Three hundred grams of fresh ovine lung was homogenised in 3ml/g of ice cold 
Buffer A (20mM MOPS pH 7.5, 5mM EDTA, 5mM EGTA, 5mM βME) containing 
protease inhibitors (2.5μM E64, 0.2mM phenylmethylsulponylflouride and 0.1mM 
trypsin inhibitor) using 3 bursts of 30 seconds in a Waring blender (Waring, Ct., 
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USA). The resultant homogenate was centrifuged at 13 800 x g for 1 hr at 4ºC in a 
Beckman J2-MI Centrifuge using a JA14 rotor (Beckman, Ca., USA). The supernatant 
was filtered through damp cheese cloth to remove any solid particles and the pellet 
was discarded. The volume of the supernatant was measured and (NH4)2SO4 was 
added slowly over 2 hr to 50% saturation (29.54g/100mls of supernatant), at 4°C. This 
suspension was then centrifuged at 13 800 x g for 1 hr at 4ºC in a Beckman J2-MI 
Centrifuge using a JA14 rotor (Beckman, Ca., USA). The supernatant was discarded 
and the pellet containing the calpains was resuspended in Buffer A. The suspension 
was centrifuged at 13 800 x g  for 1 hr at 4ºC in a Beckman J2-MI Centrifuge using a 
JA14 rotor (Beckman, Ca., USA) to remove any particles of undissolved (NH4)2SO4. 
The supernatant was filtered, collected and loaded onto a Phenyl Sepharose 
(Pharmacia, Uppsala, Sweden) XK26 column (30cm x 2.6cm), equilibrated in Buffer 
A + 0.5M NaCl at a flow rate of 2ml/min. Five hundred millilitres of Buffer A +0.5M 
NaCl was pumped through the column at a flow rate of 4ml/min to remove any 
unbound proteins. The calpains were eluted with 100% Buffer A at a flow rate of 
4ml/min and 140 x 8ml fractions were collected.  BODIPY-FL casein assay (see 
3.2.3.1) was used to determine which fractions contained the calpains and the relevant 
fractions containing activity were then pooled. 
 
The pooled calpain was loaded onto a diethylaminoethyl (DEAE) ion-exchange 
column (Pharmacia, Uppsala, Sweden) XK26 (35cm x 2.6cm) equilibrated in Buffer 
A. Two hundred millilitres of Buffer A then 200mls of 10% Buffer A +1M NaCl, was 
washed through to remove any unbound or weakly bound proteins. The calpains were 
eluted and separated with a 0.1-0.4M NaCl linear gradient of Buffer A +1M NaCl. 
150 x 8mL fractions were collected. Calpain activity was assayed using the BODIPY-
FL casein assay and the fractions containing calpain 1 and calpain 2 were pooled 
separately. 
 
3.2.1.1 Calpain 2 purification continued 
 
Calpain 2 was further purified on Reactive Red Agarose (Pharmacia, Uppsala, 
Sweden) XK1.6 (13cm x 1.6cm) column. Sodium Chloride was added to 50mL of 
calpain 2 from the DEAE column to increase the concentration to 0.5M NaCl. The 
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calpain 2 was loaded on to the Reactive Red column at a flow rate of 1-2mL/min. 
Thirty millilitres of Buffer A + 0.5M NaCl was washed through to remove any 
unbound proteins and calpain 2 was eluted with 100% H2O. Again calpain activity 
was determined by BODIPY-FL casein assay and the relevant active fractions were 
pooled. 
 
For the final purification step the pooled calpain 2 was loaded onto a 1ml Mono Q® 
column (Pharmacia, Uppsala, Sweden) equilibrated in Buffer A. The calpain was 
eluted with a linear gradient of 0-1M NaCl in Buffer A. Calpain activity was 
determined using BODIY-FL casein assay. For Ca2+ dependence studies the final step 
was performed using Buffer A without EDTA or EGTA. 
 
3.2.1.2 Calpain 1 purification continued 
 
Calpain 1 was further purified on Reactive Red Agarose, 50mL of calpain 1 from 
DEAE ion-exchange was added to a Reactive Red column equilibrated in Buffer A 
+0.5M NaCl. Buffer A + 0.5M NaCl was washed through at 0.5mL/min until the 
absorbance (280nm) was level and then the calpain 1 was eluted with Buffer A + 1M 
NaCl. Calpain activity was determined by BODIPY-FL casein assay and relevant 
calpain 1 containing fractions were pooled. 
 
To further purify and concentrate the calpain 1, 30mL of calpain 1 from the Reactive 
Red was added to a 5ml HiTrap® Phenyl Sepharose Column (Pharmacia, Uppsala, 
Sweden) equilibrated in Buffer A + 0.5M NaCl. Unbound proteins were removed with 
Buffer A +0.5M NaCl at 0.5ml/min. Proteins were eluted with a linear gradient of 0-
100% H2O, over 20mL and 100% H2O for 5mL.  
 
3.2.2 Lp82 purification 
 
Young lamb eyes were obtained post-mortem from Ashley Dene farm (Lincoln 
University, New Zealand). The lenses was removed, weighed and each whole lens 
was homogenised in 3μL/mg of lens weight Buffer A containing Mini Complete 
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Inhibitor cocktail (Roche, Mannheim, Germany), one tablet per 10mL. The 
homogenate was centrifuged at 20 400 x g for 45min at 4ºC to remove the insoluble 
lens protein (Beckman J2-MI Centrifuge, Beckman, USA). The supernatant (total 
soluble protein) was applied to a DEAE Ion Exchange column equilibrated in Buffer 
A, and the calpains were eluted using a 500mL linear gradient of 0-500mM NaCl. All 
fractions were assayed for protease activity using the BODIPY-Fl localisation assay 
(3.2.3.1) and the different calpain isoforms were determined using a combination of 
western blot and casein zymography. Fractions containing Lp82 and Calpain 2 were 
pooled separately. The Lp82 fraction was then concentrated using ultrafiltration 
(Amicon Ultracel-10k, Millipore, Ma., USA) at 2050 x g for 45min at 4ºC. The 
concentrated Lp82 containing fraction was then run through a Superose 6 Gel 
Filtration (Pharmacia, Uppsala, Sweeden) (30cm x 1cm) column and Lp82 containing 
fractions were determined, pooled and concentrated by ultrafiltration as above. For the 
final step Lp82 was diluted 1:3 with Buffer A + 2M NaCl and applied to a Reactive 
Red Agarose Column equilibrated in Buffer A + 0.5M NaCl. Lp82 was eluted using 
dH2O.  
 
3.2.3 BODIPY-FL casein assay 
 
To determine calpain activity the BODIPY-FL casein assay was used. BODIPY-FL 
was purchased from Molecular Probes, Invitrogen, USA and the BODIPY-FL casein 
stock reagent was prepared as described by Thompson et al., (2000). 
 
3.2.3.1 Calpain localisation 
 
The calpain localisation assay was used to determine which fractions from the FPLC 
contained calpain activity. Fifty microlitres of each fraction was combined with 
100μL of BODIPY-FL casein substrate (2mM NaN3, 50μl BODIPY-FL casein 
stock/10ml final volume, 10mM CaCl2, 0.1% β-ME in 20mM Tris-HCl, pH 7.8). The 
assay was performed in black microtiter plates and the fluorescence immediately read 
every minute for 10 minutes in a BMG Fluorescence plate reader (Fluostar, BMG 
Labtechnologies GMbH. Offenburg, Germany) with an excitation wavelength of 
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485nm and emission wavelength of 538nm. Calpain activity was determined as an 
increase of fluorescence over 10 minutes. 
 
3.2.3.2 Calpain specific activity 
 
To determine specific activity during the purification procedure the above method was 
adapted. In the calpain specific activity assay 50μl of pooled sample was combined 
with 50μL of Buffer A (without EDTA or EGTA) and 100μl of BODIPY-FL casein 
substrate. The calcium blanks contained 100μl of Buffer A (without EDTA or EGTA) 
and 100μl of BOPIDY-FL casein substrate. EDTA blanks contained 50μl of 100mM 
EDTA (pH 7.5), 50μl of pooled sample and 100μL of BOPIDY-FL casein substrate. 
 
The following calculations were used to determine the specific activity of the calpain 
after each purification step. Specific activity was measured in units of fluorescence 
released per 10 minutes per mg of protein. 
 
1. Fluorescence change per 10 minutes: [(fluorescence at 10 minutes)-(fluorescence at 
zero minutes)] – [average (calcium+ EDTA blanks)] 
 
2. Total calpain activity: Fluorescence (1) x 20 (correction for 50μl sample used to 
take it up to 1ml) x volume of pooled sample volume. 
 
3. Specific activity U/mg: Total calpain activity (2) ÷ total protein in sample (mg) as 
determined by BCA assay. 
 
3.2.3.3 Calpastatin assay 
 
To assess whether the endogenous calpain inhibitor calpastatin was present in any of 
the samples the calpastatin assay was utilised. Ten microlitres of purified calpain 2 
was incubated with 90μL of sample and 100μL of BODIPY-FL casein and the change 
in fluorescence measured. Calpastatin presence was shown as a decrease in the 
fluorescence recorded compared with the control which contained 90μL of Buffer A.  
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 3.2.3.4 BCA protein assay 
 
Protein concentration in each sample was determined using Bicinchoninic Acid 
reagent (Pierce, Rockford, Il., USA) according to manufactures instructions. 10μl 
samples were assayed in triplicate and compared to a standard curve generated using 
dilutions of 2mg/ml Albumin Standard (Pierce, Rockford, Illinois, USA), to provide 
concentrations ranging from 0.0625mg/ml to 1mg/ml.  
 
3.2.4 SDS-PAGE, Western blot and casein zymography 
 
To determine the relative purity and confirm the presence of each calpain a 
combination of Sodium dodecyl sulphate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE), western blotting and casein zymography was used. 
 
3.2.4.1 SDS-PAGE 
 
SDS-PAGE was performed using NuPAGE® 4-12% Bis-Tris precast gels (Invitrogen, 
California, USA) using the NuPAGE® Surelock system. Twenty micrograms of 
protein from each purification step was combined with six times SDS-PAGE loading 
buffer (350mM Tris-HCL, pH 6.8; 10%SDS, 30% glycerol, 5% βME, 0.012% 
Bromophenol Blue). The samples were denatured by heating at 90ºC for 5 min. 
Samples were loaded into individual wells and the gel run at 200V for 50 min with 
NuPAGE®  MOPS running buffer. 
 
After electrophoresis the gel was removed and washed 3 times for 5 min with 5mM 
HCl. After the washes the gels were stained with GelCode® Blue Stain Reagent 
(Pierce, USA) overnight. The gels were destained with 5mM HCl. All gels were 
scanned using a flat bed scanner (CanoScan D2400 U, Canon) at 600dpi and saved as 
JPEG files. 
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3.2.4.2 Western blot 
 
Gels were run as for SDS-PAGE (see 3.2.4.1). Following SDS-PAGE, the protein was 
electroblotted onto PVDF (polyvinylidene fluoride) transfer membrane (BioRad, Ca., 
USA), over 1 hr at 100V in cold transfer buffer (25mM Tris, pH 8.3; 192mM 
Glycine). After transfer the membrane was blocked with 5% non-fat dry milk powder 
in TTBS (20mM Tris-HCl, pH 7.5; 500mM NaCl, 0.05% Tween 20) for 1 hr at room 
temperature. The PVDF membrane was then washed 3 times 5 min with TTBS. 
Incubation with primary antibodies was performed in TTBS with 1% non-fat dry milk 
powder, with primary antibodies prepared according to Table 3-1, for 1 hr at room 
temperature. The membrane was washed 3 times 5 min in TTBS to remove any 
unbound primary antibody. Suitable secondary antibodies were incubated for 1 hr at 
room temperature according to Table 3-1 in TTBS with 1% non-fat dry milk powder. 
The membrane was washed 2 times 5 min in TTBS and once in TBS (TTBS without 
0.05% Tween 20). The blots were developed with an alkaline phosphatase Conjugate 
Substrate Kit (BioRad, Ca., USA), according to the manufacturers instructions.  
 
Calpain Concentration Host Species Source 
Bovine Calpain 1 
80kDa subunit 
1:2000 Mouse Affinity BioReagents Inc. 
Catalogue MA3-942 
Bovine Calpain 2 
80kDa subunit  
1:2000 Mouse Affinity BioReagents Inc. 
Catalogue MA3-940 
Rat Lp82 1:1000 Rabbit Supplied by H.Ma, OHSU, 
USA. 
Table 3-1 Primary antibodies used for western blot analysis of the calpains. 
 
3.2.4.3 Casein zymography 
 
Casein zymography was used to visualise the activity of the individual calpains. A 
10% non-denaturing gel was prepared (0.225M Tris-HCL, pH 7.5, 10% acrylamide 
(37.5:1), 0.05% casein, and set with 0.06% ammonium persulphate and 0.06% 
TEMED). A 4% non-denaturing stacking gel (0.125M Tris-HCL, pH 6.8, 4% 
acrylamide, 0.1% ammonium persulphate, 0.1% TEMED) was prepared on top of the 
resolving gel. The gel was pre-run for 15 min at 125V at 4ºC in zymography running 
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buffer (25mM Tris-HCL, pH 8.3, 192mM Glycine, 1mM EGTA, 1mM DTT). 
Samples were mixed with zymogram loading buffer (0.04M Tris-HCL, pH 6.8, 6.5% 
glycerol, 0.005% Bromophenol Blue) and loaded onto the pre-run gel. The gels were 
run at 125 V for 150 min in 4ºC zymogram running buffer. After electrophoresis the 
gels were placed in calcium incubation buffer (20mM Tris-HCl, pH 7.4, 20mM 
CaCl2, 10mM DTT) overnight at room temperature to activate the calpains. After 
incubation the gels were rinsed in dH2O for 15 minutes and then stained with Simply 
Blue™ Safe Stain (Invitrogen, CA., USA) and destained with dH2O. Calpain activity 
appeared as transparent bands on a blue stained background. 
 
3.3 Results 
 
FPLC was used to purify calpain 1, calpain 2 (Figure 3-1) and the lens specific 
calpain Lp82. This resulted in the removal of unwanted proteins from the tissues and 
produced calpains that could be used in further experiments. 
 
Reactive Red Column
Mono Q Column
DEAE Ion Exchange Column
Sheep Lung
Phenyl Sepharose
Reactive Red Column
HiTrap® Phenyl 
Sepharose
C1 C2
 
Figure 3-1 Flow Chart of Calpain 1 and 2 purification from sheep lung using FPLC. Each 
chromatography step is labelled. Calpain 1 (C1) and calpain 2 (C2) are separated after the DEAE 
Ion Exchange Column.  
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3.3.1 Calpain 1 and 2 
 
After homogenisation and (NH4)2SO4 precipitation, FPLC was used to further purify 
the calpains. The first step was to remove the endogenous calpain inhibitor 
calpastatin. This was achieved using Phenyl Sepharose hydrophobic interaction 
chromatography (Figure 3-2). High UV absorbance (Blue) was observed when 
loading the sample onto the column indicating that several proteins did not bind to the 
Phenyl Sepharose. Once the unbound proteins were washed through the column, the 
calpains were eluted with a decreasing salt concentration as shown with the sharply 
decreasing conductivity (Red) and increasing protease activity as indicated by the 
fluorescence units (Bars). The active fractions were pooled (Tags 1-2). The pooled 
sample contained both calpain 1 and calpain 2.  
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Figure 3-2 Chromatogram from Phenyl Sepharose purification of the calpains. Lines indicate UV 
absorbance @ 280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain 
Activity). Fractions that were pooled were between Tags 1 and 2. 
 
Calpastatin was separated from the calpains in this step and eluted with the unbound 
fraction. When the calpastatin assay was used the unbound fraction had no change in 
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fluorescence over ten minutes (0 FU) compared to the positive control which had an 
increase in fluorescence (290 FU). 
 
DEAE ion exchange chromatography (Figure 3-3) was used to separate calpains 1 and 
2 found in the pooled sample obtained from Phenyl Sepharose chromatography.  
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Figure 3-3 Chromatogram of DEAE Ion Exchange. Lines indicate UV absorbance @ 280nm 
(Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain Activity). Tags 
indicate fractions that were pooled for Calpain activity, Tags 1-2 Calpain 1 and Tags 3-4 Calpain 
2. 
 
DEAE ion-exchange chromatography of the Phenyl Sepharose pooled fraction, 
resulted in 3 major protein peaks measured by absorbance (Blue) and BODIPY-Fl 
casein assay. The first peak was due to the initial conductivity increase and weakly 
bound proteins being eluted. The following two peaks of BODIPY-Fl casein activity 
contained calpains 1 and 2. Calpain 1 eluted between 120mM and 200mM NaCl, 
while calpain 2 eluted between 230mM and 340mM NaCl (Figure 3-3). The calpain 2 
peak had higher activity than calpain 1, indicating a higher abundance of calpain 2 
than calpain 1 in the lung. The two calpains were pooled separately as indicated by 
the tags (1-2 for calpain 1 and 3-4 for calpain 2). These samples were used for further 
purification. 
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 3.3.1.1 Calpain 2 continued 
 
To further purify the calpain 2 fraction a Reactive Red Agarose column was used. In 
initial experiments, a linear gradient was performed from 0.5-0M NaCl in Buffer A to 
elute the calpain 2. However the calpain 2 could not be eluted from the column, as it 
was bound tightly to the matrix. A solution with lower ionic strength was required. 
Therefore a gradient from Buffer A + 0.5M NaCl to dH2O was used and it eluted 
calpain 2 from the Reactive Red (Figure 3-4). Elution with dH2O resulted in a large 
peak of protein being eluted (Blue), which contained calpain 2. The active fractions 
were pooled (Tags 1-2). 
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Figure 3-4 Chromatogram of Calpain 2 on Reactive Red Sepharose. Lines indicate UV 
absorbance @ 280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain 
Activity). Tags 1-2 indicate area of calpain 2 that was pooled and used for further purification. 
 
The pooled calpain 2 from the Reactive Red column was further purified using a 
Mono Q® ion exchange column (Pharmacia, Uppsala, Sweden). The calpain was 
eluted with an increasing salt gradient from 0-1M NaCl in Buffer A. This elution 
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produced two major protein peaks (Figure 3-5) that corresponded to two areas of 
protease activity.  The second peak of protein and protease activity at 21-25 mL, 
contained two distinct peaks of UV absorbance. The second peak corresponded to a 
sharp increase in BODIPY FL -casein activity. This peak was pooled (Tags 1-2) and 
was subsequently used for all enzymatic proteolytic assays. 
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Figure 3-5 Chromatogram of final purification step from Mono Q column. Lines indicate UV 
absorbance @ 280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain 
Activity). The final calpain 2 was pooled from between Tags 1-2. 
 
The activity of the fractions collected after each step of the purification procedure was 
determined using the BODIPY-Fl Casein assay as described in 3.2.3.2.  
 
Column Activity/ml Total Activity Specific Activity % Recovery %Total Recovery
PS 19445 10694750 19445
DEAE 25985 4937150 16241 46 46
RR 28752 3018925 17970 61 28
MONO Q 32812 820292 41015 27 8  
Table 3-2 Specific activity from each step of the purification procedure for calpain 2. PS-Phenyl 
Sepharose (Figure 3-2), DEAE- DEAE Ion exchange (Figure 3-3), RR- Reactive Red agarose 
(Figure 3-4) and Mono Q- Mono Q (Figure 3-5). Activity/ml, Total Activity and Specific Activity 
are calculated as per 3.2.3.2. Percent Recovery is calculated as the percentage of total activity 
retained from previous step. Percent Total recovery is the percentage of total activity retained 
from the first Phenyl Sepharose column. 
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 3.3.1.2 Calpain 1 continued 
 
Following DEAE ion exchange separation, calpain 1 was further purified with 
Reactive Red Agarose. The interaction of calpain 1 with this matrix is unusual. The 
protein does not bind to Reactive Red but is retarded and moves through faster as the 
salt concentration increases. This can be seen in Figure 3-6, where the unbound 
fraction elutes as a large peak of absorbance at 20mL. The calpain 1 eluted when the 
conductivity increased (Red).  
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Figure 3-6 Chromatogram of Calpain 1 on Reactive Red Agarose. Lines indicate UV absorbance 
@ 280nm (Blue), conductivity mS (Red), Fluorescence Units, Bars represent Fluorescence Units 
(Calpain Activity). The final calpain 1 was pooled from between Tags 1-2. 
 
After Reactive Red Agarose the pooled calpain 1 was further purified and 
concentrated on a HiTrap® Phenyl Sepharose Column (Pharmacia, USA). Calpain 1 
bound to this column tightly and a decreasing salt gradient using dH2O was used to 
elute the calpain (Figure 3-7). 
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Figure 3-7 Calpain 1 on HiTrap® Phenyl Sepharose Column. Lines indicate UV absorbance @ 
280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain Activity). The 
final calpain 1 was pooled from between Tags 1-2. 
 
3.3.2 Lp82 purification 
 
Separation of total soluble lens protein during DEAE ion exchange chromatography 
resulted in the total lens proteins being separated into several protein peaks (Blue 
Figure 3-8).  The BODIPY-FL casein assay showed two distinct calcium dependent 
proteolytic peaks. The first peak contained Lp82 and calpain 1 and the second and 
more active peak contained calpain 2 as determined by casein zymography (Figure 
3-9) and western blot (Figure 3-10) analysis. Active fractions in each peak were 
combined.   
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Figure 3-8 Chromatogram of DEAE Ion exchange. Total soluble lens proteins were loaded onto 
the column and calpains were eluted with an increasing NaCl gradient. Lines indicate UV 
absorbance @ 280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain 
Activity). Tags  1-2 is Lp82 and calpain 1 and 3-4 is Calpain 2.  
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Figure 3-9 Casein zymography of Fractions from DEAE Chromatography of the Lens 
Homogenate. A) Total soluble lens proteins, B) Positive control of calpain 1, C) Positive control of 
Calpain 2, D) First peak from DEAE (Lp82 and Calpain 1), E) Second Peak from DEAE (calpain 
2). 
 
Zymography showed that the first peak of activity eluted from the DEAE column 
(Figure 3-8) was the lens specific Lp82, with a small amount of residual calpain 1 
(Figure 3-9, Lane D). The second peak of activity was calpain 2 (Figure 3-9, Lane E). 
Western blot analysis confirmed this finding (Figure 3-10). A sample of the first 
pooled peak reacted with an Lp82 antibody and the second peak was reactive only to 
the calpain 2 antibody. 
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Figure 3-10 Western Blot analysis from DEAE Ion Exchange purification of Lens Homogenate 
(Figure 3-8) Lane A, Peak 2 of activity, Lane B Peak 1 of activity, Blot I is reactive to Lp82 
antibody and Blot II reactive to Calpain 2 antibody. Mw molecular weight marker (kDa). 
 
The Lp82 containing fractions were further purified using gel filtration 
chromatography. This produced two peaks of proteolytic activity (Figure 3-11). To 
determine which peak contained the Lp82, the active fractions were subjected to 
western blot analysis. The first peak of activity was not reactive to the Lp82 antibody 
(Figure 3-12, Lane 13-15). The second peak (Lanes 17-19) was reactive to the Lp82 
antibody so these fraction were pooled for further purification. Both peaks were also 
assayed by western blot for calpain 1, which was detected in both peaks (Figure 3-13).    
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Figure 3-11 Gel filtration to further purify Lp82 from DEAE.  Lines indicate UV absorbance @ 
280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units (Calpain Activity). Tags 
1-2 Peak I, Tags 3-4 Peak II . 
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Figure 3-12 Western Blot analysis of the active fractions from the Gel Filtration (Figure 3-11). 
Lane numbers correspond to the fractions from the gel filtration chromatogram.  Lp82 is as 
indicated.  Mw Molecular weight marker (kDa). 
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Figure 3-13 Western Blot analysis of the two peaks of proteolytic activity from the Gel Filtration 
(Figure 3-11). Peak I, First peak of activity Tubes 12-15 and Peak II tubes 17-20 (Figure 3-11). 
Calpain 1 is as labelled. Mw) Molecular weight marker (kDa). 
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The final pooled Lp82 fraction was purified using a Reactive Red Agarose column. 
Initially Buffer A was used to elute the Lp82 from the Reactive Red, but Lp82 failed 
to elute from the column. H20 was used as the elution buffer to remove the Lp82. This 
produced 2 peaks of proteolytic activity as determined by the BODIPY-FL Casein 
system. The first peak did not bind to the Reactive Red matrix and was removed with 
the unbound fraction. None of the fractions in this peak were reactive to the Lp82 
antibody. However, this peak was reactive to the calpain 1 antibody (Figure 3-15). 
The second peak of proteolytic activity, occurring after elution with H2O, only 
showed reaction to the Lp82 antibody  and not to the calpain 1 antibody. The fractions 
under the peak were pooled for use in subsequent analysis.  
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Figure 3-14 Reactive red purification to further purify Lp82 from gel filtration.  Lines indicate 
UV absorbance @ 280nm (Blue), conductivity mS (Red), Bars represent Fluorescence Units 
(Calpain Activity). Lp82 was pooled from Tags 1-2. 
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Figure 3-15 Western Blot analysis of the two proteolytically active peaks from the Reactive Red 
column (Figure 3-14). PI =Peak one, PII = Peak two. Blot I used Lp82 antibody and Lp82 is 
labelled, Blot II used calpain 1 antibody and calpain 1 is labelled. 
 
The BODIPY-FL Casein assay was used to determine the specific activity after each 
of the purification steps (Table 3-3).  
 
Activity/ml Total Activity Specific Activity % Recovery % Total Recovery
Lens 2380 21420 31
DEAE 590 141600 236 661 661
GF 1400 25200 359 18 118
RR 2200 8800 1157 35 41  
Table 3-3 Specific activity from each step of the purification procedure for Lp82. Lens- Lens 
homogenate, DEAE- DEAE Ion exchange (Figure 3-8), GF-Gel filtration (Figure 3-11), RR- 
Reactive Red agarose (Figure 3-14). Activity/ml, total activity specific activity were calculated (as 
per 3.2.3.2). % Recovery is calculated as the percentage of total activity preserved from previous 
step. % Total recovery was the amount of activity retained from the lens homogenate. 
 
3.3.3 SDS-PAGE, Western blot and zymography 
 
To assess the effectiveness of each purification step, a combination of protein 
biochemistry techniques were used. Namely, SDS-PAGE, western blotting and casein 
zymography. 
 
 
 
3.3.3.1 Calpain 2 
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The relative purity of the calpain 2 at each step of the purification process was 
assessed by SDS-PAGE (Figure 3-16). At each purification step a number of protein 
species were removed. During the DEAE Ion exchange (Lane E) step calpain 2 
appeared to be eluting with a significantly larger protein (100kDa). This larger protein 
was removed during the Reactive Red step which resulted in a collected sample 
containing only the calpain 2 large subunit (Figure 3-16 upper arrow). The Mono Q 
step then concentrated the protein within the sample which allowed visualisation of 
the large subunit (76kDa) and small subunit (28kDa) of calpain 2 (Figure 3-16 lower 
arrow). 
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Figure 3-16 4-12% SDS-PAGE of the calpain 2 purification procedure. Lane, Mw) Molecular 
Weight Marker, Weights in kDa are to the left of the lane, A) Lung Homogenate, B) Total 
Soluble Lung Proteins, C) After NH4SO4 precipitation, D) After Phenyl Sepharose, E) After 
DEAE Ion Exchange, F) After Reactive Red, G) After Mono Q. The calpain subunits are 
indicated by arrows, the upper arrow indicating the large subunit and the lower arrow indicating 
the small subunit.    
 
To confirm the presence of calpain 2 in samples following the purification steps, 
western blot analysis (Figure 3-17) and casein zymography were used (Figure 3-18). 
Western blot of the large subunit of calpain 2 clearly shows a protein species at 
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76kDa. This was found in all the fractions obtained after the various purification 
steps. The intensity of the band increased as the purification proceeded.  
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Figure 3-17 Western Blot analysis of calpain 2 purification steps. Lane, Mw) Molecular Weight 
Marker Weights in kDa are to the left of the lane, A) Lung Homogenate, B) Total Soluble Lung 
Proteins, C) After NH4SO4 precipitation, D) After Phenyl Sepharose, E) After DEAE Ion 
Exchange, F) After Reactive Red, G) After Mono Q. 
 
Casein zymography (Figure 3-18) was also used to identify the calpains and to show 
that they were active. Calpain 1 can be identified as the higher band of activity and 
calpain 2 as the lower double band of activity.  Both calpain 1 and 2 were present up 
to the Phenyl Sepharose purification step (Lane D Figure 3-18). DEAE ion exchange 
chromatography separated the two calpains as illustrated by the lack of the upper 
calpain 1 proteolytic band in lane E. The double band associated with calpain 2 
represents the intact (upper band) and autolysed (lower band) forms of calpain 2. 
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Figure 3-18 Casein Zymography of samples from calpain 2 purification steps. Lane, A) Lung 
Homogenate, B) Total Soluble Lung Proteins, C) After NH4SO4 precipitation, D) After Phenyl 
Sepharose, E) After DEAE Ion Exchange, F) After Reactive Red, G) After Mono Q. Calpains 1 
and 2 are as indicated. 
 
3.3.3.2 Calpain 1 
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The first four steps of the purification process removed several proteins from the 
calpain 1 containing fractions (Figure 3-19, Lane A-D). The DEAE fraction that 
separated the calpains 1 and 2 still contained some extraneous proteins (Figure 3-19 
Lane E). The Reactive Red step removed most of these undesirable proteins except 
for one large protein (150kDa) (Lane F). The final step on HiTrap® Phenyl Sepharose 
also failed to remove this large protein. Nevertheless, the large subunit (79kDa) 
(upper arrow) and the small regulatory  subunit (lower arrow) are visible in the 
concentrated sample.  
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Figure 3-19 4-12% SDS-PAGE of the calpain 1 purification procedure. Lane, Mw) Molecular 
Weight Marker, Weights in kDa are to the left of the lane, A) Lung Homogenate, B) Total 
Soluble Lung Proteins, C) After NH4SO4 precipitation, D) After Phenyl Sepharose, E) After 
DEAE Ion Exchange, F) After Reactive Red, G) HiTrap Phenyl Sepharose. The calpain subunits 
are indicated by arrows, the upper arrow indicating the large subunit and the lower arrow 
indicating the small subunit 
 
Western blot analysis was used to confirm the presence of calpain 1 in all the fractions 
collected at the various stages of the purification process (Figure 3-20). Western blot 
showed there was an increase in the intensity of the calpain 1 band as the purification 
procedure progressed and confirmed that concentrated calpain 1 was present in the 
final sample. 
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Figure 3-20 Western Blot analysis of calpain 1 purification steps. Lane, Mw) Molecular Weight 
Marker Weights, in kDa are to the left of the lane, A) Lung Homogenate, B) Total Soluble Lung 
Proteins, C) After NH4SO4 precipitation, D) After Phenyl Sepharose, E) After DEAE Ion 
Exchange, F) After Reactive Red, G) HiTrap Phenyl Sepharose. 
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Figure 3-21 Casein Zymography of samples from calpain 1 purification steps. Lane, A) Lung 
Homogenate, B) Total Soluble Lung Proteins, C) After NH4SO4 precipitation, D) After Phenyl 
Sepharose, E) After DEAE Ion Exchange, F) After Reactive Red, G) HiTrap Phenyl Sepharose. 
Calpains 1 and 2 are as indicated. 
 
Casein zymography was used to confirm that the collected samples contained active 
calpain 1. Both calpain 1 and 2 were present in the fractions until the DEAE 
separation following which there was only residual calpain 2 in the sample. This 
residual calpain 2 activity was removed from the calpain 1 fraction in the subsequent 
Reactive Red column and as a consequence the final fraction only contained calpain 
1.   
 
3.3.3.3 Lp82 
 
The purity of Lp82 was first assessed by SDS-PAGE (Figure 3-22). Although each 
step in the purification process removed some proteins, the final Lp82 fraction 
contained some contaminants. The main contaminant was the α-crystallin subunits 
αA- and αB-crystallin (Figure 3-22 Lane D). This identification was based on the size 
of the two bands of 20kDa and 19kDa, as well as the spots on 2DE (Figure 5-5). The 
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Lp82 protein was visualised in the final sample (Lane D) and has a molecular weight 
of 82kDa. 
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Figure 3-22 4-12% SDS-PAGE of Lp82 Purification Procedure. Mw) Molecular Weight Marker, 
weights in kDa on left of gel. A) Lens Homogenate, B) Lp82 Fraction after DEAE 
chromatography, C) After Gel Filtration chromatography, D) After Reactive Red 
chromatography.  
 
Western blot analysis on each fraction at each stage of purification was carried out 
(Figure 3-23). In the last two purification steps (Lanes C and D) the Lp82 could be 
visualised by western blot. The Lp82 had a molecular weight of 82kDa.  
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Figure 3-23 Western Blot analysis of Lp82 Purification Procedure. Mw) Molecular Weight 
Marker weights in kDa on left of gel. A) Lens Homogenate, B) Lp82 Fraction after DEAE 
chromatography, C) After Gel Filtration chromatography, D) After Reactive red 
chromatography.  
 
3.3.4 Calcium and pH requirement 
 
To determine the calcium dependence of calpain 2, the BODIPY-FL casein assay was 
utilised. Calpain 2 was purified in buffers without the metal ion chelators EDTA and 
EGTA. Calpain 2 was not active at concentrations of 50μM Ca2+ (Figure 3-24) and 
reached a maximum activity at 500μM with 50% of maximum activity occurring at 
190μM Ca2+.  
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Figure 3-24 Calcium concentration vs Calpain 2 activity, expressed as a % of maximum activity. 
Maximum activity was seen at 500μM. Error bars represent ± 1 S.D. 
 
Calpain 2 was active from across a wide range of pH’s, it exhibited low activity below 
5.4 and no activity above 8.4. The optimal pH for calpain 2 activity was 7.6.  
 
60 
Calpain 2
-20
0
20
40
60
80
100
120
5.4 5.8 6.2 6.6 7 7.4 7.8 8.2 8.6
pH
%
 M
ax
im
um
 
Figure 3-25 Graph of pH vs calpain 2 activity expressed as % of maximum . Bars represent ± 1 
S.D. determined by t-test.  
 
3.4 Discussion 
 
These experiments aimed to purify and characterise the three main calpains in the 
ovine lens, the ubiquitous calpains 1 and 2 as well as the lens specific Lp82. All three 
calpains were purified using a series of FPLC steps, with several different types of 
chromatography media used to achieve samples specific for each of the three calpains. 
 
Calpain 1 and 2 were both purified from lung tissue. The first purification step 
involved precipitation with ammonium sulphate to 50%. The calpains precipitate out 
between 30-45% ammonium sulphate and the calpastatin at 40-50% (Goll et al., 
2003). Therefore the resuspended precipitate still contained both the calpains and 
calpastatin. 
 
Most calpain purifications use a combination of Phenyl Sepharose and DEAE ion 
exchange as the first two steps (Thompson and Goll, 2000).  In this thesis Phenyl 
Sepharose was used as the first chromatography step for two reasons. Firstly, 
calpastatin does not bind to Phenyl Sepharose in the conditions used and consequently 
the calpains can be eluted from the column without their inhibitor (Figure 3-2). In 
comparison, if DEAE is used as the first chromatography step the calpastatin 
containing fractions overlap with the fractions containing calpain 1 (Thompson and 
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Goll, 2000, Goll et al., 2003). The fractions then have to be subsequently applied to 
another column to enable a separation of calpastatin from calpain 1. Secondly, the 
extract after ammonium sulphate precipitation already contains a large amount of salt 
and would require dialysis to remove the salt before applying the extract to a DEAE 
column to allow calpain binding.  The only negative factor about using Phenyl 
Sepharose first is that the two calpains elute together. 
 
The separation of calpain 1 from calpain 2 was achieved using ion-exchange 
chromatography on DEAE. Calpain 1 eluted between 120mM and 200mM NaCl and 
calpain 2 between 230mM and 340mM NaCl (Figure 3-3), which is comparable to the 
90-180mM KCl and 180-320mM KCl for calpains 1 and 2 respectively reported by 
Thompson and Goll, 2000. There was a small amount of overlap between the calpains 
with the calpain 1 fractions containing a small amount of calpain 2 (Figure 3-21, Lane 
E). 
 
For the purification of calpain 1 and 2 Reactive Red Agarose was used as the third 
step. This step proved highly effective at separating the calpains from other unwanted 
proteins as well separating calpain 1 and 2 from each other. This was due to the fact 
that the interaction of calpains 1 and 2 with Reactive Red are completely different. 
Calpain 2 behaves with the Reactive Red Agarose similar to a hydrophobic interaction 
(DeMartino and Croall, 1983, Thompson and Goll, 2000). In this research calpain 2 
was found to bind tightly to the Reactive Red matrix and elution with a low ionic 
strength buffer of 20mM MOPS + 5mM βME was not sufficient to elute calpain 2 
from the column. H2O was found to be an effective eluent as that had a sufficiently 
low ionic strength to elute the calpain 2 (Figure 3-4).   
 
Calpain 1’s interaction with the Reactive Red Agarose is the opposite of calpain 2 and 
is often variable in its interaction. Calpain 1 does not bind to the matrix but is retarded 
and can be “chased off” with 1M NaCl (Thompson and Goll, 2000) (V. Thompson, 
Personal Communication, 2007). This was seen with the ovine calpain 1 purification, 
where the calpain “eluted” with 1M NaCl (Figure 3-6). Therefore the Reactive Red 
provided another method to separate the two calpains and is more powerful than the 
DEAE, because the interactions of calpains 1 and 2 are at the opposite ends of the 
spectrum in terms of their elution from Reactive Red.  
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 Calpain 2 was concentrated and further purified using Mono Q. This resulted in a 
sample containing no other contaminating proteins (Figure 3-16, Lane G). Overall 
20mg of calpain 2 was isolated from the initial 300g of lung tissue. The recovered 
activity of this fraction was 8% of the total calpain activity recovered from the first 
Phenyl Sepharose column.  
 
After “elution” from the Reactive Red Agarose,  there was a large volume of calpain 1 
which was concentrated using Hitrap® Phenyl Sepharose. This final sample contained 
two major proteins, calpain 1 and a unknown protein of higher molecular weight 
(Figure 3-19 Lane G) 
 
Utilisation of all these purification procedures produced calpain 1 and 2 samples that 
were suitable for further studies.  
 
Purification of Lp82 was more difficult than the other two calpains, due to the fact 
that Lp82 is lens specific and is only found in young lamb lenses (Robertson et al., 
2005). Lamb lenses could only be collected once a year as sheep only produce one set 
of lambs per year. An additional difficulty was that the lens contains large amounts of 
protein of which 90% is crystallins. Thus, the amount of sample that could be purified 
was low and consequently the yield of Lp82 was low. 
 
Within the lamb lens, calpain 2 is the most abundant and active of the calpains (Figure 
3-8, Figure 3-9 Lane A) (Robertson et al., 2005). The first purification step used in the 
isolation of Lp82 was a DEAE ion exchange column to separate Lp82 from calpain 2.  
Lp82 eluted from the DEAE between 115mM to 163mM NaCl which is within the 
same range that calpain 1 is eluted from DEAE (120-200mM NaCl). Indeed the two 
calpains co-eluted (Figure 3-8). Calpain 2 eluted later with 200mM NaCl and was 
separated from Lp82 (Figure 3-10). Ueda et al., in 2001 claimed that in the bovine 
lens Lp82 eluted separately from calpain 1 when using DEAE ion exchange and stated 
that calpain 1 eluted with calpastatin earlier than Lp82. The statements were based on 
a paper which purified calpain 1 from rat lens (Yoshida et al., 1985). Ueda et al., 
(2001) never tested the Lp82 containing fraction for the presence of calpain 1. 
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Gel filtration resulted in two peaks with BODIPY-FL casein activity (Figure 3-11) 
and Western blot analysis showed that the second peak was reactive to Lp82 (Figure 
3-12). The first peak of activity showed no reaction to Lp82 antibody but was reactive 
to calpain 1 (Figure 3-13). Gel filtration of the bovine Lp82 from DEAE also 
produced two peaks of activity (Ueda et al., 2001), but only the second peak was 
reactive to Lp82 antibodies. The authors attributed the activity in the first peak to 
leucine amino peptidase activity. In this study calpain 1 was identified as providing 
the BODIPY-FL casein activity. Ueda et al., (2001) did not test for calpain 1. They 
tested for calpain 2 and Lp82 and assumed that calpain 1 had been removed in the 
previous ion exchange step. In this study, calpain 1 reactivity was also observed in the 
second peak that contained Lp82 (Figure 3-13 Peak II). 
 
As mentioned previously calpain purification on Reactive Red Agarose can be 
difficult. This study is the first to purify Lp82 using Reactive Red and proved to be a 
very useful tool for calpain purification. During Reactive Red purification of Lp82 it 
was found that Lp82 has a similar affinity to Reactive Red as calpain 2 and, 
consequently, bound to the matrix tightly. As with calpain 2, H2O was used to elute 
Lp82 from the Reactive Red (Figure 3-14). This final step was very useful as it 
enabled the removal of any calpain 1 that remained after gel filtration. As mentioned 
above calpain 1 does not bind to Reactive Red and is, therefore, washed out with any 
unbound proteins during purification. BODIPY-FL casein activity can be seen in the 
unbound protein fraction (Figure 3-14). Western blot analysis of this fraction was 
positive for calpain 1 but not for Lp82 (Figure 3-15 Lane PI). The second peak of 
BODIPY-Fl casein activity observed after elution with H2O, was positive for Lp82 
but not for calpain 1 (Figure 3-15 Lane PII). 
 
The percentage recovery of Lp82 after each purification step was significant. Initially 
there was a 661% increase in activity on progression from the lens homogenate to the 
Lp82 containing fraction from the DEAE column (Table 3-3). This was due to the 
presence of the protease inhibitor cocktail in the lens homogenate which was removed 
during the first chromatography step. Gel filtration retained 17% of the activity 
applied from the DEAE column. This reduction in activity is probably due to the loss 
of some calpain 1. Over all in the Lp82 fraction there was a 41% recovery of 
BODIPY-FL casein activity from the original lens homogenate. However due to the 
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presence of protease inhibitors in the lens homogenate sample this figure is not 
indicative of the actual recovery. There was a 6% recovery of activity from the DEAE 
sample but the DEAE fraction also contained calpain 1 which would contribute to 
some of the activity.  
  
Although the Lp82 purification procedure removed the other two calpains present in 
the sheep lens, it did not produce a homogenous solution containing Lp82 only. 
However Lp82 was concentrated to such a level that it could be visualised on SDS-
PAGE (Figure 3-22 Lane D) and reacted to western blot analysis (Figure 3-23 Lane 
D) when 20μg of protein was loaded. The major contaminating protein was α-
crystallin which was still present in the final sample (Figure 3-22 Lane D). This α-
crystallin could not be removed despite several attempts at using different columns 
under different conditions.  
 
3.5 Conclusion 
 
In conclusion all three calpains; calpains 1, 2 and Lp82, that are present in the ovine 
lens were able to be purified. They were purified using different FPLC techniques. 
These purified calpains were used in further experiments (Chapter 5) to examine their 
role in ovine cataractogenesis  
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   Chapter 4 
Ovine Crystallins  
 
4.1 Introduction 
 
For the eye to function effectively it needs to focus light on to the retina. This 
focusing is achieved by the lens which has the ability to change shape to 
accommodate near or far objects. The lens needs to be completely transparent to allow 
the passage of all the light entering the eye onto the retina. Any disruption to the light 
passing through the lens can lead to blindness. 
 
One way this transparency is generated and maintained is by the order and structure of 
the unique lens proteins, the crystallins. The crystallins can make up to 90% of the 
water soluble lens proteins (Andley, 2007). In mammalian lenses there are 3 groups of 
crystallins, α, β and γ crystallins. All three of these are found in the sheep lens 
(Robertson et al., 2008). 
 
α-crystallin is a multimeric protein made of two polypeptide subunits, αA which is 
acidic (pI 5.52) and the more basic αB (pI 6.57). They have molecular weights of 
19875Da and 20148Da respectively (Robertson et al., 2008). The α-crystallins found 
in sheep are similar to those found in other species. For example αA and αB share 
99% and 98% sequence homology with bovine α-crystallins respectively, and 93% 
and 97% sequence homology with human α-crystallins (Robertson et al., 2008). Early 
sequence analysis revealed that the α-crystallins were related to the small heat shock 
proteins (Ingolia and Craig, 1982). Later α-crystallins were shown to act as molecular 
chaperones and prevent the thermal aggregation of alcohol dehydrogenase, β and γ- 
crystallins (Horwitz, 1992). In vitro α-crystallin can prevent the heat-induced 
denaturation of both β and γ-crystallins (Kelley et al., 1993, Augusteyn et al., 2002). 
It is proposed that α-crystallin acts as a chaperone to prevent the insolubilisation of 
other lens proteins during ageing and that overwhelming or disrupting this system 
may lead to cataract formation.  
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 The β and γ crystallins are part of the βγ-superfamily and  make up the rest of the 
proteins in the crystallin family. The β and γ-crystallins are structurally and 
evolutionary related, with both containing a Greek key motif. The β-crystallins form 
multimers up to 200kDa in vivo whereas the γ-crystallins are monomeric proteins. The 
major difference in their primary structure are that the β-crystallins contain N- and C-
termini extensions (Graw, 1997).  There are seven mammalian β-crystallins. Four are 
acidic (βA1, βA2, βA3 and  βA4) and three basic (βB1, βB2 and βB3) (Graw, 1997). 
The β-crystallins form large multimeric proteins and contribute to the structural and 
refractive index properties of the lens. The γ-crystallin on the other hand are 
monomeric proteins and the smallest of the crystallins. There are seven mammalian γ-
crystallin (γA-γF and γS). Like the β-crystallins the γ-crystallins role in the lens is to 
contribute to the structure and refractive properties of the lens (Graw, 1997).   
 
During lens development the crystallins undergo extensive post-translational 
modifications including deamidation, phosphorylation, truncation and disulfide bond 
formation (Lampi et al., 1998, Hanson et al., 2000, Hains and Truscott, 2007b). All of 
these modifications can be seen in normal lens maturation as well as cataract 
formation. Of particular interest to this study is the truncation of the crystallins which 
occurs throughout lens maturation (Lund et al., 1996, Ma et al., 1998, Lampi et al., 
1998, Ueda et al., 2002a, Zhang et al., 2003). Both α and β-crystallins are truncated 
with lens ageing. Truncated α-crystallins are found in rat (Ueda et al., 2002b), mouse 
(Ueda et al., 2002a), bovine (Takemoto, 1995b) and human lenses (Takemoto, 1995b, 
Lund et al., 1996, Ma et al., 1998). Some of the β-crystallins are truncated in rat 
(David et al., 1994), mouse (Ueda et al., 2002a), bovine (Takemoto, 1995a, Shih et 
al., 1998) and human lenses (Takemoto, 1995b, Lund et al., 1996, Ma et al., 1998). 
 
Cataracts are described as an opacification of the lens that leads to scattering of the 
light that enters the eye resulting in partial and ultimately full blindness. There are 
significant post-translational modifications to the crystallins during cataract 
formation, including deamidation, phosphorylation, truncation, disulfide bond 
formation, oxidation and methylation (Ueda et al., 2002b, Hains and Truscott, 2007b).  
A central interest to this study is the truncation of the crystallins during 
cataractogenesis. It has been shown that increased truncation of α and β crystallin are 
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found in cataractous lenses from sheep (Robertson et al., 2008) and rats (David and 
Shearer, 1984, Ueda et al., 2002b, Takeuchi et al., 2004). It is proposed that 
truncation of the β-crystallins results in aggregation and insolubilisation of the 
crystallin which leads to light scattering. Truncation of α-crystallin has a different 
effect where it reduces the chaperone activity of α-crystallin. These two events 
contribute to the formation of cataracts.  
 
The purpose of these experiments is to examine the ovine crystallins. In particular the  
purification of α and β crystallins from the lens, mass determination, the changes in 
crystallins profiles with ageing and maturation in the ovine lens and the changes in 
crystallin profiles during the different stages of cataract formation. Only α and β-
crystallins were analysed in these experiments due to difficulties in resolving the γ-
crystallins on gel electrophoresis. This was achieved with a combination of FPLC, gel 
electrophoresis and mass spectrometry. Chromatography was used to separate the 
crystallins into families, gel electrophoresis to visualise the changes in the crystallin 
profiles and mass spectrometry to identify the crystallins and their post-translational 
modifications. 
  
4.2 Methods 
 
4.2.1 Crystallin separation 
 
Gel filtration FPLC was used to separate the crystallins into α-, β- and γ- crystallins. 
Gel filtration separates proteins on the basis of their size with the largest proteins 
leaving the column first and the smallest proteins last. A Superose 6 300/10 
(Pharmacia, Uppsala, Sweden) column was equilibrated in Buffer A (20mM MOPS 
pH 7.5, 2mM EGTA, 2mM EDTA and 5mM β-ME). One hundred microlitres of total 
soluble lens protein containing approximately 650μg of protein, from a 4 month old 
lens, was injected on to the column and the lens proteins were separated with a 
0.4mL/min flow of Buffer A, 30 x 1mL fractions were collected. 
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SDS-PAGE, using the BioRad Mini Protean System, was performed to determine 
which peaks of absorbance contained the relevant proteins. A 15% SDS resolving gel 
(0.4M Tris-HCl pH 8.8, 0.1%SDS, 15% Bis-acrylamide (BioRad, Ca, USA)) with 4% 
stacking gel (0.125M Tris-HCl pH 6.8, 0.1%SDS, 4% Bis Acrylamide (BioRad, Ca, 
USA)) was prepared. Each fraction from the gel filtration run was separated on the 
gel, by taking a 15μL aliquot and adding 3μL of SDS Loading Buffer (350mM Tris-
HCl, pH 6.8: 10% SDS, 30% Glycerol, 5% βME, 0,012% Bromophenol Blue). Each 
sample was heated at 90ºC for 5 min to denature the protein. Samples were loaded and 
the gel was run at 90 V for 15 min and then 180 V for 60 min in SDS Running buffer 
(30mM Tris, 20mM Glycine, 1% SDS). Following electrophoresis the gels were 
stained in Simply Blue stain (Pierce, Il., USA). Relevant fractions with α, β and γ 
crystallins were pooled and protein concentrations determined by BCA assay (Pierce, 
USA). 
 
4.2.2 Soluble and insoluble protein isolation 
 
Eyes were surgically removed post-mortem from fetal, 6 month and 8 year old sheep 
and cataractous sheep with stage 0, 1, 3 and 6 cataracts (Figure 1-8). The lens was 
extracted via a posterior approach, and weighed after removal. The lens epithelium 
was removed and the lens homogenised using a glass homogenisor in 3ml/g of Buffer 
A containing Minicomplete protease inhibitor (Roche, Germany). Lens homogenates 
were centrifuged at 10000 x g for 45 min (Eppendorf, Centrifuge 5415R, Hamburg, 
Germany) to separate the soluble and insoluble lens proteins. The supernatant (Water 
Soluble Fraction, WSF) was removed and stored at -20ºC. The pellet, containing the 
insoluble lens proteins, was washed 3 times with buffer A to remove any residual 
soluble proteins. Urea soluble proteins were extracted by resuspending the pellet of 
insoluble proteins in 6M urea. The suspension was centrifuged at 10000 x g for 45 
min to separate the urea soluble and insoluble proteins. The urea soluble fraction 
(USF) was pooled and stored at -20ºC. BCA assay was used to determine the protein 
concentration of the WSF and USF. 
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4.2.3 2DE  
 
To identify and measure the molecular mass of the three different crystallins, two 
dimensional electrophoresis (2DE) was used. First dimensional focusing was 
performed using pH 3-10 non-linear 18cm Immobilised pH Gradient (IPG) strips 
(BioRad, Ca., USA). Either 100μg (for individual crystallins) or 400μg (whole lens 
samples) of protein was rehydrated in 300μL of rehydration buffer (8M Urea, 2% 
CHAPS, 50mM DTT, 2% 3-10 Biolyte buffer (BioRad, Ca., USA) 2% Glycerol and 
0.001% Bromophenol Blue) and added to each strip. Focusing was performed on a 
Protean IEF Cell (BioRad, Ca., USA), for 70000Vh. Focused IPG strips were stored 
at -20ºC until the second dimension was performed. 
 
The focused strips were equilibrated twice for the second dimension in equilibration 
buffer (6M Urea, 50mM tris-HCl, 30% Glycerol, 2% SDS and 0.001% Bromophenol 
blue). The first equilibration for 15 min contained 2% dithiothreitol and the second 15 
min equilibration contained 2.5% iodoacetamide. The strips were fixed to the top of, 
16cm x 20cm 15% SDS-PAGE gels (380mM Tris-HCL, pH 8.8; 15% Bis-
Acrylamide, 0.1% SDS) with a 4% SDS-Stacking Gel (125mM Tris-HCL pH 6.8; 4% 
Bis Acrylamide, 0.1% SDS), with 1% agarose in SDS running buffer. The gels were 
run for 2 hr at 25V and then 20 hr at 100V, in SDS running buffer at 4ºC.  
 
All samples were run in duplicate so that the gels could be stained in two different 
ways. One gel was stained with Coomassie Blue for visualisation and MALDI-TOF 
analysis and the other gel was zinc negative stained for protein elution and whole 
mass measurement. 
 
Coomassie blue staining involved the gel being washed 3 times 5 min in 5mM HCl, 
then staining overnight in 0.005% Coomassie blue (R-250) in 5mM HCl. Destaining 
was achieved using 5mM HCl.  
 
For zinc negative staining, the gels were washed for 5 min in 1% NaHCO3, then 
incubated for 30 min in 200mM imidazole and 0.1% SDS. The gels was subsequently 
washed 3 times for 30s with dH2O, and finally stained with 0.1M zinc acetate.  
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 4.2.4 Mass determination 
 
Proteins were eluted from 2-DE gels and their molecular mass determined. Following 
negative staining using zinc-imidazole, spots from single gels were excised, shaken 
twice for 15 min in 192 mM glycine, 25 mM Tris base, 50 mM DTT, 0.1% SDS, and 
crushed by passing through a 20μm stainless steel frit using a 0.5 mL gas tight 
syringe.  One hundred and fifty microlitres of 96 mM glycine, 12.5 mM Tris base, 50 
mM DTT was then added to the syringe to transfer the remaining gel particles into a 
centrifuge tube, and the resulting slurry was shaken for 30 min.  The slurry was then 
transferred to an Ultrafree-MC microcentrifuge filter (UFC30HV00, Millipore, 
Bedford, MA) and centrifuged for 15 min at 13000 x g, an additional 50 μL of the 
above solution added, and the device centrifuged again.  The collected liquid was then 
dried by vacuum centrifugation and redissolved in 50 μL of 5% formic acid. The 
eluted proteins were injected onto a 1.0 x 250 mm C4 column and their masses were 
determined on-line, by electrospray ionization mass spectrometry on a model LCG 
iontrap (ThermoFinnigan, San Jose, California, USA).  A 20 μL/min flow rate and 2-
60% acetonitrile gradient over 50 min was used, and 0.05% TFA was added to the 
mobile phase to prevent formation of SDS-protein adducts during mass analysis. 
Samples were autoinjected and concentrated using a micro protein trap cartridge. 
 
In-gel trypsinization was performed as previously described (Wilmarth et al., 2004) 
and digests were analyzed by LC-MS (Wilmarth et al., 2004) to collect MS/MS 
spectra using an LCQ Classic ion trap mass spectrometer (ThermoFinnigan, San Jose, 
CA).  Proteins were identified using SEQUEST software (Thermo Finnigan) to 
correlate experimental MS/MS spectra with theoretical MS/MS spectra calculated 
from peptide sequences in a bovine subset of the Swiss-Prot protein database (Swiss-
Prot, Swiss Institute of Bioinformatics, Geneva, Switzerland) supplemented with the 
sequences of sheep αA, αB, and βB3 crystallins (Robertson et al., 2008).  SEQUEST 
results were filtered using DTASelect (Tabb et al., 2002). DeltaCN values greater 
than 0.08 were required and identified peptides had to exceed XCorr values of 2.0, 
2.5, and 3.8 for +1, +2, and +3 ions, respectively. All identified proteins also required 
two or more unique peptide matches per entry for a positive identification. 
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 4.3 Results 
 
4.3.1 Crystallin separation 
 
Gel filtration chromatography was used to separate the crystallins into their subunits.  
One hundred microlitres of total lens soluble proteins from a 4 month old lens was 
separated on a Superose 6 gel filtration column (Figure 4-1). 
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Figure 4-1 Gel filtration chromatogram of the total soluble proteins from a 4 month old sheep 
lens. UV absorbance @ 280nm is indicated by the Blue line. Fraction numbers (11-25) are on the 
upper x axis. 
 
To determine which crystallins were in each fraction and peak of the chromatogram 
(Figure 4-1), the fractions were run on a 15 % SDS-PAGE gel (Figure 4-2).  
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 Figure 4-2 15 % SDS-PAGE of each fraction from  the gel filtration separation of total soluble 
lens proteins. Numbers (12-24) indicate the fractions from (Figure 4-1), MW- Molecular Weight 
Marker (kDa). α, β, and γ-cryst labels show the crystallin fractions pooled for further analysis. 
 
Gel filtration of the total lens soluble proteins resulted in separation of the lens 
crystallins into their three groups (Figure 4-1 and Figure 4-2). The large α-crystallins 
were the first to elute from the column followed by the β-crystallins and then the 
monomeric γ-crystallins. The fractions were pooled according to the labels in Figure 
4-2. The α-crystallins had masses between 18 and 21kDa, β-crystallins 21-30kDa and 
γ-crystallin 19kDa. The BCA assay (3.2.3.4) was used to determine protein 
concentrations. The pooled crystallin fractions were used for further analysis.  
 
4.3.2 Individual crystallins 
 
The separated crystallins were run on 2DE for further identification and their whole 
mass measured by mass spectrometry. 
 
 
Figure 4-3 2DE of the α-crystallin fraction from separation using gel filtration. Numbers indicate 
the different α-crystallins according to (Table 4-1). A1-αA+phos, A2- αA, A3, αB+phos, A4-αB. 
Molecular weight (MW) in kDa and pH range are as indicated. 
 
2DE of the α-crystallin showed four major protein species (Figure 4-3 A1-A4). The 
four spots were extracted, the protein identified and the whole mass measured (Table 
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4-1). Two of the four proteins found were intact αA (A2) and αB (A4). The same 
proteins were found with a mass increase of 80Da and a positive shift on the gel (A1 
and A3 respectively) which is indicative of a single phosphorylation (αA+phos (A1) 
and αB+phos (A3)). The other spots on the gel were too small to be sequenced 
 
Spot ID Mass (Da) Modification 
A1 αA 19954.5 +Phos 
A2 αA 19874.5 Intact 
A3 αB 20187.5 +Phos 
A4 αB 20108.6 Intact 
Table 4-1 Table of α-crystallin spots from Figure 4-3, Masses and modifications were determined 
by whole mass measurement. Identification of each spot was performed by MALDI-TOF analysis 
and comparison to known ovine sequences. 
 
2DE of the β-crystallin fraction revealed 20 different β-crystallin species which were  
identified and their masses measured. At present the only ovine β-crystallin sequence 
that has been determined is βB3 (Robertson et al., 2008), therefore to identify the 
isolated β-crystallin spots the sequences derived from MADLI-TOF analysis were 
compared with the complete bovine lens proteins. Post translational modifications of 
the ovine β-crystallins  were determined by comparison to the equivalent bovine 2DE 
(Shih et al., 1998) and the comparison of the whole mass measurement to that of the 
bovine β-crystallins and the ovine βB3 sequence (Robertson et al., 2008) 
 
 
Figure 4-4 2DE of the  β-crystallin. Numbers indicate the different β-crystallins according to 
Table 4-2. Molecular weight (MW) in kDa and pH range are as indicated. 
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Spot Protein (ID) Mass Bovine Equivalent 
1 βB1 28055.9 βB11-252
2 βB1 26743.0 βB115-252  
3 βA3 25828.3 βA3 Mod 
4 βA3 25572.3 βA3  
5 βA3/βA1 25756.3 N/A  
6 βB3 24323.8 βB3 Deamidation 
7 βB2 23322.8 βB2 Deamidation 
8 βB3 24321.9 βB3 
9 βB2 23321.3 βB2  
10 βB3 24323.9 N/A 
11 βB3 23302.4 βB310-210
12 βA3/βA1 24212.1 βA312-215
13 βA3/βA1 23038.2 βA323-215
14 βA3/βA1 23497.3 βA1 
15 βA2 22387.2 βA2 
16 βA3/βA1 23496.6 βA1 
17 βA4 22879.1 βA4 Mod 
18 βA4 22696.4 βA4 
19 βA4 22912.6 βA4 Mod 
20 βA4 22752.9 βA4 Mod 
Table 4-2 Table of protein spots from Figure 4-4. Masses were determined by whole mass 
measurement. Identification of each spot was performed by MALDI-TOF analysis (see 4.2.4)  
Bovine equivalents were determined by comparison with Shih et al., (1998) and personal 
communication with L. David, 2005. N/A = not available.  
 
4.3.3 Crystallin modification with age 
 
To determine the exact crystallin modifications that are associated with 
cataractogenesis, the crystallin changes that occur in normal ovine lenses during 
ageing were established first. Then comparison could be made to the changes during 
cataractogenesis. Lens maturation was determined by comparing the crystallin 
profiles of lenses from fetal, 6 month and 8 year old sheep. The WSF and USF 
proteins from lenses of the different ages were compared.  
75 
 The percentage total soluble protein content decreased as the lens aged from fetal to 8 
years of age (Figure 4-5). There was little insoluble protein in the fetal lens and the 
amount of insoluble protein increased as the lens aged until it made up 30% of the 
total lens wet weight.  
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Figure 4-5 Total soluble (?) and insoluble (?) protein from lenses of different ages, expressed as 
a percentage of total lens wet weight.  
 
4.3.3.1 Modifications of α-crystallins with age 
 
During maturation of the lens there is modification of the α-crystallins (Figure 4-6 and 
Figure 4-7). Both αA and αB were phosphorylated in the fetal lens (Figure 4-6 Gel A 
Spots A1 and A3 respectively). This phosphorylation increased as the lens aged as 
seen by the increase in the size of spots A1 and A3 in gels A-C. The phosphorylation 
increased to the extent that the phosphorylated form of αA (Spot A1) was the major 
form of αA in the WSF of the 8 year old lens. The phosphorylation of αB did not 
increase to the same extent. Consequently, unmodified αB (A4) was still the most 
prominent form of αB in the 8 year old lens.  
 
Truncation of the α-crystallins occurs at all ages in the lens. There are three 
truncations of αA crystallin αA1-154 (A6), αA1-151 (A7) and αA1-157 (A18) which are 
all found in the WSF of the fetal and 6 month old lenses. However in the WSF of the 
8 year old lens αA1-151 (A7) was absent but was identified in the USF. The opposite is 
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d lens. 
found for αA1-154 (A6) where it was identified in the USF but not the WSF. In the 
aged lens a new protein species was identified (A12) but the whole mass and 
truncation could not be determined. There are two truncations of αB1-175, αB1-170 (A5) 
and αB1-174 (A15) with 5 and 1 residues missing from the C-terminus respectively. 
The truncation αB1-174 was also found in a phosphorylated form (A15) based on its 
position after 2DE but the mass could not be determined. Within the WSF, as the lens 
ages, the αB1-174 truncation and its phosphorylated forms are found at approximately 
the same abundance.  αB1-170 is present in fetal lenses and those of a 6 month old 
sheep but there is none in the aged lens (Figure 4-6 Gels A,B and C).  
 
In the fetal lens αA was deamidated (A13) and the amount of deamidated αA did not 
increase as the lens aged. There is also deamidation of the phosphorylated form of 
αA-phos (A14). In contrast to the deamidation of the unmodified α-crystallins, the 
deamidation of the phosphorylated form of αA increased as the lens aged. There is no 
deamidation in the fetal lens or 6 month old lens of αA-phos but there are large 
amounts of deamidated αA-phos in the 8 year old lens. 
  
Within the USF (Figure 4-7) of the same lenses there are modifications similar to 
those seen in the WSF. There are however some differences in the proteins found in 
the WSF and the USF. The truncation product αA1-151 (A7) is not present in the WSF 
of the aged lens but is present in the USF. Within the USF there is an increase in αB1-
174 (A15) to the point that the truncated form of αB1-174 (A15) is the most dominant 
species of αB crystallin in the lens. The truncation product αB1-170 (A5) is only 
present in the USF fraction of the 8 year ol
 
 Figure 4-6 Total soluble lens proteins from sheep of different ages. A) fetal lens, B) 6 month old lens, C) 8 year old lens. Spots are labelled for the α-crystallins only 
and correspond to Table 4-3. Molecular weight (MW) in kDa and pH range are as indicated for gel A only. 
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Figure 4-7 Urea soluble lens  proteins from sheep of different ages. A) fetal lens, B) 6 month old lens, C) 8 year old lens. Spots are labelled for the α-crystallins only 
and correspond to Table 4-3. 
 
Spot ID Mass (Da) Predicted Mass (Da) Modification 
A1 αA 19954.5 19955.1 αA-Phos 
A2 αA 19874.5 19875.1 αA 
A3 αB 20187.5 20188.8 αB-Phos 
A4 αB 20108.6 20108.8 αB 
A5 αB 19614.3 19613.1 αB1-170
A6 αA 17879.3 17879.0 αA1-154
A7 αA 17614.3 17613.7 αA1-151
A18 αA 18251.3 18251.0 αA1-157
A12 αA N/A N/A N/A 
A13 αA N/A 19876.1 αA Deamidation 
A14 αA N/A 19956.1 αA-Phos Deamidation 
A15 αB 19980.3 19980.6 αB1-174  
A16 αB N/A 20060.6 αB1-174-Phos  
Table 4-3 Masses and modifications of the α-crystallins seen during ageing of the ovine lens from 
Figure 4-6 and Figure 4-7. N/A = not available 
 
4.3.3.2 Modifications of β-crystallins with age 
 
Within the fetal lens there is a full complement of intact ovine β-crystallins (Figure 
4-8 A) βB1 (1), βB2 (9), βB3 (8), βA1 (14), βA3 (4), βA4 (18) and βA2 (15). The 
intact unmodified β-crystallins are the most abundant of the total β-crystallin species 
in the fetal lens.  All of these crystallins are also found in the fetal lens in a modified 
form due to deamidation or truncation. βB2, βB3 and βA1 are all deamidated in the 
fetal lens (Spots 6, 7, and 16 respectively). βB1 is truncated at the N-terminus with 
species missing 15 and  24 amino acids (2, 21). βA3 also undergoes truncation at the 
N-terminus in the fetal lens, removing 12 and 23 amino acids (Spots 12 and 13). 
There is a single modification to βB3 missing 10 amino acids from the N-terminus 
(spot 11). βA4 is also modified (spot 17) with a mass increase of 180Da from the 
native βA4. 
 
There are changes in the β-crystallins as the lens ages and matures. At 6 months 
(Figure 4-8 B) and 8 years (Figure 4-8 C) of age the major intact β-crystallins are all 
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present in the WSF. There is also an increase in the post translational modifications of 
the β-crystallins. 
 
Intact βB1 is the most abundant species of this crystallin in the fetal lens. However, as 
the lens matures, the amount of the intact βB1 decreases. The major truncation of βB1 
is missing 15 amino acids from the N-terminus (2). At 6 months of age there are 
approximately equal amounts of the intact form (1) and the major truncated form (2). 
By 8 years old only a small amount of intact βB1 was found and the major form of 
βB1 is the truncation βB116-252 (2). There are other minor truncations of βB1 that 
change during lens maturation. Spot 21, which is a βB1 species missing 24 amino 
acids from the N-terminus (21), is found in the fetal and 6 month old lens but is 
missing from the mature 8 year old lens. Spot 22, which is βB1 missing 24 amino 
acids from the N-terminus and 5 amino acids from the C-terminus, is absent in the 
fetal lens but present in the 6 month and 8 year old lens. Spot 23, which is βB1 
missing 10 amino acids from the N-terminus, is present in the fetal lens but its 
abundance decreases as the lens matures through to 8 years of age. 
 
The intact form of βB2 is the dominant β-crystallin in the lenses from sheep of all 
ages (Figure 4-8 A,B and C 9). The only modification seen to βB2 during lens 
maturation is deamidation (7) which increases in quantity as the lens ages.  
 
There is a large amount of intact βB3 found in the fetal lens, however by 6 months of 
age the amount of βB3 has decreased and in a 8 year old lens intact βB3 only makes 
up a small amount of the β-crystallins. βB3 modifications are found in both 
deamidated and truncated forms. The deamidated form (6) is found in the same 
amount in lenses of all ages. The truncated form, missing 10 amino acids from the N-
terminus (11), decreases in quantity from fetal to 6 month to 8 years of age. 
 
βA3 undergoes truncation, deamidation and possibly glycation with the amounts of 
the  intact and modified forms of βA3 changing throughout lens maturation. Intact 
βA3 decreases as the lens matures (Figure 4-8 A, B, and C 4). βA3 is truncated in the 
fetal lens to produce 2 spots, one spot is missing 11 amino acids and the other 22 
amino acids from the N-terminus (12 and 13, respectively). Both of these truncations 
are found at increased levels by 6 months of age. However at 8 years of age the 
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species missing 11 amino acids (12) is decreased and there is an increased amount of 
the -22 amino acid species (13). 
 
βA4 (18) in the intact form is present in lenses at all ages but is only found in small 
amounts in the 8 year old lens. The only modification that changes during lens ageing 
is spot 17 which is an unknown modification adding a mass of 180Da to the normal 
βA4. This could be glycation since the addition of a monosaccharide moiety to a 
protein increases the mass by 180Da. 
 
βA1(14) is present in lenses of all ages and becomes increasingly deamidated as the 
lens matures (16).  There is no change to the βA2 (15) profile as the lens ages.  
 
For the fetal lens the profile of the β-crystallins in the WSF (Figure 4-8 Gel A) and 
USF (Figure 4-9 Gel A) are similar. By 6 months of age there start to be small 
differences between the WSF (Figure 4-8 Gel B) and USF (Figure 4-9 Gel B) of the 
lens. For example in the USF there are increased amounts of the modified β-
crystallins compared with the WSF. In the USF the truncated form of βB1 (missing 15 
amino acids) is increased (2) and is more prevalent than the unmodified βB1. There is 
increased deamidation of βB2 (7), and βB3 (6) in the USF at 6 months of age.  There 
are decreased amounts of all the β-crystallins in the USF of an 8 year old lens. With 
intact βA3 and βB1 missing from the USF of an 8 year old lens. 
 Figure 4-8 Total soluble lens proteins from sheep of different ages. A) fetal lens, B) 6 month old lens, C) 8 year old lens. Spots are labelled for the β-crystallins only 
and correspond to Table 4-4 and Table 4-6. Molecular weight (MW) in kDa and pH range are as indicated for gel A only. 
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Figure 4-9 Total Urea Soluble lens proteins  from sheep of different ages. A) fetal lens, B) 6 month old lens, C) 8 year old lens. Spots are labelled for the β-crystallins 
only and correspond to Table 4-4 and Table 4-6. 
 
Spot Protein (ID) Mass Bovine Equivalent 
1 βB1 28055.9 βB1 
2 βB1 26743.0 βB116-252
3 βA3 25828.3 βA3 Modification 
4 βA3 25572.3 βA3  
5 βA3/βA1 25756.3 N/A  
6 βB3 24323.8 βB3 Deamidation 
7 βB2 23322.8 βB2 Deamidation 
8 βB3 24321.9 βB3 
9 βB2 23321.3 βB2  
10 βB3 24323.9 N/A 
11 βB3  23302.4 βB310-210
12 βA3/βA1 24212.1 βA312-215
13 βA3/βA1 23038.2 βA323-215
14 βA3/βA1 23497.3 βA1 
15 βA2 22387.2 βA2 
16 βA3/βA1 23496.6 βA1 
17 βA4 22879.1 βA4 Mod 
18 βA4 22696.4 βA4 
19 βA4 22912.6 βA4 Mod 
20 βA4 22752.9 βA4 Mod 
21 βB1 25935.3 βB125-252
22 βB1 25414.9 βB125-247
23 βB1 27199.8 βB110-252
Table 4-4 Table of modifications to the β-crystallins seen during ageing (Figure 4-8 and Figure 
4-9). The crystallins were identified by MADLI-TOF analysis and mass determined by LC/MS. 
Bovine equivalents were determined by comparison with Shih et al., (1998) and personal 
communication with L. David, 2005. N/A = not available. 
 
4.3.4 Crystallin modification with cataract progression 
 
2DE was used to analyse the changes in lens proteins during cataract formation from 
lenses with stage 0 (normal), 1, 3 and 6 cataracts (Figure 1-8). The lenses were 
separated into the WSF and USF and run on 2DE. 
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 As cataracts develop in the lens there are changes in the lens protein profile (Figure 
4-10 and Figure 4-11). The most obvious changes are in the crystallin profiles and in 
particular truncation of the α- and β-crystallins. 
 
 
Figure 4-10 2DE of WSF from cataractous lenses 0) Normal lens, 1) Stage 1 cataractous lens, 3)  
Stage 3 cataractous lens and 6) Stage 6 cataractous lens. Molecular weight (MW) in kDa and pH 
range are as indicated for gel 0 only. 
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 Figure 4-11 2DE of the USF from cataractous lenses 0) Normal lens, 1) Stage 1 cataractous lens, 
3) Stage 3 cataractous lens, 6) Stage 6 cataractous lens. 
 
4.3.4.1 α-crystallin changes with cataract formation 
 
There are modifications to the α-crystallins as the cataract progresses from normal (0) 
through to full cataract (6) (Figure 4-12, Figure 4-13 and Table 4-5).  
 
At stage 1 of the cataract there are few changes in the profile of the α-crystallins. The 
only visible change is an increase in αB1-170 (A5). The equivalent truncation removing 
5 amino acids from the C-terminus of αA is not seen however that may be due to the 
large intact αA spot overshadowing the smaller truncated product.  
 
By stage 3 of cataract formation there is extensive truncation and modification of the 
α-crystallins. The most abundant modification of αA is a truncation removing 5 amino 
acids from the C-terminus forming αA1-168 (A8). This truncation product is in equal 
amounts to its parent species (A2). A second new truncation seen at the stage 3 
cataract is αA1-163 (A9). The αA1-151 (A7) truncation that is seen in the control lens is 
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increased in abundance at the stage 3 cataract.  The amount of αA-phos (A1) is 
decreased in the stage 3 cataract and there is a truncated form of αA-phos missing 5 
amino acids, αA-phos1-168 (A17) present. There is increased deamidation of αA (A13) 
and αA-phos (A14) in the stage 3 lens compared with stage 1 and the control lens. 
The αB1-170 truncation product (A5) is increased in the stage 3 cataract and is more 
abundant than its parent compound. There is a decrease in the amount of αB-phos 
(A3) in the stage 3 cataract and it is also truncated to form αB-phos 1-170 (A10). There 
is a second truncation of αB in the stage 3 cataract αB1-163 (A11) missing 12 amino 
acids from the C-terminus. There is no change in the deamidated forms of αB (A15) 
and αB-phos (16) in the stage 3 cataract.  
 
During progression from stage 3 to stage 6 cataract there are further changes in the α-
crystallins in the WSF. The amount of αA-phos (A1) and its truncation product αA-
phos1-168 (A17) are reduced in the stage 6 cataract. There is an increase in deamidated 
αA (A13) and no changes in any other αA species. By stage 6 cataract there is no αB-
phos (A3) present and reduced amounts of the truncation product αB-phos1-170 (A10). 
There is an increase in the deamidated form of αB (A15) and an increase in the 
deamidated αB-phos (A16). 
 
The α-crystallins are also modified in the USF as the cataract progresses (Figure 
4-13). These changes are similar to those seen in the soluble fraction for α-crystallin. 
The only differences between the WSF and USF are seen in the stage 6 cataract. Both 
αA1-163 (A9) and αA1-154 (A6) are absent in the USF of the stage 6 cataract. There is a 
reduced amount of αB (A4) and increased amount of αB1-170 (A5) in the USF of the 
stage 6 cataract compared with the USF in the other stages of cataract and with the 
WSF of the same lens.  
 
 
 
 
Figure 4-12 2DE of the WSF from cataractous lenses 0) Normal lens, 1) Stage 1 cataractous lens, 3) Stage 3 cataractous lens, 6) Stage 6 cataractous lens. Molecular 
weight (MW) in kDa and pH range are as indicated for gel 0 only. 
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 Figure 4-13 2DE of the USF from cataractous lenses 0- Normal lens, 1- Stage 1 cataractous lens, 3- Stage 3 cataractous lens, 6- Stage 6 cataractous lens.  
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 Spot No Crystallin Mass 
(Da) 
Predicted 
Mass(Da) 
Modification 
A1 αA 19954.4 19955.1 αA-phos 
A2 αA 19873.1 19875.1 Intact 
A3 αB 20187.5 20188.8 αB-phos 
A4 αB 20108.6 20108.8 Intact 
A5 αB 19614.3 19613.1 αB1-170 (-5aa) 
A6 αA 17879.3 17879.0 αA1-154 (-19aa) 
A7 αA? 17614.3 17613.7 αA1-151 (-22aa) 
A8 αA 19446.0 19445.7 αA1-168 (-5aa) 
A9 αA 18873.3 18875.1 αA1-163 (-10aa) 
A10 αB 19692.7 19693.1 αB-phos 1-170 (+phos -5aa) 
A11 αB 18860.0 18858.3 αB1-163 (-12aa) 
A13 αA N/A 19876.1 αA Deamidation 
A14 αA N/A 19956.1 αA-phos Deamidation 
A15 αB 19980.3 19980.6 αB1-174  
A16 αB N/A 20060.6 αB1-174-phos 
A17 αA N/A 19526.7 αA-phos1-168
Table 4-5 Table of modifications to soluble α-crystallins during cataract formation, Spot 
numbers correspond to Figure 4-12 and Figure 4-13.  Predicted masses and modifications were 
made by comparison with the known ovine sequence (Robertson et al., 2008). 
 
αA
N term 150 V  D A G H  S E R A I P V S  R  E E K P S  S A P S S 173 C term
αB
N term 162 R E E K P A V T  A A P K K 175 C term
-5aa-10aa-22aa -19aa
-5aa-12aa -1aa
 
Figure 4-14 C-terminal regions of αA and αB-crystallin showing the points at which they are 
cleaved during ageing and cataract formation. 
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4.3.4.2 Changes in β-crystallins with cataract formation 
 
The β-crystallins are modified during cataract formation (Figure 4-15 0-6) with 
truncation and deamidation being the main modifications. There is a decrease in the 
intact form of βB1 (1) during cataract formation. In the control lens there are three 
truncations of βB1, βB16-252 (2), βB125-252 (21) and βB125-247 (22). All of these 
truncations decrease in the water soluble fraction as the cataract progresses.  During 
cataract formation three other modifications of βB1 appear and increase as the 
cataract progresses but only two of these truncations could be determined, βB19-252 
(24) and βB113-252 (26). These truncations first appear in the stage 3 cataract and are 
decreased in the stage 6 cataract. In the stage 6 cataract there is a reduced amount of 
βB1 in all forms.  
 
The intact form of βB2 is the dominant β-crystallin in all cataract stages and the 
deamidated βB2 (7) increases as the cataract progresses. A truncated product of βB2 
with 7 amino acids missing from the N-terminus (25), appears in the stage 6 cataract.  
 
The intact form of βB3 (8) decreases as cataract forms, and the deamidated form of 
βB3 (7) stays consistent throughout formation. The only truncation of βB3, with 9 
amino acids from the N-terminus missing (11), stays consistent throughout cataract 
formation. 
 
With cataract progression there is a decline in the intact form of βA3 (4). The two 
βA3 truncations seen in the control lens, βA312-215 and βA323-215 (12 and 13, 
respectively), stay at consistent levels in stage 1 and 3 cataracts and decrease in stage 
6 cataract.  Both βA1 (15) and βA2 (16) decrease during cataract formation and βA4 
(18) stays the same throughout cataract formation. 
 
In the USF there are changes to the β-crystallins which are similar to those seen in the 
WSF of the cataract lenses (Figure 4-15 and Figure 4-16). The only differences are in 
the USF of the stage 6 cataract, where βA3 (4) and βB28-204 are absent in the USF. 
 Figure 4-15 2DE of the WSF from cataractous lenses 0) Normal lens, 1) Stage 1 cataractous lens, 3) Stage 3 cataractous lens, 6) Stage 6 cataractous lens. 93
 
Figure 4-16 2DE of the USF from cataractous lenses 0) Normal lens, 1) Stage 1 cataractous lens, 3) Stage 3 cataractous lens, 6) Stage 6 cataractous lens
 
 
94
Spot Protein (ID) Mass Bovine Equivalent 
1 βB1 28055.9 βB1 
2 βB1 26743.0 βB116-252
4 βA3 25572.3 βA3  
5 βA3/βA1 25756.3 N/A  
6 βB3 24323.8 βB3 Deamidation 
7 βB2 23322.8 βB2 Deamidation 
8 βB3 24321.9 βB3 
9 βB2 23321.3 βB2  
11 βB3  23302.4 βB310-210
12 βA3/βA1 24212.1 βA312-215
13 βA3/βA1 23038.2 βA323-215
14 βA3/βA1 23497.3 βA1 
15 βA2 22387.2 βA2 
16 βA3/βA1 23496.6 βA1 
17 βA4 22879.1 βA4 Mod 
18 βA4 22696.4 βA4 
21 βB1 25935.3 βB125-252
22 βB1 25414.9 βB125-247
23 βB1 27199.8 βB110-252
24 βB1 27358.7 βB111-252
25 βB2 N/A βB28-204
26  βB1 27028.6 βB113-252
Table 4-6 Table of modifications to soluble β-crystallins during cataract formation, Spot 
numbers correspond to Figure 4-15 and Figure 4-16.  Bovine equivalents were determined by 
comparison with Shih et al., (1998) and personal communication with L. David, 2005. N/A = not 
available. 
 
4.4 Discussion 
 
This study focused on the ovine lens crystallins, their masses and post translational 
modifications using 2DE and mass spectrometry techniques. This allowed the 
visualisation and determination of the changes in the crystallins during ageing and 
cataractogenesis in both the WSF and USF of the lens. The described research 
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expands on early work by Robertson (2005), where normal and cataract lenses were 
compared by 2DE. This work investigated the changes during normal ageing of the 
lens and the changes at each stage of cataractogenesis. 
 
In the fetal lens there was the full complement of the α and β-crystallins; αA, αB, 
βB1, βB2, βB3, βA1, βA3, βA2 and βA4 (Figure 4-6 and Figure 4-7) which are the 
same crystallins found in newborn mouse (Ueda et al., 2002a), 16 day old rat (Lampi 
et al., 2002b), bovine (Takemoto, 1995b, Shih et al., 1998) and human (Lampi et al., 
1998, Lapko et al., 2003) lenses. 
 
4.4.1 α-Crystallin modification during lens ageing and maturation 
 
With increasing age both αA and αB undergo post-translational modification 
including phosphorylation, truncation and deamidation.  
 
Phosphorylated forms of αA and αB were present at all ages in ovine lenses. 
Phosphorylated α-crystallins have also been detected in human (Miesbauer et al., 
1994, Takemoto, 1996, Ma et al., 1998), mouse (Ueda et al., 2002a), rat (Wang et al., 
2000) and bovine (Carver et al., 1996) lenses. Ovine αA is phosphorylated at serine 
122 (Robertson et al., 2008). The site of phosphorylated αB has not been determined 
in ovine lens. However, both human (Miesbauer et al., 1994) and bovine  (Voorter et 
al., 1989) αB have three phosphorylation sites at serine residues 19, 45 and 59, these 
serines are found in ovine αB-crystallin. 
 
 αA becomes increasingly phosphorylated as the lens ages in both the WSF and USF 
of the lens, so much so that by 8 years of age αA+phos is the prominent form of αA-
crystallin in the lens. A similar pattern has been observed in the ageing of mouse lens 
with phosphorylated αA comprising one third of total αA by 51 weeks of age (Ueda et 
al., 2002a). αB-crystallin phosphorylation also increased with age but not to the same 
extent as αA. Consequently the level of phosphorylated αB was less than that of 
normal αB. In the mouse lens phosphorylated αB does not increase after 10 weeks of 
age (Ueda et al., 2002a). In human lenses no phosphorylation was detected in infant 
lens (up to 4 months of age) but phosphorylation was detected in 12 year old lenses 
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and increased as the lens aged (Takemoto, 1996). There are two mechanisms for 
phosphorylation detected in the lens, a cAMP-dependent kinase pathway and both α-
crystallins also show autokinase activity (Kantorow and Piatigorsky, 1998). There is 
evidence that the  phosphorylation may be reversible as indicated by the discovery of 
a lens phosphatase (Chiesa and Spector, 1989). 
 
Phosphorylation is important as it can alter the oligomerisation (Ito et al., 2001) and 
chaperone activity (Kamei et al., 2001, Ecroyd et al., 2007) of the α-crystallins. There 
is evidence that phosphorylation of αB decreases its chaperone ability by up to 30% in 
vitro (Kamei et al., 2001, Aquilina et al., 2004, Ecroyd et al., 2007). However 
research into the effect of phosphorylation of αA on its chaperone ability has been 
contradictory. Some groups report that phosphorylation has no effect on the 
chaperone function of αA (Wang et al., 1995, Carver et al., 1996), whilst others have 
found an increase in chaperone activity (van Boekal et al., 1996). More research is 
needed to determine (i) the exact role of phosphorylation of α-crystallin in the lens, 
(ii) why αA continues to become phosphorylated in the aged ovine lens and (iii) why 
αB phosphorylation does not increase as the lens ages.  
 
Truncation of α-crystallins during lens maturation is well documented in rat (Ueda et 
al., 2002b), mouse (Ueda et al., 2002a), cow (Takemoto, 1995b) and human lenses 
(Takemoto, 1995b, Lund et al., 1996, Ma et al., 1998). In this study there was only 
minor truncation of the α-crystallins, with only three truncations of αA being 
identified. They are: αA1-154, αA1-151 and αA1-157. All three of these truncations were 
present in the fetal and 6 month old lens but only αA1-157 and αA1-154 were present in 
the 8 year old lens. The αA1-151 modification is found in several other animal lenses 
during maturation. For example αA1-151 is in 16 day, 6 week old (Ueda et al., 2002b) 
and 85 day old lenses from rats (Takeuchi et al., 2004). αA1-151 has also been found in 
two year old bovine lenses (Smith et al., 1991). αA1-154 missing 19 residues from the 
C-terminus of αA crystallin, has previously been detected in 85 day old rat (Takeuchi 
et al., 2004) and 2 year old bovine lenses (Smith et al., 1991). The αA1-157 truncation, 
missing 16 residues from the C-terminus, is only a minor component in ovine lenses 
of all ages. The same modification has been found in 16 day and 6 week old rat lenses 
(Ueda et al., 2002b) as well as 85 day old rats (Takeuchi et al., 2004).  
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These were the only αA-crystallin truncations that could be detected in the ovine lens 
during ageing. Other αA-crystallin truncations found during maturation in other 
species include αA1-172 and  αA1-168,  which were found in human (Takemoto, 1995b, 
Lund et al., 1996), rat (Ueda et al., 2002b) and bovine (Takemoto, 1995b) lenses. 
Within the rat lens, αA1-163 and αA1-162 have also been found (Ueda et al., 2002b, 
Takeuchi et al., 2004) during ageing. None of these truncations were found in the 
ovine lens. This maybe due to the detection sensitivity limitations of the 
electrophoretic and mass spectrometric techniques used in this study. αA1-172, and 
αA1-168 may have comigrated with αA1-173 in the 2DE, and been overshadowed by the 
intact αA. In some of the above studies these two truncations were detected by direct 
mass spectrometry of the lens sample without prior separation on 2DE as was the case 
here.  
  
Within normal ovine lens the only truncation of αB observed was αB1-170, removing 5 
residues from the C-terminal region. This modification was seen only in the fetal and 
6 month old lenses. The same truncation product is found in human (Colvis et al., 
2000) and rat (Ueda et al., 2002b, Takeuchi et al., 2004) lenses. αB1-174 has been 
found in human (Lund et al., 1996, Colvis et al., 2000) and rat (Takeuchi et al., 2004) 
lenses. A second αB truncation αB1-163  has also been detected in human (Colvis et 
al., 2000) and rat (Ueda et al., 2002b, Takeuchi et al., 2004) lenses. Neither of these 
truncations were detected in the ovine lens at any age.  
 
The C-terminal region of the α-crystallins is important for chaperone function 
(Takemoto et al., 1993, Smulder et al., 1996). For further discussion on chaperone 
function and the C-terminal extension of α-crystallin see 1.4.2. Briefly modifications 
that affect the C-terminal region of α-crystallins can alter the chaperone function of α-
crystallin within the lens. In particular truncation of the C-terminal region reduces the 
chaperone ability of α-crystallin (Takemoto et al., 1993). 
 
Although truncation of the C-terminal region of the α-crystallins reduces their 
chaperone function, there is only a limited amount of truncation of both α-crystallins 
during ovine lens ageing. Therefore the majority of α-crystallin within the aged lens is 
in the intact form and would function as a “normal” chaperone and so prevent the 
insolubilisation of other proteins in the lens. However during cataract formation there 
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is an increase in truncation of the α-crystallins which may reduce the chaperone 
function within the lens.  
 
4.4.2 α-Crystallin modification during cataract formation 
 
During cataract formation there is extensive truncation of the α-crystallins. At stage 1 
cataract there is little change to αA-crystallin profile in either the WSF or the USF. 
However by stage 3 cataract there is extensive truncation of αA-crystallin. The major 
truncation seen in the stage 3 cataract is αA1-168 where αA has lost the 5 C-terminal 
residues. This same modification is one of the major αA-crystallin truncations seen in 
the rat selenite cataract (Ueda et al., 2002b) and is also found in the ICR/f rat cataract 
(Takeuchi et al., 2004). Interestingly αA1-168 has been found in the aged lens of 
human, bovine and rat lenses, but not the ovine lens (See 4.4.1 for further discussion). 
Another new truncation seen in the stage 3 cataract is αA1-162 missing 10 amino acids 
from the C-terminus. This protein species was only a minor truncation seen in the 
stage 3 cataract. This modification has been observed in two types of rat cataract, the 
selenite (Ueda et al., 2002b) and ICR/f hereditary cataract (Takeuchi et al., 2004), and 
in aged human, bovine and rat lenses (4.4.1). αA1-151 is found in aged ovine lens and 
the amount of this protein species increased in the stage 3 cataract. The 
phosphorylated form of αA also underwent truncation in the stage 3 cataract, at the 
same truncation sites as the unmodified αA to produce αA1-168+phos, αA1-162+phos 
and αA1-151+phos.  
 
With progression from stage 3 to stage 6 cataract there are a number of changes in the 
αA-crystallin profile. There was a decrease in the truncated forms of αA within the 
stage 6 cataract with the most notable changes being a decrease in the amount of 
αA+phos and αA1-151 observed in the WSF and USF. αA1-162 and αA1-154 are not 
present at all in the USF. These observed differences could be attributed to the 
physical loss of cortical sample when dissecting stage 6 lenses. That is, the cortical 
region of the stage 6 lens is almost entirely liquid and the nucleus is normal (solid). 
Consequently when dissecting the lens there is some loss of the cortical region of the 
lens, which would reduce the amount of cortical proteins compared to the nuclear 
proteins within the sample.  
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 There is also increased truncation of αB during cataract formation. Three truncations 
are seen in αB during cataract formation, they are αB1-174, αB1-170 and αB1-163. The 
only truncation seen in early cataract (stage 1) is αB1-170, and this truncation increases 
in abundance as the cataract progresses, and αB1-170 is the main form of αB found 
within the USF of a stage 6 cataract. The equivalent truncation is found in the 
phosphorylated form. This truncation is found in cataractous lenses from selenite 
(Ueda et al., 2002b) and ICF/r rats (Takeuchi et al., 2004), as well as from human 
lenses with Soemmering’s ring (Colvis et al., 2000), which is a phenomenon that 
occurs after cataract surgery.   At stage 3 of cataract formation, αB1-163 is present. 
This modification has also been detected in selenite (Ueda et al., 2002b) and ICR/f 
(Takeuchi et al., 2004) rat cataracts and human Soemmering’s ring (Colvis et al., 
2000). The final modification of αB is the removal of the C-terminal lysine (αB1-174) 
which is seen in the final stage of cataract development. This modification has been 
found in aged and cataractous human lenses (Lund et al., 1996, Colvis et al., 2000). 
 
4.4.3 Chaperone function of α-crystallin  
 
One of the important features of α-crystallin is its ability to function as a molecular 
chaperone, where it binds to denatured proteins and prevents them aggregating and 
being insolublised. During bovine lens ageing there is a decrease in the chaperone 
function of α-crystallin (Augusteyn et al., 2002).  
 
In this study there is an increase in phosphorylation of α-crystallin within the lens 
during ageing. However the role of phosphorylation in chaperone function is not 
entirely understood with some research reporting no change (Wang et al., 1995, 
Augusteyn et al., 2002) and others reporting an increase (Ecroyd et al., 2007) or 
decrease (Aquilina et al., 2004) in chaperone activity. The effect of increased 
phosphorylation of α-crystallins within the ovine lens is therefore unclear. 
 
Many studies have shown the importance of the C-terminal region of α-crystallin to 
chaperone function. During ovine cataract formation αA-crystallin was found to be 
truncated at the C-terminus. Previous studies have shown that removal of C-terminal 
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residues dramatically alters the chaperone function of α-crystallin (Kelley et al., 1993, 
Takemoto et al., 1993, Takemoto, 1994). Kelley et al., (1993) showed that in the 
selenite cataract there is truncation of the α-crystallin and that this truncation resulted 
in a reduction of the chaperone function of α-crystallin. In the ovine cataract there 
were truncations that produced αA1-168, αA1-163, αA1-154 and αA1-151. The effect of 
some of these truncations on chaperone function has been determined. The major αA 
modification in the cataractous lens is the αA1-168 truncation, which has been shown 
to reduce the chaperone function by 12-23% (Aziz et al., 2007). As more residues 
(from 5-11) are removed from the C-terminus there is greater reduction of the 
chaperone function. For example, αA1-162 showed a 65% reduction in chaperone 
protection (Rajan et al., 2006). The observation that there is increased truncation in 
cataract lens and that C-terminal truncation of α-crystallin reduces chaperone function 
suggests that within the ovine lens there is a decrease in chaperone function during 
cataract formation. This reduction in chaperone function could result in an increase in 
insolubilisation and aggregation of lens proteins and as a consequence promote 
cataract development. 
 
4.4.4 β-Crystallin modification during lens ageing and maturation 
 
The β-crystallins role in the lens is to provide structure. They pack tightly and 
generate a  refractive index for the lens to focus light. During ageing of the lens the β-
crystallins undergo many post-translational modifications including truncation and 
deamidation, which assist in the functioning and maturation of the lens. Within the 
ovine lens all 7 β-crystallins were found; βB1, βB2, βB3, βA1, βA2, βA3 and βA4. 
The same 7 crystallins are found in mice (Ueda et al., 2002a), rat (Lampi et al., 
2002b) and bovine (Shih et al., 1998) lenses. Early studies of human lenses showed 
that only 6 β-crystallins were present as βA2 was not detected (Lampi et al., 1998, Ma 
et al., 1998). However later work identified βA2 in the human lens (Lapko et al., 
2003). At present only one of the ovine lens crystallins (βB3) has been sequenced 
(Robertson et al., 2008). Protein identification in this study was therefore performed 
by comparison to the bovine crystallin sequences. This was able to be performed 
because of the closeness of the bovine and ovine genomes. For example, ovine and 
bovine βB3 are both 210 amino acids long and have masses of 24352 Da and 24322 
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Da respectively. Also the mass of bovine βB1 is 28054.5 Da and the measured mass 
of ovine βB1 is 28055.9 Da suggesting that they have identical protein sequences with 
1-252 residues. 
 
Within the fetal lens there is already truncation of βB1 with the loss of residues from 
the N-terminus to produce βB116-252, βB125-252 and βB110-252. By 6 months of age 
another truncation appears when βB125-252 loses 5 residues from its C-terminal end to 
form βB125-197. The major βB1 modification in the ovine lens is βB1 missing 15 
residues from the N-terminus. This is also found in human (David et al., 1996, Lampi 
et al., 1997, Zhang et al., 2003) and bovine (Shih et al., 1998) lenses. During 
maturation of the ovine lens the intact βB1 decreases in abundance and the truncation 
product βB116-252 increases in abundance. This is also observed during bovine (Shih et 
al., 1998) and human (Ma et al., 1998) lens maturation. This would suggest that this 
truncation is “normal” and is required for lens maturation. In human lenses there are 
more truncations of βB1 between residues 33 and 41 (David et al., 1996, Lampi et al., 
1997), and in the rat there have been truncations of βB1 from 27-49 residues (David 
et al., 1994). None of these truncations were found in the ovine lens during 
maturation. Loss of the N-terminus of βB1 results in a reduction in the βH aggregate 
which is an important part of the lens proteome (Lampi et al., 1998, Ma et al., 1998). 
Removal of the entire N-terminus of βB1 resulted in an increased rate of heat-induced 
denaturation which meant more αA-crystallin was required to prevent denaturation 
than wildtype βB1 (Lampi et al., 2002a).  
 
βB3 is the dominant β-crystallin in the fetal lens. However as the lens ages there is a 
decrease in the amount of βB3 within the WSF and USF. During ageing of the bovine 
lens the same results were observed with a decrease in βB3 occurring (Shih et al., 
1998). Within the rat lens there is a decrease in βB3 gene expression after birth (Aarts 
et al., 1989) and during mouse lens maturation there is decrease in βB3 during ageing 
(Ueda et al., 2002a). Within the human lens βB3 is only detected in lenses aged less 
than 3 years (Ma et al., 1998). There are two post-translational modifications in the 
ovine fetal lens, deamidation and truncation. The truncation between residues 9Q/A10 
of βB3 which produces βB310-210 in the ovine lens has also been found in rat lenses 
(David et al., 1994). A βB3 spot in a similar position was found in the  bovine lens 
but the truncation could not be confirmed by Edman sequencing as it contained a 
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blocked N-terminus (Shih et al., 1998). Deamidation of βB3 was evident in the fetal 
lens by a mass shift of +1 and a positional shift on the 2DE to be more positive.  
 
The sequence of ovine βA3 has not been determined. However the N-terminal 
sequence has been discovered by a BLAST search of the sheep genome (J Wood, 
Personal communication, 2008), which means that any truncation to the N-terminus 
should be detectable. There were two truncations of βA3 found in the fetal lens, 
βA312-215 and βA323-215. In the ovine lens these two βA3 species have been identified 
in similar positions on 2DE to those found in the bovine lens (Shih et al., 1998, 
Werten et al., 1999) which confirms the ovine truncations. These same truncations to 
βA3 have been found in bovine (Shih et al., 1998), rat (David et al., 1994) and mouse 
(Ueda et al., 2002a) lenses. Only βA323-215 has been found in human lenses (Lampi et 
al., 1997, Ma et al., 1998). During maturation of the ovine lens there is a decrease in 
βA3 in the lens which also happens in the bovine lens (Werten et al., 1999). This 
decrease in intact βA3 sees an increase in βA312-215 and βA323-215 at 6 months of age. 
Interestingly, in the 8 year old lens there is little βA3 and βA312-215 and the amount of 
βA323-215 is increased. This situation is mirrored in the bovine lens (Werten et al., 
1999). Any discussion of truncation of βA3 larger than 17 amino acids needs to 
consider βA1. Both βA3 and βA1 are translated from the same βA3/A1 mRNA. The 
two proteins have start codons in the same reading frame which means that they are 
identical except for βA3 having an extra 17 amino acids at its N-terminus. Therefore 
the truncation βA323-215 could also be βA15-197. In the bovine lens there is only a small 
decrease in the βA1 protein during lens ageing and there is a total disappearance in 
βA3. Therefore, it has been suggested that βA323-215 arises from truncation of βA3 
and not βA1 (Werten et al., 1999). Within the ovine lens there is no change in βA1 
during ageing which means the same conclusion could be reached about the origins of 
the βA323-215 truncation. Truncation of βA3 results in a protein species that is more 
prone to association and has a higher affinity for association (Sergeev et al., 2000, 
Zhang et al., 2003). 
 
βB2 is the most prominent β-crystallin within the ovine lens, there is little 
deamidation of this protein during lens ageing which is similar to what is seen in 
human lenses (Ma et al., 1998). There was no truncation of βB2 recorded in this 
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study. In contrast, the bovine lens shows a truncation of βB2 missing 8 residues in the 
aged lens (Shih et al., 1998).  
 
The changes in the profile of the ovine β-crystallins with age appear to be consistent 
with those found in rat, mouse, bovine and human lenses. This suggests that the 
maturation of the crystallins, like the crystallins themselves, is a well conserved 
process amongst species. The purpose of the numerous post-translational 
modifications to the β-crystallins during lens ageing is thought to help in the packing 
of the lens proteins. That is, removal of the N-terminal extensions of the β-crystallins 
allows the crystallins to pack tighter together as the lens ages, which contributes to 
setting up the refractive index within the lens. 
 
4.4.5 β-Crystallin modification cataract formation 
 
During ovine cataract formation there are changes in the β-crystallins within the lens. 
Interestingly many of these changes are the same as those observed during the ageing 
of the ovine lens. During cataractogenesis there is a loss of βA3 which is also seen in  
aged ovine lenses. What is interesting to note is that there is no increase in the two 
truncation products of βA3 (βA312-215 and βA323-215), suggesting that these are 
truncated in the ovine cataract to smaller products or that the reduction in intact βA3 
is via a different mechanism in cataractous lenses. In human cataractous lenses there 
is an increase in βA3 fragments (Harrington et al., 2004). During selenite cataract 
formation there is an increase in the truncation of βA3, between residues 11/12, and 
21/22 (David and Shearer, 1993, David et al., 1993). Overall the changes seen to βA3 
during cataractogenesis are the same as those seen during ageing and maturation of 
the lens. For example, the βA3 profile of a 6 month old cataractous lens is similar to 
an 8 year old normal lens. 
 
One difference between normal, cataractous and aged lenses is the truncation of βB1. 
In aged and normal lenses the major truncation of βB1 is ββ115-252 and this truncation 
decreases with cataract development. Within the cataract lens there are three 
truncations βB19-252, βB113-252, and an unknown truncation. None of these truncations 
are seen in aged matched controls. In human cataractous lenses there is an increase in 
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βB1 fragments compared with controls. In the human study the exact location of the 
truncation was not determined except that it did occur at the N-terminus (Harrington 
et al., 2004). No other research has demonstrated these unique truncations seen in the 
ovine cataract in either normal or cataractous lenses. 
 
βB2 is the main β-crystallin in the ovine lens. During ageing the only modification to 
βB2 is deamidation, but during cataract formation there is truncation of βB2 in the 
ovine lens. The truncation removes 7 residues from the N-terminus and a limited 
amount of βB28-204 was detected in the stage 3 cataract and increased in the stage 6 
cataract. This truncation has been reported in aged mouse (Ueda et al., 2002a) and 
bovine (Shih et al., 1998) lenses only. Interestingly, in this study βB28-204 was only 
found in the cataractous lens.  
 
N-terminal cleavage of rat β-crystallins results in an increase in turbidity and 
insolubilisation of the β-crystallins (David et al., 1992). 
 
Overall the changes in the ovine β-crystallins during cataract formation can be split 
into two types: ageing and cataract-specific changes. Ageing changes are those that 
are seen in an aged ovine lens and in the younger cataractous lens, suggesting that 
cataract formation is an advanced disease of ageing. The cataract-specific changes are 
modifications only seen in the cataractous lenses indicating that the ovine cataract is a 
specific disease and is independent of age.  Therefore it appears that the ovine cataract 
is a combination of advanced ageing and specific cataract changes. 
  
4.5 Conclusion  
 
During ageing of the lens there is a specific pattern of post-translational modifications 
that occur to the lens proteins. This enables the lens fibre cells to age and mature 
without the ability to synthesis new proteins. The highly conserved nature of these 
modifications amongst lenses of the same species and between lenses of different 
species suggests that this process is essential for normal lens growth. When this 
process is disrupted in some way, it can lead to cataract formation. During cataract 
formation in the ovine lens there are patterns of modification to the β-crystallins that 
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are similar to those observed in the aged lens (8 year old). However the aged lens is 
completely transparent. In the aged lens there is a large amount of intact α-crystallin 
which can act as a chaperone and prevent the aggregation and insolubilisation of the 
modified β-crystallins. On the other hand in the cataractous lens, α-crystallins are 
truncated at the C-termini, which has been shown to reduce the chaperone function of 
the α-crystallins. Therefore a possible mechanism for cataract formation can be 
proposed. There is an increase in truncation of the crystallins. These truncated 
crystallins cannot be prevented from aggregating because of the reduced chaperone 
capability of α-crystallin and therefore the denatured crystallins become insoluble and 
as a consequence initiate the onset of cataractogenesis.  
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   Chapter 5 
Proteolysis of the Lens Proteins by the Calpains 
 
5.1 Introduction 
 
During cataract formation the lens proteins undergo uncontrolled proteolysis which 
disrupts their structure and function. In many cortical cataracts there is an increase in 
Ca2+ concentration within the lens (Duncan and Bushell, 1975, Hightower et al., 1987, 
Robertson et al., 2005). This has lead to the hypothesis that the increased calcium 
activates the calcium dependent cysteine proteases, (calpains) which then truncate the 
crystallins and this leads to cataract formation. In rodents the crystallins are 
particularly susceptible to uncontrolled enzymatic proteolysis by the calpain family 
(David and Shearer, 1984, David and Shearer, 1993, Ueda et al., 2002b). 
 
Calpains have been implicated in several models of cataract including the selenite 
(David and Shearer, 1984), galactose (Azuma et al., 1995), diamide (Azuma and 
Shearer, 1992) and Shumiya (Inomata et al., 1997a) cataracts in rats and the heritable 
sheep cataract (Robertson et al., 2005, Robertson et al., 2008). In many of these 
models the calpains have been shown to cleave either the α or β-crystallins in a 
similar way to the truncated forms of the crystallins found in cataract. 
 
Within the lens there are three ubiquitous calpains; calpain 2 (Yoshida et al., 1984), 
calpain 1 (Roy et al., 1983), and calpain 10 (Ma et al., 2001). There are also two 
splice variants of calpain 3, Lp82 (Ma et al., 1998b) and Lp85 (Ma et al., 2000b) both 
of which are lens specific. So far Lp85 has only been found in rodent lenses. Calpain 
1, 2 and Lp82 but not calpain 10 have been discovered in the ovine lens (Robertson et 
al., 2005). The expression of the ovine calpains varies across the lens and with the age 
of the lens (Robertson, 2003). Calpain 2 is found in all fractions of the sheep lens and 
in lenses of various ages, however calpain 1 is only detected in the cortex of ovine 
lenses. Lp82 is found in both the cortex and nucleus of young lamb lenses (Robertson 
et al., 2005). Calpain 10 has been found in rat, mouse and human lenses and is 
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concentrated in the epithelial cells (Ma et al., 2001). Within the same study it was 
shown that calpain 10 mRNA levels increased during selenite cataract formation. No 
calpain 10 has been discovered in the ovine lens to date (personal communication, J. 
Wood, 2008). 
 
Bovine and rat calpain 2 and Lp82 both truncate αA and αB-crystallin at the C-
terminus in vitro. Calpain 2 removes 10 or 11 amino acids from the C-terminus of αA 
(Yoshida et al., 1986, Ueda et al., 2002b), Lp82 also removes 10 amino acids but not 
11 from αA-crystallin. Lp82 has a second, unique, truncation site for αA removing 5 
amino acids (Ueda et al., 2002b). Both calpain 2 and Lp82 remove 5 amino acids 
from the C-terminus of αB-crystallin and calpain 2 also removes 12 residues (Yoshida 
et al., 1986, Ueda et al., 2002b). The removal of these amino acids from the C-
terminal end by the calpains has been shown to reduce the chaperone function of α-
crystallin (Kelley et al., 1993).  
 
The role of β-crystallins in the lens is to provide structure and the refractive index. In 
rats, calpain 2 has been shown to truncate the β-crystallins in a similar way to that 
seen in selenite cataract (David et al., 1992, David and Shearer, 1993). Rat calpain 2 
truncates βB1, βB3, βA3 and βA4-crystallins from rat lenses by removing residues 
from the N-terminus of these proteins (David and Shearer, 1993). When the sequences 
for the rat β-crystallins were determined the exact cleavage points could be identified 
and were found to correspond to the crystallins isolated from cataractous lenses 
(David et al., 1993). Incubation of bovine β-crystallins with calpain 2 also produced 
cleavage at the N-termini of βB1, βB2, βB3 and βA3 (Shih et al., 1998). Some of 
these truncation products were found in normal and aged bovine lenses.  
 
Incubation of β-crystallins with calpain 2 resulted in the formation of insoluble 
proteins which could be isolated by centrifugation (David et al., 1992). Increases in 
the proportion of insoluble protein are a hallmark of cataractous lenses. 
 
The purpose of these experiments is to observe the effect ovine calpain 1, 2 and Lp82 
have on ovine α and β-crystallin and cytoskeletal proteins and to determine the 
specific truncation points for each of these calpain isoforms. 
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5.2 Methods 
 
5.2.1 Crystallin incubations 
 
The purified calpains 1 and 2 (Chapter 2), were incubated with the purified crystallins 
(Chapter 3) according to Table 5-1. Two different controls were used with all the 
incubations; (i) a calcium control where the crystallins where incubated with calcium 
alone to determine if there was any endogenous protease activity in the crystallin 
samples, and (ii) a calpain control where the calcium chelator EDTA was added to the 
incubation mixture to determine if there was any non-calcium dependent protease 
activity. The calpain activity in each incubation was 82 Fluorescence Units (FU) 
(units released per minute using the BODIPY-FL casein assay) for calpain 1 and 164 
FU for calpain 2. 
 
 Calpain Crystallin Ca2+ EDTA pH 7.5 Total Volume 
Calpain  50μL 200μg 2mM X 200μL 
Calcium Control X 200μg 2mM X 200μL 
Calpain Control 50μL 200μg 2mM 4mM 200μL 
Table 5-1 Protocol for incubation of calpain 1 and 2 with the lens crystallins.  Concentrations 
given are the final concentrations in the incubation. 
 
The mixtures were incubated at 37ºC for 4 hours, the reaction was stopped with the 
addition of excess 100mM EDTA pH 7.5 and Minicomplete protease inhibitor (1 
tablet per 10ml) (Roche, Manneheim, Germany).  
 
The purified Lp82 still contained some residual α-crystallin after the final 
chromatography step (see Chapter 2). Therefore for the α-crystallin incubations, 
calcium was added directly, to a concentration of 2mM, to the Lp82 fraction which 
contained endogenous α-crystallin. The Lp82 fraction contained 22 FU of activity. 
This mixture was incubated at 37ºC for 4 hours and the reaction stopped as before. 
For the β-crystallin incubations 200μg of purified β-crystallin was added to the Lp82 
and incubated with 2mM calcium. Calcium and calpain controls were as for calpain 1 
and 2 (Table 5-1).  
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 To visualise the changes in α- and β-crystallin profiles after the calpain incubations, 
all the samples were separated and visualised by 2DE (4.2.3) 
 
5.2.2 Calpain 2 and Lp82 with cytoskeletal proteins  
 
Lens cytoskeletal proteins were isolated from a 4 month old lamb lens. The lens was 
dissected into cortical and nuclear regions. The cortex was homogenised in 3ml/g of 
Buffer A containing Minicomplete protease inhibitor (Roche, Manneheim, Germany). 
The insoluble proteins were isolated by centrifugation at 15000 x g for 1 hr at 4ºC. 
The supernatant containing the soluble proteins was discarded and the pellet 
containing the insoluble protein was washed three times with Buffer A to remove any 
residual soluble proteins. To isolate the cytoskeletal proteins the pellet was 
resuspended by sonication in 6M Urea. The urea soluble fraction (USF) was isolated 
by centrifugation at 15000 x g for 1 hr at 4ºC. The USF, containing the cytoskeletal 
proteins, was removed and the protein concentration determined using the BCA assay 
(3.2.3.4). 
 
To determine if Lp82 and calpain 2 can modify the lens cytoskeletal proteins, each 
was incubated with lens cytoskeletal proteins in the presence of calcium (Table 5-2). 
Calpain and calcium controls were performed as before (5.2.1). 164 FU of calpain 2 
was used and 22 FU of Lp82. The reaction was started with the addition of calcium, 
and incubated for 4 hours at 37ºC. The reaction was stopped with the addition 12.5μL 
of six times SDS loading buffer and the samples boiled for 5 minutes to denature the 
proteins. 
 
 Calpain Cytoskeletal 
Proteins 
Ca2+ EDTA pH 
7.5 
Total 
Volume 
Calpain (C2 or Lp82) 50μL 50μg 12mM X 62.5μL 
Calcium Control X 50μg 12mM X 62.5μL 
Calpain Control 50μL 50μg X 24mM 62.5μL 
Table 5-2 Protocol for incubation of calpain 2 an Lp82 with the lens cytoskeletal proteins. 
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To visualise the changes in the cytoskeletal proteins 1-DE SDS-PAGE was used. 
Fifteen micrograms of each sample was loaded on to a 4-12% NuPAGE® Novex® 
Bis-Tris Mini Gel (Invitrogen, Ca., USA) along with a molecular weight marker (All 
Blue Prestained Marker®, BioRad, Ca., USA). The gel was run at 200V for 50 min in 
NuPAGE® MOPS Running buffer in a XCell SureLock™ Mini-Cell. After running 
the gel was stained with Simply Blue™ Stain (Pierce, Il., USA).  Cytoskeletal 
proteins were identified by comparison to western blots by McDermott (2007). 
 
5.2.3 Insolubilisation of lens crystallins 
 
To determine if calpain 2 truncation of the crystallins could induce their 
insolubilisation, purified calpain 2 was incubated with whole soluble lens proteins in 
the presence of calcium and centrifugation used to pellet any insoluble protein 
produced.  
 
Calpain 2 was purified as per chapter 2 but without using the Phenyl Sepharose 
column and using Buffer C (20mM MOPS, 0.1mM EGTA and 2mM DTT) during the 
final step. Proteins were isolated from both normal and cataractous lenses. The lenses 
were homogenised in 3ml/g of Buffer C and centrifuged at 8000 x g for 15 min to 
separate the soluble and insoluble lens proteins. A BCA assay was used to determine 
the protein concentrations. The soluble proteins from the normal lens were incubated 
with calpain 2 as per Table 5-3, the samples were incubated for 2 hours and the 
reaction terminated using excess 100mM EDTA pH 7.5. Controls were performed as 
before (see 5.2.1). After termination of the incubation the insoluble proteins were 
separated by centrifugation at 8000 x g for 15 min. The pellet containing the insoluble 
protein was washed three times with Buffer C, and then resolubilsed by sonication in 
Buffer C and the amount of insoluble protein was determined using the BCA assay.  
 
 Calpain Lens Proteins Ca2+ EDTA Total Volume 
Calpain 2 83μL 100μg 5mM X 332μL 
Calcium Control X 100μg 5mM X 332μL 
Calpain Control 83μL 100μg 5mM 6mM 332μL 
Table 5-3 Protocol for incubation of calpain 2  with the total soluble lens proteins. 
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 To visualise the insoluble proteins produced after incubation 2DE was performed 
using the BioRad Criterion-XT system. First dimensional focusing used pH 3-10 non-
linear 11cm IPG strips (BioRad, Ca., USA), 100μg of protein was rehydrated in 
175μL of rehydration buffer (8M Urea, 2% CHAPS, 50mM DTT, 2% 3-10 Biolyte 
buffer (BioRad, Ca., USA) 2% Glycerol and 0.001% Bromophenol Blue) and added 
to each strip. Focussing was performed on a BioRad Protean IEF Cell for 33000Vh. 
Focussed IPG strips were stored at -20ºC until the second dimension was completed. 
Second dimension was performed on 12% XT-MES gels using the Criterion XT 
system (BioRad, Ca., USA) at 200 V for 45 min. The separated proteins were 
visualised with Simply Blue™ Stain (Pierce, Il.,, USA).  
 
5.2.4 Protein identification and mass spectrometry analysis 
 
Proteins were eluted from 2-DE gels and molecular mass determined as per (4.2.4) 
 
5.3 Results 
 
Incubation of calpain 1, 2 and Lp82 with the lens proteins resulted in truncation of 
some of the lens proteins. 
 
5.3.1 Calpain 2 
 
Purified calpain 2 (Chapter 2) was incubated with purified α- and β-crystallins 
(Chapter 3). This resulted in truncation of both the α- and β-crystallins.  
 
The incubation of calpain 2 with α-crystallin produced 15 truncations which were 
visible on 2DE (Figure 5-1 and Table 5-4). Proteolysis of αA crystallin by calpain 2 
produced 6 unique protein spots (CA1-6). The truncations removed 10-28 residues 
from the C-terminus of αA1-73, the truncations seen were αA1-162 (CA1), αA1-157 
(CA2), αA1-154 (CA3), αA1-151 (CA5) and αA1-145 (CA6). Calpain 2 also cleaved the 
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phosphorylated form of αA-crystallin 6 times (CA7-12). αA1-163+phos (CA12) was 
the only mass that could be measured, the masses for all of the other protein spots 
could not be determined directly. However, the mass and modification (Table 5-4) 
could be predicted from the equivalent protein species in the unphosphorylated form 
of αA, eg CA9 can be identified by comparison to CA3. Therefore all the 
modifications seen with the intact αA were also seen with αA+phos. The most 
prevalent truncation, based on size and intensity of the protein spot on 2DE, of αA 
and αA+phos were αA1-163 (CA4) and αA1-154 (CA3), which were missing 10 and 19 
amino acids respectively 
 
Calpain 2 truncated αB1-175 in two places, αB1-170 and αB1-163 (CA14 and CA15), 
missing 5 and 12 residue respectively from the C-terminus. The phosphorylated form 
of αB was also truncated by 5 residues (CA13). Calpain 2 truncated almost all of the 
αB crystallin so that only a small amount of intact αB and no αB-phos was present 
after incubation.   
 
 
Figure 5-1 Incubation of α-crystallin with calpain 2. Con) α-crystallin before incubation, C2) 
Control incubation with no calpain 2. αA, αA-phos, αB and αB-phos are labelled and all other 
spots are identified in Table 5-4. Molecular weight (MW) in kDa and pH range are as indicated. 
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Spot ID Mass (Da) Predicted Mass (Da) Modification 
αA αA 19874.0 19875.1 αA1-173
αA-phos αA 19954.5 19955.1 αA1-173+phos 
αB αB 20108.6 20108.8 αB1-175
αB-phos αB 20187.5 20188.8 αB1-175+phos 
CA1 αA 18720.0 18718.9 αA1-162
CA2 αA 18251.0 18251.3 αA1-157
CA3 αA 17879.3 17879.0 αA1-154
CA4 αA 18873.3 18875.1 αA1-163
CA5 αA 17614.3 17613.7 αA1-151
CA6 αA 17059.5 17059.1 αA1-145
CA7 αA N/A 18798.9 αA1-162+phos 
CA8 αA N/A 18331.3 αA1-157+phos 
CA9 αA N/A 17959.0 αA1-154+phos 
CA10 αA N/A 17693.7 αA1-151+phos 
CA11 αA N/A 17139.1 αA1-145+phos 
CA12 αA 18957.2 18955.1 αA1-163+phos 
CA13 αB N/A 19693.1 αB1-170+phos 
CA14 αB 19613 19613.1 αB1-170
CA15 αB 18860.0 18858.3 αB1-163
Table 5-4 Table of truncations of α-crystallin after incubation with calpain 2 (Figure 5-1) and 
calpain 1 (Figure 5-3). Proteins were identified by MALDI-TOF and masses were determined by 
whole mass measurement. N/A indicate spots where whole mass measurement was not able to be 
performed.  
 
Incubation of purified β-crystallin with purified calpain 2 resulted in truncation of  
βB1, βB3 and  βA3 (Figure 5-2). After incubation with calpain 2 the intact form of 
βB1 (spot 1) was not present, and there was an increase in the truncated forms of βB1 
(Box), the spots within the box could not be resolved or massed. Another crystallin 
that was truncated by calpain 2 is βB3 (8), both the intact and deamidated form (6) of 
βB3 were not present after calpain 2 incubation (Figure 5-2 C2). In the control sample 
before incubation there was a truncation product βB310-210 (11) already present. This 
gel spot increased in size and intensity following calpain incubation (Figure 5-2). In 
the control sample there were two truncation products of βA3 already present βA312-
215 and βA323-215 (12 and 13 respectively). After incubation with calpain 2 there is an 
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increase in the amount of βA312-215 (12) protein, but no increase in βA323-215. As a 
consequence of this increased truncation, the intact βA31-215 (4) was not present after 
incubation with calpain 2. Incubation with calpain 2 had no effect on βB2, βA4, βA2 
and βA1. 
 
 
Figure 5-2 Incubation of β-crystallin with purified calpain 2. Con) Control incubation with no 
calpain 2, C2) Incubation with calpain 2 and calcium. Spots are labelled as in Figure 4-4 and 
identified in Table 5-5. Molecular weight (MW) in kDa and pH range are as indicated. 
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Spot Protein (ID) Mass Bovine Equivalent 
1 βB1 28055.9 βB11-252
Box βB1 N/A N/A 
4 βA3 25572.3 βA31-215  
6 βB3 24323.8 βB31-210 Deamidation 
8 βB3 24321.9 βB31-210
9 βB2 23321.3 βB2  
11 βB3  23302.4 βB311-210
12 βA3/βA1 24212.1 βA312-215
13 βA3/βA1 23038.2 βA323-215
Table 5-5 Table of modifications to β-crystallins after incubation with calpain 2 (Figure 5-2). 
Masses were determined by whole mass measurement. Each spot was identified by MALDI-TOF 
analysis and comparison to total bovine cDNA from the lens except for βB3 which was compared 
to the known ovine sequence.  Bovine equivalent modifications were determined by comparison 
with Shih et al., (1998).  
  
5.3.2 Calpain 1 
 
Purified calpain 1 (Chapter 2) was incubated with purified α and β-crystallin (Chapter 
3). This resulted in truncation of the α and β-crystallins (Figure 5-3 and Figure 5-4).  
 
There were 13 truncations of the α-crystallins when incubated with calpain 1 and the 
protein profile was similar to that seen with calpain 2 (Figure 5-1 and Table 5-4).  
 
αA-crystallin was truncated five times to produce αA1-162 (CA1), αA1-157 (CA2), αA1-
154 (CA3), αA1-145 (CA6) and αA? (CAX). Once again the equivalent truncations were 
seen with the phosphorylated form of αA spots αA1-162+phos (CA7), αA1-157+phos 
(CA8), αA1-154+phos (CA9) and αA1-145+phos (CA11) (Figure 5-3 and Table 5-4). 
Comparing the calpain 1 and 2 incubations showed a number of differences. Firstly, 
spot αA1-151 (CA5) and αA1-151+phos (CA10) were not present in the Calpain 1 
sample, secondly that the major spot in the calpain 2 incubation, αA1-154 (Figure 5-1 
CA3) was only a minor spot in the calpain 1 incubation (Figure 5-3 CA3).  Thirdly, 
the presence of a new protein species (CAX), whose mass could not be measured, 
which was absent in the calpain 2 sample.  
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αB, once again, was only truncated twice. Firstly to produce αB1-170 (CA14) and the 
equivalent truncation on the phosphorylated form of αB-phos1-170 (CA13) and 
secondly, αB1-163 (CA15). These truncations were identical to those found with 
calpain 2. 
 
 
Figure 5-3 Incubation of calpain 1 with α-crystallin. Con) Control incubation with no calpain 1, 
CI) calpain 1 with α-crystallin and calcium. Spots labelled correspond to Table 5-4. The control 
gel was stained with Commassie blue and the lower gel with Zinc negative staining for greater 
sensitivity. 
 
Incubation of calpain 1 with the β-crystallins resulted in the truncation of βB1 and 
βA3 only (Figure 5-4). The intact form of βB1 (1) was decreased after incubation and 
four truncation products were observed (box) with each truncation missing amino 
acids from their N-terminus. The amount of the intact form of βA31-215 (4) decreased 
after incubation with calpain 1 and the truncation product βA312-215 (12) increased. 
 
Unlike calpain 2, calpain 1 had no effect on βB31-210. The intact form (8) and 
truncated βB311-210 (11) form were present in the same amounts before and after 
incubation with calpain 1. In contrast incubation with calpain 2 truncated βB3 (Figure 
5-2) (8) and the truncation product βB311-210 (11) increased after incubation. 
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 Figure 5-4 Incubation of β-crystallin with purified calpain 1. Con) Control incubation with no 
calpain 1, CI) Incubation of β-crystallin with calpain 1 and calcium. Spots are labelled as in 
Figure 4-4 and identified in Table 5-5 
 
5.3.3 Lp82 
 
Purified Lp82 was incubated with α and β-crystallin. The purified Lp82 was incubated 
with calcium and the endogenous α-crystallin from the purification procedure 
(Chapter 2) (Figure 5-5). Lp82 truncated αA in two places (L2) and the same 
truncation was seen in the phosphorylated form (L1). There was also another 
truncation, L3. The masses of the spots could not be determined. However the 
truncation αA1-168 can be tentatively applied by comparison to cataract gels and the 
literature (see 5.4.1). 
 
αB was truncated in only one place (L5) and the phosphorylated form of αB was 
truncated in the same place (L4). Again the masses of the spots could not be 
determined from these spots but by comparison to equivalent spots in other gels and 
comparison with the literature they were assigned αB1-170.  
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Figure 5-5 Incubation of Lp82 with α-crystallin, Con) Lp82 fraction without Ca2+, Lp82) Lp82 
and α-crystallin with Ca2+. Spots are identified and masses predicted in Table 5-6. 
 
Spot ID Mass Predicted Mass ID 
L1 αA N/A 19445.7 αA1-168
L2 αA N/A 19525.7 αA1-168+phos 
L3 αA N/A N/A N/A 
L4 αB N/A 19592.0 αB1-170+phos 
L5 αB N/A 19512.0 αB1-170
Table 5-6 Truncations of α-crystallin with Lp82. N/A indicate spots where whole mass 
measurement was not able to be performed. Modifications were determined by comparison to 
Ueda et al., (2002b) and previously run gels. 
 
Purified Lp82 was incubated with β-crystallin and truncated both βB1 (1) and βA3 (4) 
(Figure 5-6 and Table 5-5). The intact form of βB1 and the truncation product βB112-
252 (2) are less abundant in the Lp82 gel. Four new truncation products can be 
identified (Box) with each missing amino acids from their N-terminus. The intact 
form of βA3 (4) also decreased after incubation with Lp82 whilst the truncation 
product βA311-215 (12) increased. As found with calpain 1, Lp82 had no effect on βB3 
and the intact form (8) was present in the same amount before and after incubation. 
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The truncated form βB310-210 (11) had not increased. This was in contrast with calpain 
2 incubation where there was a decrease in βB3 and increase in βB310-210 (Figure 5-1). 
 
 
Figure 5-6 Incubation of Lp82 with β-crystallin. Con) Control incubation with no calcium, Lp82) 
Incubation with lp82 and calcium. Spots are labelled as in Figure 4-4 and identified in Table 5-5. 
 
5.3.4 Insolubilisation of lens proteins 
 
Incubation of calpain 2 with the soluble lens proteins resulted in the production of an 
insoluble protein pellet. The controls produced no pellet and consequently no 
insoluble protein was detected. Analysis of the insoluble proteins from the calpain 2 
incubations revealed a number of changes to the crystallins. Spot identifications were 
determined by comparing the 2DE pattern with patterns from previous calpain 
incubations with α-crystallin (Figure 5-1 and Table 5-4) and β-crystallins (Figure 5-2 
and Table 5-5) and cataractous 2DE gels (4.3.4). The soluble and insoluble proteins 
that were produced were compared directly to cataractous soluble and insoluble 
protein after being run on the same 2DE systems (see 5.2.3) 
 
The major crystallin modification found in the insoluble proteins produced after 
incubation with calpain 2 was truncation. The crystallins that were modified were αA, 
αB, βA3, βB3 and βB1.  
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The calpain 2 specific cleavage products αA1-162 (CA4)  and αA1-162+phos (CA12) 
(Figure 5-7 SC2, IC2) were found in both the insoluble and soluble fraction after 
incubation with calpain 2. The same truncations were found in the cataractous lenses 
(SCA, ICA A9). Other truncations of αA-crystallin seen after incubation with calpain 
2 were αA1-157 (CA2), αA1-154 (CA3), αA1-151 (CA5) and αA1-145 (CA6) and their 
phosphorylated equivalents αA1-157+phos (CA8), αA1-154+phos (CA9), αA1-151+phos 
(CA10) and αA1-145+phos (CA11).  
 
Calpain 2 truncated αB to produce the αB1-170 (CA14) (Figure 5-7 SC2, IC2) fragment 
which was seen in both the insoluble and soluble fraction after incubation. The same 
fragment was also found in the soluble and insoluble cataract (SCA, ICA A5). The 
equivalent truncation to the phosphorylated form of αB was found in the calpain 2 
incubation (SC2, IC2 CA13) and cataractous lenses (SCA, ICA A10). 
 
Amongst the β-crystallins only βB1, βA3 and βB3 were truncated by calpain 2. Intact 
βA3 (Figure 5-7 SC2, IC2 4) was absent from both the insoluble and soluble fractions 
of the crystallins after incubation with calpain 2.  The intact form of βB1 was also 
absent from the soluble and insoluble fractions of the calpain 2 incubation (1). 
Truncation products of βB1 were found in both the soluble and insoluble fraction of 
the calpain 2 incubations (Boxed area). Similar proteins were found in the soluble and 
insoluble cataract fractions (SCA and ICA boxed area). Another β-crystallin that is 
truncated by calpain 2 is βB3 (8). It is less abundant in the calpain 2 soluble and 
insoluble fractions and the truncation product βB310-210 (11) increased after incubation 
with calpain 2.  
 
There were no visible differences between the soluble and insoluble proteins 
produced after incubation with calpain 2.  
 Figure 5-7 2DE of total lens proteins. SN) Soluble protein from a normal lens, IN) Insoluble protein from a normal lens, SC2) soluble protein after incubation with 
calpain 2, IC2) Insoluble protein produced after incubation with calpain 2, SCA) Soluble protein from a cataractous lens, ICA) Insoluble protein from a 
cataractous lens. α-crystallins are labelled. CAX=α-crystallin species produced after incubation with calpain 2 Table 5-4. AX=α-crystallin species in cataractous 
lenses Table 4-5 . Numbers=β-crystallin species Table 5-5. Molecular weight (MW) in kDa and pH range are as indicated for SN gel only.  
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5.3.5 Cytoskeletal incubations 
 
The purified calpain 2 and Lp82 were incubated with the isolated cytoskeletal proteins 
and their profiles compared using SDS-PAGE (Figure 5-8). Both calpain 2 (Lane 1) 
and Lp82 (Lane 4) proteolysed spectrin, Lp82 produced breakdown fragments at 
150kDa, whereas calpain 2 produced smaller fragments at 130kDa. Filensin and 
vimentin were also proteolysed by calpain 2 and Lp82.  
 
 
Figure 5-8 4-12% SDS PAGE of Lens Cytoskeletal Proteins after incubation with Lp82 and 
Calpain 2.. Lane Mw: Molecular Weight marker, 1) Urea Soluble Fraction (USF) + Lp82 + Ca2+ 
2) USF + Lp82 – Ca2+ 3) USF – Lp82 + Ca2+ 4) USF +C2+ Ca2+ 5) USF +C2 – Ca2+, 6) USF only.  
Spectrin, Filensin, Vimentin and the crystallins were identified by comparison to Robertson et al., 
(2005) and McDermott, (2007). 
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5.4 Discussion 
 
During cataract formation some of the lens proteins are truncated, specifically α and β 
crystallins and the cytoskeletal proteins: spectrin, vimentin and filensin. Purified 
calpains were incubated with these proteins to determine whether members of the 
calpain family of proteases are responsible for the uncontrolled proteolytic cleavage 
seen in cataract formation. 
 
5.4.1 α-Crystallins incubated with the calpains 
 
Incubation of the α-crystallins with calpain 1, 2 and Lp82 resulted in truncation at the 
C-termini of both αA and αB-crystallin. Some of these truncations were the same as 
those found during lens maturation and cataractogenesis. Originally it was proposed 
that calpain 2 activity was responsible for the cleavage of α-crystallins seen in vivo 
(Yoshida et al., 1986). However since the discovery of the lens specific Lp82, there 
has been evidence that this is the major calpain isoform within the rat lens (Ueda et 
al., 2002b). Calpain 1, calpain 2 and Lp82 have all been found in sheep lenses 
(Robertson et al., 2008) 
 
In this present study Lp82 cleaved αA at two places but the masses of the products 
and therefore exact truncation sites could not be determined. The reported literature 
shows that Lp82 in vitro can remove 5 residues from the C-terminus of rat (Ueda et 
al., 2002b), mouse (Nakamura et al., 2000) and bovine (Ueda et al., 2001) αA-
crystallin to produce the fragment αA1-168. The seven C-terminal amino acids for all 
the above species are identical, 167PSSAPSS173, and Lp82 truncates between 
167PS/SA170. Ovine αA-crystallin (AY819022) has the same C-terminal residues 
167PSSAPSS173, showing that the Lp82 truncation site 167PS/SA170 is present. 
Therefore the truncation of αA by Lp82 in this study was assigned αA1-168, based on 
the literature, sequence analysis and the location of the spot on 2DE when compared 
to the αA1-168 species in the 2DE of cataract proteins (Figure 4-12 and Figure 4-13). 
This αA1-168 truncation was not observed with calpain 1 or calpain 2. The inability for 
calpain 2 to produce αA1-168 in vitro has been well documented in other species 
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(Yoshida et al., 1986, Nakamura et al., 2000, Ueda et al., 2001, Inomata et al., 2002, 
Ueda et al., 2002b). No αA1-168 was found in normal ovine lens of any age studied. 
αA1-168 has been found within the aged lenses of cattle (Takemoto, 1995b, Ueda et al., 
2001) and rats (Inomata et al., 2002, Ueda et al., 2002b). Interestingly, αA1-168 has 
been found in aged human lenses (Takemoto, 1995b) despite there being no Lp82 in 
human lenses due to the presence of a stop codon in the sequence (Fougerousse et al., 
2000). This suggests that there might be an Lp82 like protease in human lens, filling 
the role that Lp82 plays in other mammalian lenses. The Lp82 specific αA1-168 was 
found in stage 3 cataractous ovine lenses and onwards and was the major αA-
crystallin truncation product in the cataractous lenses. It is possible that the αA1-168 
species in the stage 1 lens was overshadowed by its parent protein αA, which resolves 
closely to αA1-168 (Figure 4-12 and Figure 4-13).  αA1-168 has been found at increased 
levels in the  Shimuya (Inomata et al., 2002) and selenite (Ueda et al., 2002b) rat 
cataracts. Although this was the only truncation seen with ovine Lp82, rat Lp82 has 
been shown to cleave the C-terminus of αA at multiple sites to produce αA1-165, αA1-
163, αA1-157, αA1-156 and αA1-151 (Ueda et al., 2002b).  
 
Incubation of calpain 2 with the α-crystallins produced multiple truncations of αA at 
the C-terminus with the removal of between 10-28 amino acids. Of particular interest 
is the truncation 1-162 with 11 residues removed, which has been shown to be an in 
vitro calpain 2 specific truncation with rat (Ueda et al., 2002b) and bovine (Yoshida et 
al., 1986, Ueda et al., 2001) calpain 2 and αA-crystallin . This provides a unique 
marker for calpain 2 activation within the lens. This truncation was not found in 
normal lenses at any age but was found in cataractous lenses from stages 3 and 6, 
showing that calpain 2 is active within the ovine cataract. However, αA1-162 is less 
abundant than other truncations within the cataractous ovine lens. Shimuya rat 
cataract (Inomata et al., 2002), selenite rat cataract (Ueda et al., 2002b) and buthinone 
sulphoximine mouse cataract (Nakamura et al., 2000), have all contained αA1-162 in 
the lens. The other calpain 2 truncations of αA include αA1-163, αA1-157, αA1-154, αA1-
151 and αA1-145. Some of these truncations namely, αA1-157, αA1-154, and αA1-151, were 
found in the fetal ovine lens and their levels increased as the age of the lens increased. 
Within the cataract lens there are increased levels of the calpain 2 truncation products, 
αA1-163 and αA1-151. This shows a role for calpain 2 within ovine cataractogenesis. 
However some of these protein species: αA1-163, αA1-157 and αA1-151 have also been 
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shown to be produced by Lp82 in the rat lens (Ueda et al., 2002b). These truncations  
were not observed with Lp82 in this study but this may be due to the limited amount 
of Lp82 that was purified and incubated with α-crystallins (22 FU for Lp82 compared 
with 162 FU for calpain 2). 
 
In this study calpain 1 also produced truncations in a similar position to that of calpain 
2 as observed by 2DE. Further analysis needs to be performed to determine if the 
truncations are the same truncations as are produced by calpain 2.  
 
All three calpains, when incubated with αB, produced the same truncation where 5 
residues were removed from the C-terminus to produce αB1-170. Calpain 2 also 
produced a second truncation removing 12 amino acids to produce αB1-163. αB1-170 
was found in normal, fetal and 6 month old ovine lenses but not in 8 year old ovine 
lenses. αB1-170 is a major component of the cataractous ovine lens, to the extent that it 
is the most prevalent form of αB in the USF of a stage 6 cataractous lens. This 
truncation has been well documented and occurs during lens maturation and 
cataractogenesis. Calpain 2 and Lp82 from rat (Ueda et al., 2002b) and bovine 
(Yoshida et al., 1986, Ueda et al., 2001) lenses both produce αB1-170. This truncation 
was found in the Shimuya rat cataract (Inomata et al., 1997a), selenite rat cataract 
(Ueda et al., 2002b) and ICR/f rat (Takeuchi et al., 2004) lenses. In human lenses 
αB1-170 has been found in normal lenses and at increased levels in lenses with 
Soemmerrings rings (Colvis et al., 2000). From these results it can be concluded that 
αB truncation in vivo could be attributed to any of the three calpains present within 
the ovine lens. 
 
When the calpains were incubated with the α-crystallins they also truncated the 
phosphorylated forms of αA and αB in the same place as the unmodified forms. There 
was no evidence of preference for either form of the α-crystallins which suggests that 
phosphorylation of target proteins has no effect on their proteolysis. 
 
As previously described, the C-terminal end of α-crystallin is important for chaperone 
function and truncation of this tail has a detrimental effect on α-crystallins (for more 
information see 3.4). Therefore, calpain truncation of the α-crystallins should reduce 
the chaperone function of the α-crystallins. This is supported by the research of Kelly, 
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et al., (1993) who showed that when calpain 2 was incubated with α-crystallin it 
reduced the chaperone function of α-crystallin to a similar level as that seen in the 
selenite cataract. 
 
In conclusion it appears that all three calpains present in the ovine lens, calpain 1, 2 
and Lp82, could be responsible for the truncation of α-crystallin observed during lens 
ageing and cataractogenesis. The majority of the truncations within the cataractous 
lens could be attributed to all three calpains. However, the most common, αA1-168 
found in the cataractous lens was produced only by Lp82. This suggests that Lp82 is 
the major calpain protease active in the ovine lens and responsible for the majority of 
the proteolytic damage. A similar conclusion was reached by Ueda et al., (2002b) in 
the selenite rat cataract. However the calpain 2 specific αA1-162 was also found in the 
ovine cataract, which means that calpain 2 could also be contributing to the 
cataractogenesis. Further investigation with calpain 1 needs to be performed before its 
exact role in ovine cataractogenesis can be determined.  
 
5.4.2 β-Crystallins incubated with the calpains 
 
All three calpains found in the lens truncated some of the β-crystallins. The three β-
crystallins affected by the calpains were βB1, βB3 and βA3. βB1 was truncated by all 
three calpains examined. Calpain 2, Lp82 and calpain 1 truncated βB1 to produce four 
truncation products but the masses of the spots could not be determined. The spots 
however, were in the same place as the four βB1 truncations found in the ovine 
cataractous lens (4.3.4.2). This would suggest that they are the same truncations as 
those that occur in cataractogenesis. Mass analysis will be needed to confirm this. The 
results show that activation of calpain 1, calpain 2 or Lp82 occurred during 
cataractogenesis, where they truncated the N-terminus of βB1, in a similar manner to 
that observed within the ovine cataract. In other species calpain 2 has been shown to 
truncate βB1 in multiple places. Bovine calpain 2 was shown in vitro to truncate βB1 
in two places to produce βB115-252 and βB112-252 (Shih et al., 1998). In humans, 
calpain 2 truncates βB1 and removes 47 residues from the N-terminus (Shih et al., 
2001). A similar truncation was found with rat calpain 2 which removed 49 residues 
(David and Shearer, 1993). Another rat calpain 2 truncation product is missing 27 
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residues (David et al., 1994).  None of these truncations were identified with any of 
the calpains studied in this research.  
 
βB3 is one of the major lens crystallins in the fetal lens and becomes increasingly 
truncated as the lens ages. Calpain 2 truncated all of the intact βB3 crystallin when 
incubated in the presence of calcium and consequently, no βB3 was left in the sample. 
Corresponding with this decrease in βB3 was an increase in the truncation product 
βB312-215. Neither calpain 1 nor Lp82 had a discernable effect on βB3. βB311-210 is 
found in fetal lenses and decreases as the lens ages, compared with cataract formation 
where it increases in abundance. The same results are seen with rat βB3 and calpain 2 
(David et al., 1994).  A second truncation was seen with rat calpain 2 in vitro which 
removed 5 residues from the N-terminus (David et al., 1994). These same two 
truncations, missing 5 and 10 amino acids, were found after incubation with bovine β-
crystallins and calpain 2 (Shih et al., 1998). The fact that βB311-210 increases as 
cataract formation progresses and that calpain 2 can produce this truncation provides 
convincing evidence that calpain 2 is involved in cataractogenesis within the ovine 
lens. 
 
The third β-crystallin that is truncated by the three lens calpains is βA3. After the β-
crystallins were incubated with calpain 2 there was complete disappearance of intact 
βA3 and with calpain 1 and Lp82 there was a reduction of intact βA3. This 
disappearance is seen during lens ageing and cataractogenesis in the ovine lens. 
Associated with the reduction in βA3 was an increase in βA312-215 with all of the three 
calpains. This truncation is already present in the fetal ovine lens and decreases as the 
lens ages. This decrease in βA3 and  βA312-215 is also seen during maturation of the 
bovine lens (Werten et al., 1999). In the ovine cataract there is a decrease in βA311-210 
as the opacity develops and there is an increase in the other truncation product of 
βA3, βA323-215. This second truncation was not observed with the calpain incubations. 
This suggests that a different protease could be responsible for this βA3 modification 
in vivo. Bovine calpain 2 also failed to produce this truncation (Shih et al., 1998) and 
a similar conclusion was reached by the authors. βA312-215 was produced in vitro with 
human (Shih et al., 2001) and rat (David et al., 1993, David et al., 1994) calpain 2 and 
it was also found in the selenite rat cataract (David and Shearer, 1993, David et al., 
1994). Lp82 also reduced the amount of intact βA3 which was accompanied by an 
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increase in βA312-215 after incubation with Lp82. Ueda et. al., in 2001 also showed 
that Lp82 could truncate βA3 at the same location. Thus the modification βA312-215 in 
vivo could be due to cleavage by any one of the three calpains, calpain 1, calpain 2 or 
Lp82.  
 
βB1, βB3 and βA3 were the only β-crystallins that were truncated by the calpains in 
this study. Researchers have found that the calpains also truncate βB2 in other 
species. In particular bovine, rat and human calpain 2 can remove seven amino acids 
from βB2 (Shih et al., 2001). This truncation was not observed with ovine calpain 2 
possibly due to it comigrating with βB311-210 on 2DE, which is where it was observed 
in the bovine lens 2DE and in previous ovine cataractous 2DE  (Robertson et al., 
2008).  
 
In conclusion the β-crystallins can be truncated by all three calpains found in the 
ovine lens and the observed truncations are similar as those found in the ovine 
cataract. As all three calpains produce the same modifications it is difficult to confirm 
which calpain is the most active and responsible for the modifications to the β-
crystallins within the ovine lens.  
 
5.4.3 Calpain 2 induced insolubilisation of the lens crystallins 
 
It has been proposed that after truncation by members of the calpain family the 
crystallins precipitate and become insoluble (David et al., 1993, Fukiage et al., 1997, 
Shih et al., 2001). When rat calpain 2 was incubated with the lens crystallins there 
was an increase in the insoluble protein within the sample. When this insoluble 
protein produced by calpain 2 was compared to the insoluble fraction of a selenite 
lens it was shown that the β-crystallins contained similar cleavage sites (David and 
Shearer, 1993). Rat and mouse crystallin solutions incubated with activated calpain 2 
showed an increase in light scatter as measured by an increase of absorbance. The 
increase in light scatter corresponded with an increase in the proteolytic cleavage of 
the β-crystallins (Fukiage et al., 1997). However no increase in light scatter was 
detected with guinea pig crystallins. Similar results experiments chicken, bovine or 
human crystallins showed that it was only rat crystallins that were susceptible to 
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calpain-induced insolubilisation (Shearer et al., 1996). Further work, however, 
showed that human, bovine and rat crystallins were susceptible to heat induced light 
scatter after incubation with calpain 2 (Shih et al., 2001). In this research calpain 2’s 
ability to insolublise the lens crystallins was studied. When purified calpain 2 was 
incubated with lens crystallins, insoluble protein was formed but no precipitate was 
seen when calcium or calpain was left out of the sample. This increase in insoluble 
protein corresponded with proteolytic cleavage of α and β-crystallin. The insoluble 
protein from the incubation had a similar profile to the insoluble protein from an 
ovine cataractous lenses on 2DE. This suggests that calpain 2 truncation in vivo could 
cause the increase in insoluble protein that is seen in the ovine cataract.  
 
5.4.4 Calpains and cytoskeletal proteins 
 
The cytoskeletal proteins within the lens are important for its structure and integrity. 
During ovine cataract formation there was breakdown of spectrin and vimentin 
(Robertson et al., 2005). In this study incubation of calpain 2 and Lp82 with the lens 
cytoskeletal proteins resulted in cleavage of spectrin, vimentin and filensin. Spectrin 
incubated with calpain 2 produced 130kDa breakdown products and Lp82 produced 
150kDa. Robertson et al., (2005) showed that during cataract formation there is a 
decrease in intact spectrin and in increase in the 145 and 150kDa breakdown products. 
These results would suggest that Lp82 alone is responsible for the formation of the 
145kDa and 150kDa products seen in cataracts. However calpain 2 has been 
previously shown to produce 145kDa and 150kDa truncations (Goll et al., 2003, 
McDermott, 2007) and in this study they may have been further broken down by 
calpain 2 (Yoshida et al., 1995). Vimentin was also broken down when incubated 
with calpain 2 and Lp82. Again in the ovine cataractous lens there is breakdown of 
vimentin (Robertson et al., 2005), in a similar pattern to that seen here in vitro. In this 
study there was breakdown of the cytoskeletal protein filensin by calpain 2 and Lp82. 
Breakdown of filensin was seen in cultured bovine and rat lenses after incubation with 
a calcium ionophore (Sanderson et al., 2000). In cultured ovine lenses, there is 
breakdown of spectrin, vimentin and filensin after incubation with a calcium 
ionophore (Lee et al., 2008). This is the first study to show that Lp82 can breakdown 
the cytoskeletal proteins spectrin, vimentin and filensin.  
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 These results show that calpain 2 and Lp82 have the ability to proteolyse cytoskeletal 
proteins. Previously it was thought that calpain 2 was responsible for the cytoskeletal 
truncation seen with ovine cataracts (Robertson et al., 2005, McDermott, 2007) but 
the results in this research suggest that Lp82 could also have a role in this breakdown. 
 
5.5 Conclusion 
 
In summary, all three calpains found in the ovine lens posses the ability to truncate the 
α and β-crystallins. Lp82 and calpain 2 produced unique truncations with αA-
crystallin. This provides important markers for the activation of these calpains within 
the lens. All three calpains truncated αB-crystallin in the same place. The β-crystallins 
that were truncated by the calpains were βB1, βB3 and βA3. βB1 and βA3 were 
truncated in the same place with all three calpains. The βA3 truncations were already 
present within the lens and were associated with lens maturation. Only calpain 2 
truncated βB3. Incubation of the WSF from a young lens with calpain 2 resulted in 
the truncation of the crystallins and the truncated crystallins became insoluble. 
Calpain 2 and Lp82 also truncated spectrin, vimentin and filensin which are 
cytoskeletal proteins within the lens. The profile of the truncated crystallins produced 
by incubating the crystallins with the calpains was similar to the truncated crystallin 
profile observed during cataract formation. 
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   Chapter 6 
Overall Conclusion and Future Directions 
 
6.1 Overall Conclusion 
 
Cataracts are the leading cause of blindness in the world. Understanding the 
biochemical mechanism that is responsible for this debilitating disease is essential for 
finding an alternative treatment to expensive surgery. This thesis explored changes in 
the protein of the ovine lens in ageing and cataractogenesis. It also determined 
possible mechanisms for the changes observed within the ovine lens proteins during 
cataractogenesis, specifically the involvement of the calpains in this process. 
 
Three calpains have been discovered within the ovine lens, the ubiquitous calpains 1 
and 2 and the lens specific calpain 3 splice variant, Lp82. In Chapter 3 all three of 
these calpains were purified. Calpain 1 and 2 were purified from ovine lung and Lp82 
from lamb lenses. This resulted in samples that were specific for each of the calpains. 
These samples were used for further experiments in Chapter 5.  
 
During lens maturation there are numerous biochemical changes to the lens proteins 
(Table 6-1, Table 6-2). Chapter 4 deals with the changes that occur to the crystallins 
during ageing. Lenses from fetal, 6 month and 8 year old sheep were analysed by 
2DE. The results showed that there is increased phosphorylation of the α-crystallin as 
the lens ages. They also showed that both α and β-crystallin undergo minor truncation 
during ageing of the lens. The truncation of the β-crystallins is believed to help the 
crystallins pack tightly within the lens and to aid in the formation of the refractive 
index.  
 
During cataractogenesis there are extensive changes to the lens proteins (Table 6-1, 
Table 6-2). Chapter 4 examined the changes in both the WSF and USF within 
cataractous lenses from stages 0-6. As the cataract progressed there was increased 
truncation of both α- and β-crystallin.  
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 Both αA and αB-crystallin were truncated at their C-termini. Removal of residues 
from the C-terminus of the α-crystallins has been shown to reduce their chaperone 
function. Thus it can be postulated that there is a decreased chaperone function within 
the ovine cataractous lens. Three β-crystallins, βB1, βA3 and βB3, truncated at their 
N-termini were observed at increased levels within the cataractous lens. Other 
research shows that truncation of the N-termini of the β-crystallins can lead to their 
insolubilisation and aggregation (David et al., 1992). Therefore within the cataractous 
lens there is an increased level of truncated β-crystallin which becomes insoluble and 
aggregate. This aggregation cannot be prevented by α-crystallin as it has a reduced 
chaperone function due to increased C-terminal truncation. As a result of Chapter 4 
the first hypotheses: “(i) the crystallin truncations seen in cataractogenesis are unique 
to this disease and different to the truncation seen with normal maturation of the lens” 
can be confirmed. 
 
One of the questions that arises from this research is what is causing this increased 
truncation within the cataractous lens. Previous work within this area has shown an 
increase in Ca2+ within cataractous lenses and it was proposed that this could activate 
the calcium dependent cysteine proteases; the calpains. 
 
The rest of this thesis dealt with the role that the three calpains found in the ovine lens 
have in the truncation of the crystallins. In Chapter 5, calpain 1, 2 and Lp82 purified 
from Chapter 3 were incubated in the presence of calcium with α and β-crystallin. It 
was found that all three calpains could proteolytically truncate the α-crystallins (Table 
6-1). Unique truncations for calpain 2 and Lp82 were found on αA-crystallin (αA1-162 
and αA1-168 respectively). Of the two unique truncations only αA1-168, the Lp82 
specific truncation was found in the cataractous lens. The other truncations of αA 
observed in the cataractous lens could only be produced in vitro by calpain 1 and 
calpain 2 and were not found with Lp82 incubation. This may be due to the limited 
amount of Lp82 activity that could be incubated with the α-crystallins (10 times less 
than calpain 2). Researchers in other species have found that Lp82 can cause the 
equivalent truncations. Therefore it could be concluded that all three calpains could 
truncate αA-crystallin in vivo but that Lp82 is possibly the most important calpain 
isoform in this process. All three calpains cleaved αB-crystallin at the same location 
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(αB1-170), therefore αB-crystallin truncation cannot be attributed to any single calpain 
isoform. 
 
Crystallin Maturation Cataract Calpain 1 Calpain 2 Lp82 
αA      
αA+phos      
αA1-154      
αA1-157      
αA1-151      
αA1-168      
αA1-163      
αA1-162      
αA1-145      
αB      
αB+phos      
αB1-174      
αB1-170      
αB1-163       
Table 6-1 Summary of α-crystallin and truncations.  Each crystallin species is listed on the left. 
Changes were assessed as either an increase (    ), decrease (    ) or no change (       ). For calpain 
incubations (       ) indicates that the protein species was found after incubation. For maturation 
changes assessed as differences from fetal to 8 year old lens 2DE. For cataract the changes were 
assessed as differences from stage 0-6 cataractous lenses. No symbol within indicates that the 
protein species was not found. 
 
Calpain 1, calpain 2 and Lp82 all truncated some of the β-crystallins (Table 6-2). βB1 
was cleaved in a similar manner by all three calpains but the exact truncations could 
not be determined. βA3 was truncated by all three calpains and only calpain 2 
truncated βB3. The same truncations of βB1 were found at increased levels during 
cataract formation and as all three calpains studied could truncate βB1 the isoform 
responsible for the in vivo truncation of βB1 can not be determined. 
 
Both calpain 2 and Lp82 were able to cleave the lens cytoskeletal proteins vimentin, 
spectrin and filensin. Proteolysis of lens cytoskeletal proteins is found in many 
models of cataract including the heritable ovine cataract. Chapter 5 also explored the 
effect truncation of the lens proteins had on their solubility. As mentioned previously 
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there is an increase in aggregated and insoluble protein during cataractogenesis. This 
research found that truncation of the lens crystallins by calpain 2 resulted in 
insolubilisation of some of the crystallin, demonstrating that crystallin truncation by 
calpain 2 could be responsible for the increase in insoluble protein in cataract lenses. 
 
Crystallin Maturation Cataract Calpain 1 Calpain 2 Lp82 
βB1      
βB2      
βB3      
βA1      
βA2      
βA3      
βA4      
βB116-252      
βB310-210      
βA312-215      
βA323-215      
βB110-252      
βB111-252      
βB113-252      
βB28-204      
Table 6-2 Summary of β-crystallin and truncations.  Each crystallin species is listed on the left. 
Changes were assessed as either an increase (    ), decrease (    ) or no change (     ). For 
maturation changes assessed as differences from fetal to 8 year old lens 2DE. For cataract the 
changes were assessed as differences from stage 0-6 cataractous lenses. For the incubations 
changes were assessed as differences before and after incubation. No symbol indicates that the 
protein species was not found. 
 
As a result of this research the second hypothesis “(ii) That incubation of calpains 1, 2 
and Lp82 with the crystallins will result in truncation of the crystallins in a similar 
manner to that seen in cataractogenesis” can be confirmed. However which calpain 
isoform is the causing the truncation in vivo will require further investigation. 
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αB1-170
No change 
with 
maturation 
or cataract
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Cataract 
Only C1, C2, Lp82
C1, C2
Lp82
αB1-163
αB+P1-170
αB1-174
αA1-154
αA1-157
αA1-163
αA1-168
αA1-162
αA1-145
αA1-151
αA+P1-168
αA+P1-163
αA+P1-162
αA+P1-151
αA+P1-145
αA+P1-154
αA+P1-157
αAαA+P
αB+P αB
Calpain only 
truncation
 
Figure 6-1 Schematic 2DE of the changes to α-crystallin during maturation, cataractogenesis and after incubation with the calpains. For a table of the results see 
(Table 6-1). Spots are coloured to indicate how species changes with maturation and cataractogenesis. Boxes indicate those species present after incubation with 
calpains. 
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Figure 6-2 Schematic 2DE of the changes to β-crystallin during maturation, cataractogenesis and after incubation with the calpains. For a table of the results see 
(Table 6-1). Spots are coloured to indicate how species changes with maturation and cataractogenesis. Boxes indicate those species present after incubation with 
calpains. Stars represent β-crystallins that are truncated by the calpains. 137
 
Analysis of the relative amounts of each calpain and their location may give an insight 
as to which calpain is truncating the crystallins in vivo. Robertson (2005) studied the 
levels of all three calpains in sheep lenses. It was found that all three calpains were 
present in the soluble cortex (where the cataract occurs) fraction up to 7 weeks of age. 
Calpain 2 was found to be the most abundant of the calpains. By 13 weeks of age only 
calpain 1 and calpain 2 were found in the soluble cortex fraction with calpain 2 being 
the most dominant isoform and only a small amount of calpain 1 being found. In the 
present research Lp82 was able to be extracted from lenses up to 16 weeks of age. By 
24 weeks of age only calpain 2 was found in the soluble cortex. Therefore all three 
calpains are present during early cataractogenesis and only calpain 2 is present in late 
cataractogenesis.  
Although calpain 2 is the most prominent calpain within the lens this does not 
necessarily mean that calpain 2 is the most active in vivo, as the calpains within the 
lens all have different calcium concentrations required for activation. Calpain 1 
requires 3-50μm, calpain 2 400-800μM and Lp82 20μM Ca2+ for half maximal 
activation in vitro. During cataractogenesis the calcium within the lens rises 10 fold 
from 0.42mM (stage 0) to 4.9mM (stage 6). Therefore all three calpains could be 
active within a stage 6 cataract. It would be logical to assume that as the calcium level 
within the lens rises first Lp82 and calpain 1 would become active followed by 
calpain 2 once the calcium rose to a sufficient concentration for activation. This could 
explain why there is more of the Lp82 specific truncation of αA-crystallin (αA1-168) 
within the ovine lens and why this truncation appears first in cataractogenesis. 
 
In conclusion this research has documented the changes in lens crystallin with 
maturation. It has also studied the progression of crystallin truncation through stages 
0-6 in the ovine cataract. Calpain 1, 2 and Lp82 were all shown to truncate the 
crystallins in vitro. Some of the truncations seen in vitro were the same as those in 
cataract lenses. Therefore it appears that uncontrolled proteolysis of the crystallins by 
a combination of all three calpains contribute to cataract formation in the ovine 
cataract.  
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6.2 Future Directions 
 
The most obvious research for the future would be to carry out further mass 
spectromic analysis to determine all of the truncations that are seen during ageing, 
cataractogenesis and incubation with the calpains. This would involve refining of the 
2DE protein extraction and mass spectromic protocols.  Conversely, the samples 
could be analysed directly with mass spectromic techniques without prior separation 
on 2DE. This would allow greater sensitivity and would give masses for many of the 
less abundant protein species. However one of the limitations of the direct approach is 
that quantifying the protein species is difficult. Determining the protein sequence for 
the ovine β and γ-crystallins would also be beneficial for this analysis.  
 
In the ovine cataract there are extensive changes to the α and β-crystallins, however 
little research has been carried out on the γ-crystallins and the changes with them 
during ageing and cataractogenesis. Therefore optimising the 2DE for γ-crystallins 
would provide an insight into any changes that occur with the γ-crystallins during 
ageing and cataractogenesis. Although in other species the calpains do not proteolyses 
the γ-crystallin it would be beneficial to test this with ovine γ-crystallins. 
 
The theory of cataract formation presented in this thesis suggests that C-terminal 
truncation of α-crystallin results in loss of the chaperone function of the α-crystallin in 
vivo. An obvious extension of this research would be to isolate the α-crystallin from 
cataractous lens and compare its chaperone ability to that of α-crystallin isolated from 
normal lenses. This could then be compared to the chaperone function of α-crystallin 
after truncation with the calpains.  
 
Mutating specific amino acids within the C-terminal extension of α-crystallin by site 
directed mutagenesis would allow the determination of which amino acids are 
important for calpain in choosing truncation position. This would also help in 
establishing why Lp82 has a different truncation site than calpains 1 and 2.  
 
At present only three calpains have been discovered within the ovine lens. There is 
evidence in other species for a fourth calpain, calpain 10 within the lens. Determining 
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if this calpain is present within the ovine lens could provide further evidence for the 
calpain theory of cataractogenesis. Biochemical analysis, in particular determination 
of the calcium concentration requirements of the three calpains studied here would 
provide further insight as to their activation within the ovine lens. 
 
At present the only way to determine if a sheep within the cataract flock has cataracts 
is by visual confirmation. Development of a genetic test which could predict which 
lambs will develop cataract would be a vital tool for further cataract research. It 
would mean that any changes with in the lens before clinical manifestation of the 
disease could by researched, in particular changes in the crystallins or other lens 
proteins that precedes cataract formation.  
 
This research showed that the calpains could truncate the cytoskeletal proteins. A 
logical step from this would be to analyse the cytoskeletal proteins from the ovine 
lens using 2DE and mass spectrometry. 
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